<!DOCTYPE HTML>
<html lang="en" class="sidebar-visible no-js rust">
    <head>
        <!-- Book generated using mdBook -->
        <meta charset="UTF-8">
        <title>Medical Summary</title>
        
        <meta name="robots" content="noindex" />
        
        


        <!-- Custom HTML head -->
        


        <meta content="text/html; charset=utf-8" http-equiv="Content-Type">
        <meta name="description" content="">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        <meta name="theme-color" content="#ffffff" />

        
        <link rel="icon" href="favicon.svg">
        
        
        <link rel="shortcut icon" href="favicon.png">
        
        <link rel="stylesheet" href="css/variables.css">
        <link rel="stylesheet" href="css/general.css">
        <link rel="stylesheet" href="css/chrome.css">
        
        <link rel="stylesheet" href="css/print.css" media="print">
        

        <!-- Fonts -->
        <link rel="stylesheet" href="FontAwesome/css/font-awesome.css">
        
        <link rel="stylesheet" href="fonts/fonts.css">
        

        <!-- Highlight.js Stylesheets -->
        <link rel="stylesheet" href="highlight.css">
        <link rel="stylesheet" href="tomorrow-night.css">
        <link rel="stylesheet" href="ayu-highlight.css">

        <!-- Custom theme stylesheets -->
        
        <link rel="stylesheet" href="src/custom.css">
        

        
    </head>
    <body>
        <!-- Provide site root to javascript -->
        <script type="text/javascript">
            var path_to_root = "";
            var default_theme = window.matchMedia("(prefers-color-scheme: dark)").matches ? "navy" : "rust";
        </script>

        <!-- Work around some values being stored in localStorage wrapped in quotes -->
        <script type="text/javascript">
            try {
                var theme = localStorage.getItem('mdbook-theme');
                var sidebar = localStorage.getItem('mdbook-sidebar');

                if (theme.startsWith('"') && theme.endsWith('"')) {
                    localStorage.setItem('mdbook-theme', theme.slice(1, theme.length - 1));
                }

                if (sidebar.startsWith('"') && sidebar.endsWith('"')) {
                    localStorage.setItem('mdbook-sidebar', sidebar.slice(1, sidebar.length - 1));
                }
            } catch (e) { }
        </script>

        <!-- Set the theme before any content is loaded, prevents flash -->
        <script type="text/javascript">
            var theme;
            try { theme = localStorage.getItem('mdbook-theme'); } catch(e) { }
            if (theme === null || theme === undefined) { theme = default_theme; }
            var html = document.querySelector('html');
            html.classList.remove('no-js')
            html.classList.remove('rust')
            html.classList.add(theme);
            html.classList.add('js');
        </script>

        <!-- Hide / unhide sidebar before it is displayed -->
        <script type="text/javascript">
            var html = document.querySelector('html');
            var sidebar = 'hidden';
            if (document.body.clientWidth >= 1080) {
                try { sidebar = localStorage.getItem('mdbook-sidebar'); } catch(e) { }
                sidebar = sidebar || 'visible';
            }
            html.classList.remove('sidebar-visible');
            html.classList.add("sidebar-" + sidebar);
        </script>

        <nav id="sidebar" class="sidebar" aria-label="Table of contents">
            <div class="sidebar-scrollbox">
                <ol class="chapter"><li class="chapter-item "><a href="genetics/index.html"><strong aria-hidden="true">1.</strong> Genetics</a><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><a href="genetics/01.html"><strong aria-hidden="true">1.1.</strong> Genetics Terms</a></li><li class="chapter-item "><a href="genetics/02.html"><strong aria-hidden="true">1.2.</strong> X-Linked Recessive Diseases</a></li><li class="chapter-item "><a href="genetics/03.html"><strong aria-hidden="true">1.3.</strong> Autosomal Dominant Diseases</a></li><li class="chapter-item "><a href="genetics/04.html"><strong aria-hidden="true">1.4.</strong> Autosomal Recessive Disease</a></li><li class="chapter-item "><a href="genetics/05.html"><strong aria-hidden="true">1.5.</strong> Trisomy (21, 18, and 13) &amp; Nondisjunction Genetics</a></li><li class="chapter-item "><a href="genetics/06.html"><strong aria-hidden="true">1.6.</strong> Prader-Willi vs. Angelman Syndrome</a></li><li class="chapter-item "><a href="genetics/07.html"><strong aria-hidden="true">1.7.</strong> Hardy-Weinberg Equations &amp; Genetics</a></li><li class="chapter-item "><a href="genetics/08.html"><strong aria-hidden="true">1.8.</strong> X-linked Pedigrees</a></li><li class="chapter-item "><a href="genetics/09.html"><strong aria-hidden="true">1.9.</strong> Trinucleotide Repeats</a></li></ol></li><li class="chapter-item "><a href="biochemistry/index.html"><strong aria-hidden="true">2.</strong> Biochemistry &amp; Molecular Science</a><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><a href="biochemistry/01.html"><strong aria-hidden="true">2.1.</strong> Notifiable Diseases</a></li><li class="chapter-item "><a href="biochemistry/02.html"><strong aria-hidden="true">2.2.</strong> P450 Enzyme System (Inducers, Inhibitors, &amp; Subtypes)</a></li><li class="chapter-item "><a href="biochemistry/03.html"><strong aria-hidden="true">2.3.</strong> Vitamins</a></li><li class="chapter-item "><a href="biochemistry/04.html"><strong aria-hidden="true">2.4.</strong> Glycolysis</a></li><li class="chapter-item "><a href="biochemistry/05.html"><strong aria-hidden="true">2.5.</strong> Pyruvate Pathways &amp; Metabolism</a></li><li class="chapter-item "><a href="biochemistry/06.html"><strong aria-hidden="true">2.6.</strong> TCA/Citric Acid (Krebs) Cycle</a></li><li class="chapter-item "><a href="biochemistry/07.html"><strong aria-hidden="true">2.7.</strong> Electron Transport Chain (Oxidative Phosphorylation)</a></li><li class="chapter-item "><a href="biochemistry/08.html"><strong aria-hidden="true">2.8.</strong> HMP Shunt (Pentose Pathway)</a></li><li class="chapter-item "><a href="biochemistry/09.html"><strong aria-hidden="true">2.9.</strong> Catecholamine Synthesis</a></li><li class="chapter-item "><a href="biochemistry/10.html"><strong aria-hidden="true">2.10.</strong> Amino Acids</a></li><li class="chapter-item "><a href="biochemistry/11.html"><strong aria-hidden="true">2.11.</strong> Urea Cycle</a></li><li class="chapter-item "><a href="biochemistry/12.html"><strong aria-hidden="true">2.12.</strong> Fatty Acid Synthesis</a></li><li class="chapter-item "><a href="biochemistry/13.html"><strong aria-hidden="true">2.13.</strong> Fatty Acid (Beta) Oxidation</a></li><li class="chapter-item "><a href="biochemistry/14.html"><strong aria-hidden="true">2.14.</strong> Ketone Body Synthesis</a></li><li class="chapter-item "><a href="biochemistry/15.html"><strong aria-hidden="true">2.15.</strong> Glutathione Pathways</a></li><li class="chapter-item "><a href="biochemistry/16.html"><strong aria-hidden="true">2.16.</strong> Metabolic Fuel &amp; Starvation</a></li><li class="chapter-item "><a href="biochemistry/17.html"><strong aria-hidden="true">2.17.</strong> Lipid Transport</a></li><li class="chapter-item "><a href="biochemistry/18.html"><strong aria-hidden="true">2.18.</strong> Familial Dyslipidemia’s</a></li><li class="chapter-item "><a href="biochemistry/19.html"><strong aria-hidden="true">2.19.</strong> Glycogen Storage Diseases</a></li><li class="chapter-item "><a href="biochemistry/20.html"><strong aria-hidden="true">2.20.</strong> Fructose Metabolism</a></li><li class="chapter-item "><a href="biochemistry/21.html"><strong aria-hidden="true">2.21.</strong> Galactose Metabolism</a></li><li class="chapter-item "><a href="biochemistry/22.html"><strong aria-hidden="true">2.22.</strong> Lysosomal Storage Diseases</a></li><li class="chapter-item "><a href="biochemistry/23.html"><strong aria-hidden="true">2.23.</strong> Alcohol Metabolism</a></li><li class="chapter-item "><a href="biochemistry/24.html"><strong aria-hidden="true">2.24.</strong> Types of Collagen</a></li></ol></li><li class="chapter-item "><a href="pharmacology/index.html"><strong aria-hidden="true">3.</strong> Pharmacology</a><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><a href="pharmacology/01.html"><strong aria-hidden="true">3.1.</strong> High Yield USMLE</a></li><li class="chapter-item "><a href="pharmacology/02.html"><strong aria-hidden="true">3.2.</strong> Pharmacodynamics and Weak Acids and Bases</a></li><li class="chapter-item "><a href="pharmacology/03.html"><strong aria-hidden="true">3.3.</strong> ADME and Pharmacokinetics</a></li><li class="chapter-item "><a href="pharmacology/04.html"><strong aria-hidden="true">3.4.</strong> Antibiotics, Cell Wall Inhibitors</a></li><li class="chapter-item "><a href="pharmacology/05.html"><strong aria-hidden="true">3.5.</strong> Antibiotics, Protein Synthesis Inhibitors</a></li><li class="chapter-item "><a href="pharmacology/06.html"><strong aria-hidden="true">3.6.</strong> Antibiotics, MISC</a></li><li class="chapter-item "><a href="pharmacology/07.html"><strong aria-hidden="true">3.7.</strong> Anti-Fungal Agents</a></li><li class="chapter-item "><a href="pharmacology/08.html"><strong aria-hidden="true">3.8.</strong> Anti-Tuberculosis Drugs</a></li><li class="chapter-item "><a href="pharmacology/09.html"><strong aria-hidden="true">3.9.</strong> Malaria</a></li><li class="chapter-item "><a href="pharmacology/10.html"><strong aria-hidden="true">3.10.</strong> Misc Parasites</a></li><li class="chapter-item "><a href="pharmacology/11.html"><strong aria-hidden="true">3.11.</strong> Anti-virals &amp; HIV</a></li><li class="chapter-item "><a href="pharmacology/12.html"><strong aria-hidden="true">3.12.</strong> Immunosuppressants</a></li><li class="chapter-item "><a href="pharmacology/13.html"><strong aria-hidden="true">3.13.</strong> Anti-Neoplastics</a></li><li class="chapter-item "><a href="pharmacology/14.html"><strong aria-hidden="true">3.14.</strong> Anticoagulants &amp; Antiplatelets</a></li><li class="chapter-item "><a href="pharmacology/15.html"><strong aria-hidden="true">3.15.</strong> Hematinics</a></li><li class="chapter-item "><a href="pharmacology/16.html"><strong aria-hidden="true">3.16.</strong> Anti-Hyperlipidemia Agents</a></li><li class="chapter-item "><a href="pharmacology/17.html"><strong aria-hidden="true">3.17.</strong> Diuretics</a></li><li class="chapter-item "><a href="pharmacology/18.html"><strong aria-hidden="true">3.18.</strong> Anti-Hypertensives</a></li><li class="chapter-item "><a href="pharmacology/19.html"><strong aria-hidden="true">3.19.</strong> Anti-Arrhythmics</a></li><li class="chapter-item "><a href="pharmacology/20.html"><strong aria-hidden="true">3.20.</strong> Inotropes, Heart Failure, and Anti-Angina</a></li><li class="chapter-item "><a href="pharmacology/21.html"><strong aria-hidden="true">3.21.</strong> Toxicology</a></li><li class="chapter-item "><a href="pharmacology/22.html"><strong aria-hidden="true">3.22.</strong> Alternative Medicine</a></li><li class="chapter-item "><a href="pharmacology/23.html"><strong aria-hidden="true">3.23.</strong> Rheumatoid Arthritis Pharmacology</a></li><li class="chapter-item "><a href="pharmacology/24.html"><strong aria-hidden="true">3.24.</strong> Gout Pharmacology</a></li><li class="chapter-item "><a href="pharmacology/25.html"><strong aria-hidden="true">3.25.</strong> Muscle Relaxants</a></li><li class="chapter-item "><a href="pharmacology/26.html"><strong aria-hidden="true">3.26.</strong> Dermatology</a></li><li class="chapter-item "><a href="pharmacology/27.html"><strong aria-hidden="true">3.27.</strong> NSAIDS and Prostaglandins</a></li><li class="chapter-item "><a href="pharmacology/28.html"><strong aria-hidden="true">3.28.</strong> Cholinergic Nervous System</a></li><li class="chapter-item "><a href="pharmacology/29.html"><strong aria-hidden="true">3.29.</strong> Adrenergic Nervous System</a></li><li class="chapter-item "><a href="pharmacology/30.html"><strong aria-hidden="true">3.30.</strong> Reproductive Pharmacology</a></li><li class="chapter-item "><a href="pharmacology/31.html"><strong aria-hidden="true">3.31.</strong> Pharmacology Asthma &amp; COPD</a></li><li class="chapter-item "><a href="pharmacology/32.html"><strong aria-hidden="true">3.32.</strong> Anti-Histamines</a></li><li class="chapter-item "><a href="pharmacology/33.html"><strong aria-hidden="true">3.33.</strong> Calcium Homeostasis</a></li><li class="chapter-item "><a href="pharmacology/34.html"><strong aria-hidden="true">3.34.</strong> Hypothalamic and Pituitary Agents</a></li><li class="chapter-item "><a href="pharmacology/35.html"><strong aria-hidden="true">3.35.</strong> Adrenocorticosteroids</a></li><li class="chapter-item "><a href="pharmacology/36.html"><strong aria-hidden="true">3.36.</strong> Thyroid Acting Agents</a></li><li class="chapter-item "><a href="pharmacology/37.html"><strong aria-hidden="true">3.37.</strong> Diabetes</a></li><li class="chapter-item "><a href="pharmacology/38.html"><strong aria-hidden="true">3.38.</strong> Nausea &amp; Vomiting</a></li><li class="chapter-item "><a href="pharmacology/39.html"><strong aria-hidden="true">3.39.</strong> Inflammatory Bowel Disease</a></li><li class="chapter-item "><a href="pharmacology/40.html"><strong aria-hidden="true">3.40.</strong> Constipation &amp; Diarrhea</a></li><li class="chapter-item "><a href="pharmacology/41.html"><strong aria-hidden="true">3.41.</strong> GERD Pharmacology</a></li><li class="chapter-item "><a href="pharmacology/42.html"><strong aria-hidden="true">3.42.</strong> Parkinson's Disease</a></li><li class="chapter-item "><a href="pharmacology/43.html"><strong aria-hidden="true">3.43.</strong> Anti-Epileptic Drugs</a></li><li class="chapter-item "><a href="pharmacology/44.html"><strong aria-hidden="true">3.44.</strong> Headaches</a></li><li class="chapter-item "><a href="pharmacology/45.html"><strong aria-hidden="true">3.45.</strong> Stimulants and Weight Loss</a></li><li class="chapter-item "><a href="pharmacology/46.html"><strong aria-hidden="true">3.46.</strong> Opioids</a></li><li class="chapter-item "><a href="pharmacology/47.html"><strong aria-hidden="true">3.47.</strong> Local Anesthetics</a></li><li class="chapter-item "><a href="pharmacology/48.html"><strong aria-hidden="true">3.48.</strong> General Anesthesia</a></li><li class="chapter-item "><a href="pharmacology/49.html"><strong aria-hidden="true">3.49.</strong> Drugs of Abuse &amp; Ethanol</a></li><li class="chapter-item "><a href="pharmacology/50.html"><strong aria-hidden="true">3.50.</strong> Anti-Anxiety / Sleep Pharmacology</a></li><li class="chapter-item "><a href="pharmacology/51.html"><strong aria-hidden="true">3.51.</strong> Bipolar (Lithium) Pharmacology</a></li><li class="chapter-item "><a href="pharmacology/52.html"><strong aria-hidden="true">3.52.</strong> Anti-Depressants</a></li><li class="chapter-item "><a href="pharmacology/53.html"><strong aria-hidden="true">3.53.</strong> Anti-Psychotics</a></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">4.</strong> Psychiatry</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">4.1.</strong> Dopamine Pathways, Antipsychotics, and EPS</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.2.</strong> Eating Disorders</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.3.</strong> Ego Defenses</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.4.</strong> Serotonin Syndrome vs. Neuroleptic Malignant Syndrome</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.5.</strong> Schizophrenia vs. Schizophreniform vs. Schizoaffective vs. Schizoid vs. Schizotypal</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.6.</strong> Bipolar Disorder: criteria, types, symptoms, and treatment</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.7.</strong> Somatoform Disorders (Somatic Symptom, Conversion, Illness Anxiety, Factitious, Malingering)</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.8.</strong> Major Depression and SSRI's/SNRI's</div></li><li class="chapter-item "><div><strong aria-hidden="true">4.9.</strong> Normal Grief vs. Pathologic Grief vs. Major Depression vs. Adjustment Disorder vs. Anxiety</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">5.</strong> Immunology</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">5.1.</strong> Blood Transfusion Reactions</div></li><li class="chapter-item "><div><strong aria-hidden="true">5.2.</strong> Chediak-Higashi vs. Chronic Granulomatous vs. Leukocyte Adhesion vs. Wiskott-Aldrich</div></li><li class="chapter-item "><div><strong aria-hidden="true">5.3.</strong> Autoantibodies Rapid Review</div></li><li class="chapter-item "><div><strong aria-hidden="true">5.4.</strong> Hypersensitivity</div></li><li class="chapter-item "><div><strong aria-hidden="true">5.5.</strong> HLA Subtypes &amp; Associations</div></li><li class="chapter-item "><div><strong aria-hidden="true">5.6.</strong> Transplant Rejection</div></li><li class="chapter-item "><div><strong aria-hidden="true">5.7.</strong> Vaccines</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">6.</strong> Neurology</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">6.1.</strong> Circle of Willis</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.2.</strong> Vertigo (Different Types, Dix-Hallpike Maneuver, Treatment)</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.3.</strong> Brain Tumors</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.4.</strong> Neuromuscular Junction</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.5.</strong> Weber vs. Rinne Test &amp; Conductive vs. Sensorineural Hearing Loss</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.6.</strong> Strokes &amp; The Rule of 4s</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.7.</strong> Upper vs. Lower Motor Neuron Lesions</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.8.</strong> Spinal Cord Pathways</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.9.</strong> Visual Field Defects</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.10.</strong> Neurocutaneous Disorders</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.11.</strong> Sleep (Cycle, EEG)</div></li><li class="chapter-item "><div><strong aria-hidden="true">6.12.</strong> Basal Ganglia (Direct vs. Indirect Pathways)</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">7.</strong> Ethics, Biostats, and Epidemiology</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">7.1.</strong> Core Ethical Principles</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.2.</strong> Capacity vs Competency</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.3.</strong> Informed Consent</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.4.</strong> EMTALA Laws</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.5.</strong> Sensitivity, Specificity, PPV, NPV</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.6.</strong> Case Control vs. Cohort Study</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.7.</strong> Emancipated Minors</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.8.</strong> Consent vs Assent</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.9.</strong> Next of Kin, Living Wills, &amp; Power of Attorney</div></li><li class="chapter-item "><div><strong aria-hidden="true">7.10.</strong> Ethics (USMLE/COMLEX Practice Questions)</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">8.</strong> Microbiology</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">8.1.</strong> Microbiology of Bioterrorism Agents</div></li><li class="chapter-item "><div><strong aria-hidden="true">8.2.</strong> Rabies Guidelines</div></li><li class="chapter-item "><div><strong aria-hidden="true">8.3.</strong> Coronavirus Disease 2019 (COVID-19)</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">9.</strong> Endocrinology</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">9.1.</strong> Adrenal Enzyme Deficiencies</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">10.</strong> Cardiovascular</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">10.1.</strong> Electrocardiograms (ECG)</div></li><li class="chapter-item "><div><strong aria-hidden="true">10.2.</strong> Vasculitis</div></li><li class="chapter-item "><div><strong aria-hidden="true">10.3.</strong> Chest Pain Rapid Review</div></li><li class="chapter-item "><div><strong aria-hidden="true">10.4.</strong> Heart Murmurs | Locations, Maneuvers, Buzzwords</div></li><li class="chapter-item "><div><strong aria-hidden="true">10.5.</strong> AV Blocks (1st, 2nd, and 3rd Degree)</div></li><li class="chapter-item "><div><strong aria-hidden="true">10.6.</strong> Types of Shock (Cardiogenic, Hypovolemic, Septic, Neurogenic, Anaphylactic)</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">11.</strong> Anatomy</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">11.1.</strong> Celiac Trunk Anatomy</div></li><li class="chapter-item "><div><strong aria-hidden="true">11.2.</strong> Lower Extremity Nerve Injuries</div></li><li class="chapter-item "><div><strong aria-hidden="true">11.3.</strong> Cranial Nerve Anatomy</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">12.</strong> MSK &amp; Skin</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">12.1.</strong> Dermatology</div></li><li class="chapter-item "><div><strong aria-hidden="true">12.2.</strong> Lymph Anatomy &amp; Drainage</div></li><li class="chapter-item "><div><strong aria-hidden="true">12.3.</strong> Anatomy on USMLE</div></li><li class="chapter-item "><div><strong aria-hidden="true">12.4.</strong> Upper Extremity Nerve Injuries</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">13.</strong> Renal</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">13.1.</strong> Acute Kidney Injury (AKI)</div></li><li class="chapter-item "><div><strong aria-hidden="true">13.2.</strong> Acid/Base</div></li><li class="chapter-item "><div><strong aria-hidden="true">13.3.</strong> Renal Tubular Acidosis</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">14.</strong> Reproductive &amp; Development</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">14.1.</strong> Polyhydramnios vs. Oligohydramnios</div></li><li class="chapter-item "><div><strong aria-hidden="true">14.2.</strong> Ovarian Pathology &amp; Tumors</div></li><li class="chapter-item "><div><strong aria-hidden="true">14.3.</strong> Epididymitis vs. Torsion vs. Hydrocele vs. Varicocele</div></li><li class="chapter-item "><div><strong aria-hidden="true">14.4.</strong> Ectoderm, Endoderm, &amp; Mesoderm</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">15.</strong> Respiratory</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">15.1.</strong> Obstructive vs. Restrictive Lung Disease</div></li><li class="chapter-item "><div><strong aria-hidden="true">15.2.</strong> Rales vs. Rhonchi</div></li><li class="chapter-item "><div><strong aria-hidden="true">15.3.</strong> CURB-65 Pneumonia Scale</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">16.</strong> Hematology &amp; Oncology</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">16.1.</strong> Anemia (Types, Findings, Lab Values)</div></li><li class="chapter-item "><div><strong aria-hidden="true">16.2.</strong> Bleeding Disorders (ITP vs TTP vs HUS vs DIC)</div></li><li class="chapter-item "><div><strong aria-hidden="true">16.3.</strong> Leukemia</div></li><li class="chapter-item "><div><strong aria-hidden="true">16.4.</strong> Coagulation Cascade</div></li><li class="chapter-item "><div><strong aria-hidden="true">16.5.</strong> Apoptosis (Intrinsic, Extrinsic Pathways) vs. Necrosis</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">17.</strong> Gastrointestinal (GI)</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">17.1.</strong> Crohn's vs. Ulcerative Colitis</div></li><li class="chapter-item "><div><strong aria-hidden="true">17.2.</strong> Cholecystitis vs. Cholelithiasis vs. Cholangitis vs. Choledocholithiasis</div></li><li class="chapter-item "><div><strong aria-hidden="true">17.3.</strong> Bilirubin</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">18.</strong> High Yield Images</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">18.1.</strong> 40 High Yield Images for USMLE (CT, X-Ray, Histology)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.2.</strong> High Yield Images (pt. 2)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.3.</strong> High Yield Images (pt. 3)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.4.</strong> High Yield Images (pt. 4)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.5.</strong> High Yield Images (pt. 5)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.6.</strong> High Yield Images (pt. 6)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.7.</strong> High Yield Images (pt. 7)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.8.</strong> High Yield Images (pt. 8)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.9.</strong> High Yield CT Scans (Part 1)</div></li><li class="chapter-item "><div><strong aria-hidden="true">18.10.</strong> High Yield CT Scans (Part 2)</div></li></ol></li><li class="chapter-item "><div><strong aria-hidden="true">19.</strong> Video Question Bank</div><a class="toggle"><div>❱</div></a></li><li><ol class="section"><li class="chapter-item "><div><strong aria-hidden="true">19.1.</strong> Question #1</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.2.</strong> Question #2</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.3.</strong> Question #3</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.4.</strong> Question #4</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.5.</strong> Question #5</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.6.</strong> Question #6</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.7.</strong> Question #7</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.8.</strong> Question #8</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.9.</strong> Question #9</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.10.</strong> Question #10</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.11.</strong> Question #11</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.12.</strong> Question #14</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.13.</strong> Question #15</div></li><li class="chapter-item "><div><strong aria-hidden="true">19.14.</strong> Question #16</div></li></ol></li></ol>
            </div>
            <div id="sidebar-resize-handle" class="sidebar-resize-handle"></div>
        </nav>

        <div id="page-wrapper" class="page-wrapper">

            <div class="page">
                
                <div id="menu-bar-hover-placeholder"></div>
                <div id="menu-bar" class="menu-bar sticky bordered">
                    <div class="left-buttons">
                        <button id="sidebar-toggle" class="icon-button" type="button" title="Toggle Table of Contents" aria-label="Toggle Table of Contents" aria-controls="sidebar">
                            <i class="fa fa-bars"></i>
                        </button>
                        <button id="theme-toggle" class="icon-button" type="button" title="Change theme" aria-label="Change theme" aria-haspopup="true" aria-expanded="false" aria-controls="theme-list">
                            <i class="fa fa-paint-brush"></i>
                        </button>
                        <ul id="theme-list" class="theme-popup" aria-label="Themes" role="menu">
                            <li role="none"><button role="menuitem" class="theme" id="light">Light</button></li>
                            <li role="none"><button role="menuitem" class="theme" id="rust">Rust (default)</button></li>
                            <li role="none"><button role="menuitem" class="theme" id="coal">Coal</button></li>
                            <li role="none"><button role="menuitem" class="theme" id="navy">Navy</button></li>
                            <li role="none"><button role="menuitem" class="theme" id="ayu">Ayu</button></li>
                        </ul>
                        
                        <button id="search-toggle" class="icon-button" type="button" title="Search. (Shortkey: s)" aria-label="Toggle Searchbar" aria-expanded="false" aria-keyshortcuts="S" aria-controls="searchbar">
                            <i class="fa fa-search"></i>
                        </button>
                        
                    </div>

                    <h1 class="menu-title">Medical Summary</h1>

                    <div class="right-buttons">
                        
                        <a href="print.html" title="Print this book" aria-label="Print this book">
                            <i id="print-button" class="fa fa-print"></i>
                        </a>
                        
                        
                        <a href="https://github.com/easys7/med" title="Git repository" aria-label="Git repository">
                            <i id="git-repository-button" class="fa fa-github"></i>
                        </a>
                        
                    </div>
                </div>

                
                <div id="search-wrapper" class="hidden">
                    <form id="searchbar-outer" class="searchbar-outer">
                        <input type="search" name="search" id="searchbar" name="searchbar" placeholder="Search this book ..." aria-controls="searchresults-outer" aria-describedby="searchresults-header">
                    </form>
                    <div id="searchresults-outer" class="searchresults-outer hidden">
                        <div id="searchresults-header" class="searchresults-header"></div>
                        <ul id="searchresults">
                        </ul>
                    </div>
                </div>
                

                <!-- Apply ARIA attributes after the sidebar and the sidebar toggle button are added to the DOM -->
                <script type="text/javascript">
                    document.getElementById('sidebar-toggle').setAttribute('aria-expanded', sidebar === 'visible');
                    document.getElementById('sidebar').setAttribute('aria-hidden', sidebar !== 'visible');
                    Array.from(document.querySelectorAll('#sidebar a')).forEach(function(link) {
                        link.setAttribute('tabIndex', sidebar === 'visible' ? 0 : -1);
                    });
                </script>

                <div id="content" class="content">
                    <main>
                        <h1 id="a-hrefhttpsenwikipediaorgwikigeneticsgeneticsa"><a class="header" href="#a-hrefhttpsenwikipediaorgwikigeneticsgeneticsa"><a href="https://en.wikipedia.org/wiki/Genetics">Genetics</a></a></h1>
<h1 id="genetics-terms"><a class="header" href="#genetics-terms">Genetics Terms</a></h1>
<p><img src="https://s3-us-west-2.amazonaws.com/courses-images-archive-read-only/wp-content/uploads/sites/403/2015/04/21032024/2921_Neonatal_Circulatory_System.jpg" alt="" /></p>
<h1 id="a-hrefhttpsenwikipediaorgwikix-linked_recessive_inheritancex-linked-recessive-diseasesa"><a class="header" href="#a-hrefhttpsenwikipediaorgwikix-linked_recessive_inheritancex-linked-recessive-diseasesa"><a href="https://en.wikipedia.org/wiki/X-linked_recessive_inheritance">X-Linked Recessive Diseases</a></a></h1>
<h3 id="most-common"><a class="header" href="#most-common">Most common</a></h3>
<p>The most common X-linked recessive disorders are:</p>
<ul>
<li><a href="https://en.wikipedia.org/wiki/Red%E2%80%93green_color_blindness">Red–green color blindness</a>, a very common trait in humans and frequently used to explain X-linked disorders. Between seven and ten percent of men and 0.49% to 1% of women are affected. Its commonness may be explained by its relatively benign nature. It is also known as daltonism.</li>
<li><a href="https://en.wikipedia.org/wiki/Hemophilia_A">Hemophilia A</a>, a <a href="https://en.wikipedia.org/wiki/coagulation">blood clotting</a> disorder caused by a <a href="https://en.wikipedia.org/wiki/mutation">mutation</a> of the <a href="https://en.wikipedia.org/wiki/Factor_VIII">Factor VIII</a> <a href="https://en.wikipedia.org/wiki/gene">gene</a> and leading to a deficiency of Factor VIII. It was once thought to be the &quot;royal disease&quot; found in the descendants of Queen Victoria. This is now known to have been Hemophilia B (see below).</li>
<li><a href="https://en.wikipedia.org/wiki/Hemophilia_B">Hemophilia B</a>, also known as Christmas disease, a <a href="https://en.wikipedia.org/wiki/coagulation">blood clotting</a> disorder caused by a <a href="https://en.wikipedia.org/wiki/mutation">mutation</a> of the <a href="https://en.wikipedia.org/wiki/Factor_IX">Factor IX</a> <a href="https://en.wikipedia.org/wiki/gene">gene</a> and leading to a deficiency of Factor IX. It is rarer than <a href="https://en.wikipedia.org/wiki/hemophilia_A">hemophilia A</a>. As noted above, it was <a href="https://en.wikipedia.org/wiki/Haemophilia_in_European_royalty">common</a> among the descendants of Queen Victoria.</li>
<li><a href="https://en.wikipedia.org/wiki/Duchenne_muscular_dystrophy">Duchenne muscular dystrophy</a>, which is associated with mutations in the <a href="https://en.wikipedia.org/wiki/dystrophin">dystrophin</a> gene. It is characterized by rapid progression of muscle degeneration, eventually leading to loss of skeletal muscle control, respiratory failure, and death.</li>
<li><a href="genetics/Becker&#x27;https://en.wikipedia.org/wiki/s_muscular_dystrophy">Becker's muscular dystrophy</a>, a milder form of Duchenne, which causes slowly progressive muscle weakness of the legs and <a href="https://en.wikipedia.org/wiki/pelvis">pelvis</a>.</li>
<li><a href="https://en.wikipedia.org/wiki/X-linked_ichthyosis">X-linked ichthyosis</a>, a form of <a href="https://en.wikipedia.org/wiki/ichthyosis">ichthyosis</a> caused by a <a href="https://en.wikipedia.org/wiki/genetic_disorder">hereditary deficiency</a> of the <a href="https://en.wikipedia.org/wiki/steroid_sulfatase">steroid sulfatase</a> (STS) enzyme. It is fairly rare, affecting one in 2,000 to one in 6,000 males.</li>
<li><a href="https://en.wikipedia.org/wiki/X-linked_agammaglobulinemia">X-linked agammaglobulinemia</a> (XLA), which affects the body's ability to fight infection. XLA patients do not generate mature <a href="https://en.wikipedia.org/wiki/B_cell">B cells</a>. B cells are part of the immune system and normally manufacture antibodies (also called <a href="https://en.wikipedia.org/wiki/immunoglobulin">immunoglobulins</a>) which defends the body from infections (the <a href="https://en.wikipedia.org/wiki/humoral">humoral</a> response). Patients with untreated XLA are prone to develop serious and even fatal infections.</li>
<li><a href="https://en.wikipedia.org/wiki/Glucose-6-phosphate_dehydrogenase_deficiency">Glucose-6-phosphate dehydrogenase deficiency</a>, which causes nonimmune hemolytic anemia in response to a number of causes, most commonly infection or exposure to certain medications, chemicals, or foods. Commonly known as &quot;favism&quot;, as it can be triggered by chemicals existing naturally in broad (or fava) beans.</li>
</ul>
<h3 id="less-common-disorders"><a class="header" href="#less-common-disorders">Less common disorders</a></h3>
<p>Theoretically, a mutation in any of the <a href="https://en.wikipedia.org/wiki/Category:Genes_on_human_chromosome_X">genes on chromosome X</a> may cause disease, but below are some notable ones, with short description of symptoms:</p>
<ul>
<li><a href="https://en.wikipedia.org/wiki/Adrenoleukodystrophy">Adrenoleukodystrophy</a>; leads to progressive brain damage, failure of the adrenal glands and eventually death.</li>
<li><a href="https://en.wikipedia.org/wiki/Alport_syndrome">Alport syndrome</a>; glomerulonephritis, endstage kidney disease, and hearing loss. A minority of Alport syndrome cases are due to an autosomal recessive mutation in the gene coding for <a href="https://en.wikipedia.org/wiki/type_IV_collagen">type IV collagen</a>.</li>
<li><a href="https://en.wikipedia.org/wiki/Androgen_insensitivity_syndrome">Androgen insensitivity syndrome</a>; variable degrees of undervirilization and/or infertility in XY persons of either sex</li>
<li><a href="https://en.wikipedia.org/wiki/Barth_syndrome">Barth syndrome</a>; metabolism distortion, delayed motor skills, stamina deficiency, hypotonia, chronic fatigue, delayed growth, cardiomyopathy, and compromised immune system.</li>
<li><a href="https://en.wikipedia.org/wiki/Blue_cone_monochromacy">Blue cone monochromacy</a>; low vision acuity, color blindness, photophobia, infantile nystagmus.</li>
<li><a href="https://en.wikipedia.org/wiki/Centronuclear_myopathy">Centronuclear myopathy</a>; where cell nuclei are abnormally located in skeletal muscle cells. In CNM the nuclei are located at a position in the center of the cell, instead of their normal location at the periphery.</li>
<li><a href="https://en.wikipedia.org/wiki/Charcot%E2%80%93Marie%E2%80%93Tooth_disease">Charcot–Marie–Tooth disease (CMTX2-3)</a>; disorder of nerves (neuropathy) that is characterized by loss of muscle tissue and touch sensation, predominantly in the feet and legs but also in the hands and arms in the advanced stages of disease.</li>
<li><a href="https://en.wikipedia.org/wiki/Coffin%E2%80%93Lowry_syndrome">Coffin–Lowry syndrome</a>; severe mental retardation sometimes associated with abnormalities of growth, cardiac abnormalities, kyphoscoliosis as well as auditory and visual abnormalities.</li>
<li><a href="https://en.wikipedia.org/wiki/Fabry_disease">Fabry disease</a>; A lysosomal storage disease causing anhidrosis, fatigue, angiokeratomas, burning extremity pain and ocular involvement.</li>
<li><a href="https://en.wikipedia.org/wiki/Hunter_syndrome">Hunter syndrome</a>; potentially causing hearing loss, thickening of the heart valves leading to a decline in cardiac function, obstructive airway disease, sleep apnea, and enlargement of the liver and spleen.</li>
<li><a href="https://en.wikipedia.org/wiki/Hypohidrotic_ectodermal_dysplasia">Hypohidrotic ectodermal dysplasia</a>, presenting with hypohidrosis, hypotrichosis, hypodontia</li>
<li><a href="https://en.wikipedia.org/wiki/Kabuki_syndrome">Kabuki syndrome</a> (the <em><a href="https://en.wikipedia.org/wiki/KDM6A">KDM6A</a></em> variant); multiple congenital anomalies and mental retardation.</li>
<li><a href="https://en.wikipedia.org/wiki/Spinal_and_bulbar_muscular_atrophy">Spinal and bulbar muscular atrophy</a>; muscle cramps and progressive weakness</li>
<li><a href="https://en.wikipedia.org/wiki/Lesch%E2%80%93Nyhan_syndrome">Lesch–Nyhan syndrome</a>; neurologic dysfunction, cognitive and behavioral disturbances including self-mutilation, and uric acid overproduction (hyperuricemia)</li>
<li><a href="https://en.wikipedia.org/wiki/Lowe_syndrome">Lowe syndrome</a>; hydrophthalmia, cataracts, intellectual disabilities, aminoaciduria, reduced renal ammonia production and vitamin D-resistant rickets</li>
<li><a href="https://en.wikipedia.org/wiki/Menkes_disease">Menkes disease</a>; sparse and coarse hair, growth failure, and deterioration of the nervous system</li>
<li><a href="https://en.wikipedia.org/wiki/Nasodigitoacoustic_syndrome">Nasodigitoacoustic syndrome</a>; misshaped nose, <a href="https://en.wikipedia.org/wiki/brachydactyly">brachydactyly</a> of the <a href="https://en.wikipedia.org/wiki/distal_phalanges">distal phalanges</a>, sensorineural deafness</li>
<li><a href="https://en.wikipedia.org/wiki/Nonsyndromic_deafness">Nonsyndromic deafness</a>; hearing loss</li>
<li><a href="https://en.wikipedia.org/wiki/Norrie_disease">Norrie disease</a>; cataracts, leukocoria along with other developmental issues in the eye</li>
<li><a href="https://en.wikipedia.org/wiki/Occipital_horn_syndrome">Occipital horn syndrome</a>; deformations in the skeleton</li>
<li><a href="https://en.wikipedia.org/wiki/Ocular_albinism">Ocular albinism</a>; lack of pigmentation in the eye</li>
<li><a href="https://en.wikipedia.org/wiki/Ornithine_transcarbamylase_deficiency">Ornithine transcarbamylase deficiency</a>; developmental delay and mental retardation. Progressive liver damage, skin lesions, and brittle hair may also be seen</li>
<li><a href="https://en.wikipedia.org/wiki/Siderius_X-linked_mental_retardation_syndrome">Siderius X-linked mental retardation syndrome</a>; cleft lip and palate with mental retardation and facial dysmorphism, caused by mutations in the histone demethylase <a href="https://en.wikipedia.org/wiki/PHF8">PHF8</a></li>
<li><a href="https://en.wikipedia.org/wiki/Simpson%E2%80%93Golabi%E2%80%93Behmel_syndrome">Simpson–Golabi–Behmel syndrome</a>; coarse faces with protruding jaw and tongue, widened nasal bridge, and upturned nasal tip</li>
<li><a href="https://en.wikipedia.org/wiki/Spinal_muscular_atrophy">Spinal muscular atrophy</a> caused by <a href="https://en.wikipedia.org/wiki/UBE1">UBE1</a> gene mutation; weakness due to loss of the motor neurons of the spinal cord and brainstem</li>
<li><a href="https://en.wikipedia.org/wiki/Wiskott%E2%80%93Aldrich_syndrome">Wiskott–Aldrich syndrome</a>; eczema, thrombocytopenia, immune deficiency, and bloody diarrhea</li>
<li><a href="https://en.wikipedia.org/wiki/X-linked_severe_combined_immunodeficiency">X-linked severe combined immunodeficiency</a> (SCID); infections, usually causing death in the first years of life</li>
<li><a href="https://en.wikipedia.org/wiki/X-linked_sideroblastic_anemia">X-linked sideroblastic anemia</a>; skin paleness, fatigue, dizziness and enlarged spleen and liver.</li>
</ul>
<h1 id="a-hrefhttpsenwikipediaorgwikicategoryautosomal_dominant_disordersautosomal-dominant-diseasesa"><a class="header" href="#a-hrefhttpsenwikipediaorgwikicategoryautosomal_dominant_disordersautosomal-dominant-diseasesa"><a href="https://en.wikipedia.org/wiki/Category:Autosomal_dominant_disorders">Autosomal Dominant Diseases</a></a></h1>
<h3 id="more-important-examples"><a class="header" href="#more-important-examples">More important examples</a></h3>
<ul>
<li><a href="https://en.wikipedia.org/wiki/Von_Hippel%E2%80%93Lindau_disease">Von Hippel–Lindau disease</a></li>
<li><a href="https://en.wikipedia.org/wiki/Von_Willebrand_disease">Von Willebrand disease</a></li>
<li><a href="https://en.wikipedia.org/wiki/Amyotrophic_lateral_sclerosis">Amyotrophic lateral sclerosis</a></li>
<li><a href="https://en.wikipedia.org/wiki/Retinoblastoma">Retinoblastoma</a></li>
<li><a href="https://en.wikipedia.org/wiki/Multiple_endocrine_neoplasia">Multiple endocrine neoplasia</a></li>
<li><a href="https://en.wikipedia.org/wiki/Tuberous_sclerosis">Tuberous sclerosis</a></li>
<li><a href="https://en.wikipedia.org/wiki/Hereditary_spherocytosis">Hereditary spherocytosis</a></li>
<li><a href="https://en.wikipedia.org/wiki/Huntington%27s_disease">Huntington's disease</a></li>
<li><a href="https://en.wikipedia.org/wiki/Marfan_syndrome">Marfan syndrome</a></li>
<li><a href="https://en.wikipedia.org/wiki/Ehlers%E2%80%93Danlos_syndromes">Ehlers–Danlos syndromes</a></li>
<li><a href="https://en.wikipedia.org/wiki/Neurofibromatosis">Neurofibromatosis</a></li>
<li><a href="https://en.wikipedia.org/wiki/Familial_adenomatous_polyposis">Familial adenomatous polyposis</a></li>
</ul>
<h1 id="a-hrefhttpsenwikipediaorgwikicategoryautosomal_recessive_disordersautosomal-recessive-diseasea"><a class="header" href="#a-hrefhttpsenwikipediaorgwikicategoryautosomal_recessive_disordersautosomal-recessive-diseasea"><a href="https://en.wikipedia.org/wiki/Category:Autosomal_recessive_disorders">Autosomal Recessive Disease</a></a></h1>
<h3 id="more-important-examples-1"><a class="header" href="#more-important-examples-1">More important examples</a></h3>
<ul>
<li><a href="https://en.wikipedia.org/wiki/Alpha-1_antitrypsin_deficiency">Alpha-1 antitrypsin deficiency</a></li>
<li><a href="https://en.wikipedia.org/wiki/Beta_thalassemia">Beta thalassemia</a></li>
<li><a href="https://en.wikipedia.org/wiki/Phenylketonuria">Phenylketonuria</a></li>
<li><a href="https://en.wikipedia.org/wiki/Hereditary_haemochromatosis">Hereditary haemochromatosis</a></li>
<li><a href="https://en.wikipedia.org/wiki/Wilson%27s_disease">Wilson's disease</a></li>
<li><a href="https://en.wikipedia.org/wiki/Bernard%E2%80%93Soulier_syndrome">Bernard–Soulier syndrome</a></li>
<li><a href="https://en.wikipedia.org/wiki/Hartnup_disease">Hartnup disease</a></li>
<li><a href="https://en.wikipedia.org/wiki/Glanzmann%27s_thrombasthenia">Glanzmann's thrombasthenia</a></li>
<li><a href="https://en.wikipedia.org/wiki/Fanconi_syndrome">Fanconi syndrome</a></li>
</ul>
<h1 id="trisomy-21-18-and-13--nondisjunction-genetics"><a class="header" href="#trisomy-21-18-and-13--nondisjunction-genetics">Trisomy (21, 18, and 13) &amp; Nondisjunction Genetics</a></h1>
<h1 id="prader-willi-vs-angelman-syndrome"><a class="header" href="#prader-willi-vs-angelman-syndrome">Prader-Willi vs. Angelman Syndrome</a></h1>
<h1 id="hardy-weinberg-equations--genetics"><a class="header" href="#hardy-weinberg-equations--genetics">Hardy-Weinberg Equations &amp; Genetics</a></h1>
<h1 id="x-linked-pedigrees"><a class="header" href="#x-linked-pedigrees">X-linked Pedigrees</a></h1>
<h1 id="trinucleotide-repeats"><a class="header" href="#trinucleotide-repeats">Trinucleotide Repeats</a></h1>
<h1 id="biochemistry--molecular-science"><a class="header" href="#biochemistry--molecular-science">Biochemistry &amp; Molecular Science</a></h1>
<h1 id="a-hrefhttpsenwikipediaorgwikilist_of_notifiable_diseasesnotifiable-diseasesa"><a class="header" href="#a-hrefhttpsenwikipediaorgwikilist_of_notifiable_diseasesnotifiable-diseasesa"><a href="https://en.wikipedia.org/wiki/List_of_notifiable_diseases">Notifiable Diseases</a></a></h1>
<h3 id="more-important-examples-2"><a class="header" href="#more-important-examples-2">More important examples</a></h3>
<ul>
<li><a href="https://en.wikipedia.org/wiki/Hepatitis_A">Hepatitis A</a></li>
<li><a href="https://en.wikipedia.org/wiki/Hepatitis_B">Hepatitis B</a></li>
<li><a href="https://en.wikipedia.org/wiki/Hepatitis_C">Hepatitis C</a></li>
<li><a href="https://en.wikipedia.org/wiki/HIV/AIDS">HIV</a></li>
<li><a href="https://en.wikipedia.org/wiki/Syphilis">Syphilis</a></li>
<li><a href="https://en.wikipedia.org/wiki/Gonorrhea">Gonorrhea</a></li>
<li><a href="https://en.wikipedia.org/wiki/Measles">Measles</a></li>
<li><a href="https://en.wikipedia.org/wiki/Mumps">Mumps</a></li>
<li><a href="https://en.wikipedia.org/wiki/Rubella">Rubella</a></li>
<li><a href="https://en.wikipedia.org/wiki/Chickenpox">Chicken Pox</a></li>
<li><a href="https://en.wikipedia.org/wiki/Tuberculosis">Tuberculosis</a></li>
<li><a href="https://en.wikipedia.org/wiki/Salmonella">Salmonella</a></li>
<li><a href="https://en.wikipedia.org/wiki/Shigella">Shigella</a></li>
</ul>
<h1 id="a-hrefhttpsenwikipediaorgwikicytochrome_p450p450-enzyme-systema"><a class="header" href="#a-hrefhttpsenwikipediaorgwikicytochrome_p450p450-enzyme-systema"><a href="https://en.wikipedia.org/wiki/Cytochrome_P450">P450 Enzyme System</a></a></h1>
<h3 id="cyp-families-in-humans"><a class="header" href="#cyp-families-in-humans">CYP families in humans</a></h3>
<p>Humans have 57 genes and more than 59
<a href="https://en.wikipedia.org/wiki/pseudogene">pseudogenes</a> divided among 18 families of
cytochrome P450 genes and 43 subfamilies. This is a summary of the
genes and of the proteins they encode. See the homepage of the
cytochrome P450 Nomenclature Committee for detailed information.</p>
<table><thead><tr><th></th><th></th><th></th><th></th><th></th></tr></thead><tbody>
<tr><td><strong>Family</strong></td><td><strong>Function</strong></td><td><strong>Members</strong></td><td><strong>Genes</strong></td><td><strong>pseudogenes</strong></td></tr>
<tr><td><strong>CYP1</strong></td><td>drug and steroid (especially <a href="https://en.wikipedia.org/wiki/estrogen">estrogen</a>) metabolism, <a href="https://en.wikipedia.org/wiki/Benzo(a)pyrene">benzo(a)pyrene</a> toxification (forming <a href="https://en.wikipedia.org/wiki/(%2B)-Benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide">(+)-Benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide</a>)</td><td>3 subfamilies, 3 genes, 1 <a href="https://en.wikipedia.org/wiki/pseudogene">pseudogene</a></td><td><a href="https://en.wikipedia.org/wiki/CYP1A1">CYP1A1</a>, <a href="https://en.wikipedia.org/wiki/CYP1A2">CYP1A2</a>, <a href="https://en.wikipedia.org/wiki/CYP1B1">CYP1B1</a></td><td><a href="https://en.wikipedia.org/wiki/CYP1D1P">CYP1D1P</a></td></tr>
<tr><td><strong>CYP2</strong></td><td>drug and <a href="https://en.wikipedia.org/wiki/steroid">steroid</a> metabolism</td><td>13 subfamilies, 16 genes, 16 <a href="https://en.wikipedia.org/wiki/pseudogene">pseudogenes</a></td><td><a href="https://en.wikipedia.org/wiki/CYP2A6">CYP2A6</a>, <a href="https://en.wikipedia.org/wiki/CYP2A7">CYP2A7</a>, <a href="https://en.wikipedia.org/wiki/CYP2A13">CYP2A13</a>, <a href="https://en.wikipedia.org/wiki/CYP2B6">CYP2B6</a>, <a href="https://en.wikipedia.org/wiki/CYP2C8">CYP2C8</a>, <a href="https://en.wikipedia.org/wiki/CYP2C9">CYP2C9</a>, <a href="https://en.wikipedia.org/wiki/CYP2C18">CYP2C18</a>, <a href="https://en.wikipedia.org/wiki/CYP2C19">CYP2C19</a>, <a href="https://en.wikipedia.org/wiki/CYP2D6">CYP2D6</a>, <a href="https://en.wikipedia.org/wiki/CYP2E1">CYP2E1</a>, <a href="https://en.wikipedia.org/wiki/CYP2F1">CYP2F1</a>, <a href="https://en.wikipedia.org/wiki/CYP2J2">CYP2J2</a>, <a href="https://en.wikipedia.org/wiki/CYP2R1">CYP2R1</a>, <a href="https://en.wikipedia.org/wiki/CYP2S1">CYP2S1</a>, <a href="https://en.wikipedia.org/wiki/CYP2U1">CYP2U1</a>, <a href="https://en.wikipedia.org/wiki/CYP2W1">CYP2W1</a></td><td>Too many to list</td></tr>
<tr><td><strong>CYP3</strong></td><td>drug and <a href="https://en.wikipedia.org/wiki/steroid">steroid</a> (including <a href="https://en.wikipedia.org/wiki/testosterone">testosterone</a>) metabolism</td><td>1 subfamily, 4 genes, 4 <a href="https://en.wikipedia.org/wiki/pseudogene">pseudogenes</a></td><td><a href="https://en.wikipedia.org/wiki/CYP3A4">CYP3A4</a>, <a href="https://en.wikipedia.org/wiki/CYP3A5">CYP3A5</a>, <a href="https://en.wikipedia.org/wiki/CYP3A7">CYP3A7</a>, <a href="https://en.wikipedia.org/wiki/CYP3A43">CYP3A43</a></td><td>CYP3A51P, CYP3A52P, CYP3A54P, CYP3A137P</td></tr>
<tr><td><strong>CYP4</strong></td><td><a href="https://en.wikipedia.org/wiki/arachidonic_acid">arachidonic acid</a> or fatty acid metabolism</td><td>6 subfamilies, 12 genes, 10 <a href="https://en.wikipedia.org/wiki/pseudogene">pseudogenes</a></td><td><a href="https://en.wikipedia.org/wiki/CYP4A11">CYP4A11</a>, <a href="https://en.wikipedia.org/wiki/CYP4A22">CYP4A22</a>, <a href="https://en.wikipedia.org/wiki/CYP4B1">CYP4B1</a>, <a href="https://en.wikipedia.org/wiki/CYP4F2">CYP4F2</a>, <a href="https://en.wikipedia.org/wiki/CYP4F3">CYP4F3</a>, <a href="https://en.wikipedia.org/wiki/CYP4F8">CYP4F8</a>, <a href="https://en.wikipedia.org/wiki/CYP4F11">CYP4F11</a>, <a href="https://en.wikipedia.org/wiki/CYP4F12">CYP4F12</a>, <a href="https://en.wikipedia.org/wiki/CYP4F22">CYP4F22</a>, <a href="https://en.wikipedia.org/wiki/CYP4V2">CYP4V2</a>, <a href="https://en.wikipedia.org/wiki/CYP4X1">CYP4X1</a>, <a href="https://en.wikipedia.org/wiki/CYP4Z1">CYP4Z1</a></td><td>Too many to list</td></tr>
<tr><td><strong>CYP5</strong></td><td><a href="https://en.wikipedia.org/wiki/thromboxane">thromboxane</a> A<sub>2</sub> <a href="https://en.wikipedia.org/wiki/thromboxane-A_synthase">synthase</a></td><td>1 subfamily, 1 gene</td><td><a href="https://en.wikipedia.org/wiki/Thromboxane-A_synthase">CYP5A1</a></td><td></td></tr>
<tr><td><strong>CYP7</strong></td><td><a href="https://en.wikipedia.org/wiki/bile_acid">bile acid</a> biosynthesis 7-alpha hydroxylase of steroid nucleus</td><td>2 subfamilies, 2 genes</td><td><a href="https://en.wikipedia.org/wiki/CYP7A1">CYP7A1</a>, <a href="https://en.wikipedia.org/wiki/CYP7B1">CYP7B1</a></td><td></td></tr>
<tr><td><strong>CYP8</strong></td><td><em>varied</em></td><td>2 subfamilies, 2 genes</td><td><a href="https://en.wikipedia.org/wiki/CYP8A1">CYP8A1</a> (<a href="https://en.wikipedia.org/wiki/prostacyclin">prostacyclin</a> synthase), <a href="https://en.wikipedia.org/wiki/CYP8B1">CYP8B1</a> (bile acid biosynthesis)</td><td></td></tr>
<tr><td><strong>CYP11</strong></td><td><a href="https://en.wikipedia.org/wiki/steroid">steroid</a> biosynthesis</td><td>2 subfamilies, 3 genes</td><td><a href="https://en.wikipedia.org/wiki/CYP11A1">CYP11A1</a>, <a href="https://en.wikipedia.org/wiki/CYP11B1">CYP11B1</a>, <a href="https://en.wikipedia.org/wiki/CYP11B2">CYP11B2</a></td><td></td></tr>
<tr><td><strong>CYP17</strong></td><td><a href="https://en.wikipedia.org/wiki/steroid">steroid</a> biosynthesis, 17-alpha hydroxylase</td><td>1 subfamily, 1 gene</td><td><a href="https://en.wikipedia.org/wiki/CYP17A1">CYP17A1</a></td><td></td></tr>
<tr><td><strong>CYP19</strong></td><td><a href="https://en.wikipedia.org/wiki/steroid">steroid</a> biosynthesis: <a href="https://en.wikipedia.org/wiki/aromatase">aromatase</a> synthesizes <a href="https://en.wikipedia.org/wiki/estrogen">estrogen</a></td><td>1 subfamily, 1 gene</td><td><a href="https://en.wikipedia.org/wiki/CYP19A1">CYP19A1</a></td><td></td></tr>
<tr><td><strong>CYP20</strong></td><td>unknown function</td><td>1 subfamily, 1 gene</td><td><a href="https://en.wikipedia.org/wiki/CYP20A1">CYP20A1</a></td><td></td></tr>
<tr><td><strong>CYP21</strong></td><td><a href="https://en.wikipedia.org/wiki/steroid">steroid</a> biosynthesis</td><td>1 subfamilies, 1 gene, 1 pseudogene</td><td><a href="https://en.wikipedia.org/wiki/CYP21A2">CYP21A2</a></td><td><a href="https://en.wikipedia.org/wiki/CYP21A1P">CYP21A1P</a></td></tr>
<tr><td><strong>CYP24</strong></td><td><a href="https://en.wikipedia.org/wiki/vitamin_D">vitamin D</a> degradation</td><td>1 subfamily, 1 gene</td><td><a href="https://en.wikipedia.org/wiki/CYP24A1">CYP24A1</a></td><td></td></tr>
<tr><td><strong>CYP26</strong></td><td><a href="https://en.wikipedia.org/wiki/retinoic_acid">retinoic acid</a> hydroxylase</td><td>3 subfamilies, 3 genes</td><td><a href="https://en.wikipedia.org/wiki/CYP26A1">CYP26A1</a>, <a href="https://en.wikipedia.org/wiki/CYP26B1">CYP26B1</a>, <a href="https://en.wikipedia.org/wiki/CYP26C1">CYP26C1</a></td><td></td></tr>
<tr><td><strong>CYP27</strong></td><td><em>varied</em></td><td>3 subfamilies, 3 genes</td><td><a href="https://en.wikipedia.org/wiki/CYP27A1">CYP27A1</a> (<a href="https://en.wikipedia.org/wiki/bile_acid">bile acid</a> biosynthesis), <a href="https://en.wikipedia.org/wiki/CYP27B1">CYP27B1</a> (vitamin D<sub>3</sub> 1-alpha hydroxylase, activates vitamin D<sub>3</sub>), <a href="https://en.wikipedia.org/wiki/CYP27C1">CYP27C1</a> (unknown function)</td><td></td></tr>
<tr><td><strong>CYP39</strong></td><td>7-alpha hydroxylation of 24-hydroxycholesterol</td><td>1 subfamily, 1 gene</td><td><a href="https://en.wikipedia.org/wiki/CYP39A1">CYP39A1</a></td><td></td></tr>
<tr><td><strong>CYP46</strong></td><td><a href="https://en.wikipedia.org/wiki/cholesterol">cholesterol</a> 24-hydroxylase</td><td>1 subfamily, 1 gene, 1 pseudogene</td><td><a href="https://en.wikipedia.org/wiki/CYP46A1">CYP46A1</a></td><td>CYP46A4P</td></tr>
<tr><td><strong>CYP51</strong></td><td><a href="https://en.wikipedia.org/wiki/cholesterol">cholesterol</a> biosynthesis</td><td>1 subfamily, 1 gene, 3 pseudogenes</td><td><a href="https://en.wikipedia.org/wiki/CYP51A1">CYP51A1</a> (<a href="https://en.wikipedia.org/wiki/lanosterol">lanosterol</a> 14-alpha demethylase)</td><td>CYP51P1, CYP51P2, CYP51P3</td></tr>
</tbody></table>
<h3 id="drug-interactions"><a class="header" href="#drug-interactions">Drug Interactions</a></h3>
<p><img src="biochemistry/../../media/biochemistry/p450-drug-interactions.webp" alt="img.1" /></p>
<h1 id="a-hrefhttpsenwikipediaorgwikivitaminvitaminsa"><a class="header" href="#a-hrefhttpsenwikipediaorgwikivitaminvitaminsa"><a href="https://en.wikipedia.org/wiki/Vitamin">Vitamins</a></a></h1>
<table>
<thead>
<tr class="header">
<th><p>Vitamin</p></th>
<th><p><a href="https://en.wikipedia.org/wiki/Vitamer">Vitamers</a> (incomplete)</p></th>
<th><p><a href="https://en.wikipedia.org/wiki/Solubility">Solubility</a></p></th>
<th><p><a href="https://en.wikipedia.org/wiki/Reference_Daily_Intake">Recommended dietary allowances</a></p></th>
<th><p>Deficiency disease(s)</p></th>
<th><p>Overdose syndrome/symptoms</p></th>
<th><p>Food sources</p></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><p><a href="https://en.wikipedia.org/wiki/Vitamin_A">Vitamin A</a></p></td>
<td><p>all-<em>trans</em>-<a href="https://en.wikipedia.org/wiki/Retinol">Retinol</a>, <a href="https://en.wikipedia.org/wiki/Retinal">Retinals</a>, and<br />
alternative <a href="https://en.wikipedia.org/wiki/provitamin">provitamin</a> A-functioning <a href="https://en.wikipedia.org/wiki/Carotenoid">Carotenoids</a><br />
including all-<em>trans</em>-<a href="biochemistry/beta-carotene" title="wikilink">beta-carotene</a></p></td>
<td><p>Fat</p></td>
<td><p>900 µg/700 µg</p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Night_blindness">Night blindness</a>, <a href="https://en.wikipedia.org/wiki/hyperkeratosis">hyperkeratosis</a>, and <a href="https://en.wikipedia.org/wiki/keratomalacia">keratomalacia</a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Hypervitaminosis_A">Hypervitaminosis A</a></p></td>
<td><p>from animal origin as Vitamin A / all-<em>trans</em>-Retinol: Fish in general, liver and dairy products;</p>
<p>from plant origin as provitamin A / all-<em>trans</em>-beta-carotene: orange, ripe yellow fruits, leafy vegetables, carrots, pumpkin, squash, spinach</p></td>
</tr>
<tr class="even">
<td><p><a href="https://en.wikipedia.org/wiki/Thiamine">Vitamin B<sub>1</sub></a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Thiamine">Thiamine</a></p></td>
<td><p>Water</p></td>
<td><p>1.2 mg/1.1 mg</p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Beriberi">Beriberi</a>, <a href="biochemistry/Wernicke–Korsakoff_syndrome" title="wikilink">Wernicke-Korsakoff syndrome</a></p></td>
<td><p>Drowsiness and muscle relaxation</p></td>
<td><p>Pork, wholemeal grains, brown rice, vegetables, potatoes, liver, eggs</p></td>
</tr>
<tr class="odd">
<td><p><a href="https://en.wikipedia.org/wiki/Riboflavin">Vitamin B<sub>2</sub></a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Riboflavin">Riboflavin</a></p></td>
<td><p>Water</p></td>
<td><p>1.3 mg/1.1 mg</p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Ariboflavinosis">Ariboflavinosis</a>, <a href="https://en.wikipedia.org/wiki/glossitis">glossitis</a>, <a href="https://en.wikipedia.org/wiki/angular_stomatitis">angular stomatitis</a></p></td>
<td></td>
<td><p>Dairy products, bananas, green beans, asparagus</p></td>
</tr>
<tr class="even">
<td><p><a href="https://en.wikipedia.org/wiki/Niacin">Vitamin B<sub>3</sub></a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Niacin">Niacin</a>, <a href="https://en.wikipedia.org/wiki/Niacinamide">Niacinamide</a>, <a href="https://en.wikipedia.org/wiki/Nicotinamide_riboside">Nicotinamide riboside</a></p></td>
<td><p>Water</p></td>
<td><p>16 mg/14 mg</p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Pellagra">Pellagra</a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Liver">Liver</a> damage (doses &gt; 2g/day) and <a href="biochemistry/Niacin#Toxicity" title="wikilink">other problems</a></p></td>
<td><p>Meat, fish, eggs, many vegetables, mushrooms, tree nuts</p></td>
</tr>
<tr class="odd">
<td><p><a href="https://en.wikipedia.org/wiki/Pantothenic_acid">Vitamin B<sub>5</sub></a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Pantothenic_acid">Pantothenic acid</a></p></td>
<td><p>Water</p></td>
<td><p>5 mg/5 mg</p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Paresthesia">Paresthesia</a></p></td>
<td><p>Diarrhea; possibly nausea and heartburn.</p></td>
<td><p>Meat, broccoli, avocados</p></td>
</tr>
<tr class="even">
<td><p><a href="https://en.wikipedia.org/wiki/Vitamin_B6">Vitamin B<sub>6</sub></a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Pyridoxine">Pyridoxine</a>, <a href="https://en.wikipedia.org/wiki/Pyridoxamine">Pyridoxamine</a>, <a href="https://en.wikipedia.org/wiki/Pyridoxal">Pyridoxal</a></p></td>
<td><p>Water</p></td>
<td><p>1.3–1.7 mg/<br>1.2–1.5 mg</p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Anemia">Anemia</a>, <a href="https://en.wikipedia.org/wiki/Peripheral_neuropathy">Peripheral neuropathy</a></p></td>
<td><p>Impairment of <a href="https://en.wikipedia.org/wiki/proprioception">proprioception</a>, nerve damage (doses &gt; 100 mg/day)</p></td>
<td><p>Meat, vegetables, tree nuts, bananas</p></td>
</tr>
<tr class="odd">
<td><p><a href="https://en.wikipedia.org/wiki/Biotin">Vitamin B<sub>7</sub></a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Biotin">Biotin</a></p></td>
<td><p>Water</p></td>
<td><p>AI: 30 µg/30 µg</p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Dermatitis">Dermatitis</a>, <a href="https://en.wikipedia.org/wiki/enteritis">enteritis</a></p></td>
<td></td>
<td><p>Raw egg yolk, liver, peanuts, leafy green vegetables</p></td>
</tr>
<tr class="even">
<td><p><a href="https://en.wikipedia.org/wiki/Folate">Vitamin B<sub>9</sub></a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Folate">Folates</a>, <a href="https://en.wikipedia.org/wiki/Folic_acid">Folic acid</a></p></td>
<td><p>Water</p></td>
<td><p>400 µg/400 µg</p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Megaloblastic_anemia">Megaloblastic anemia</a> and deficiency during pregnancy is associated with <a href="https://en.wikipedia.org/wiki/birth_defects">birth defects</a>, such as <a href="https://en.wikipedia.org/wiki/neural_tube">neural tube</a> defects</p></td>
<td><p>May mask symptoms of vitamin B<sub>12</sub> deficiency; <a href="biochemistry/Folate#Toxicity" title="wikilink">other effects</a>.</p></td>
<td><p>Leafy vegetables, pasta, bread, cereal, liver</p></td>
</tr>
<tr class="odd">
<td><p><a href="https://en.wikipedia.org/wiki/Vitamin_B12">Vitamin B<sub>12</sub></a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Cyanocobalamin">Cyanocobalamin</a>, <a href="https://en.wikipedia.org/wiki/Hydroxocobalamin">Hydroxocobalamin</a>, <a href="https://en.wikipedia.org/wiki/Methylcobalamin">Methylcobalamin</a>, <a href="https://en.wikipedia.org/wiki/Adenosylcobalamin">Adenosylcobalamin</a></p></td>
<td><p>Water</p></td>
<td><p>2.4 µg/2.4 µg</p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Vitamin_B12_deficiency_anemia">Vitamin B<sub>12</sub> deficiency anemia</a></p></td>
<td><p>None proven</p></td>
<td><p>Meat, poultry, fish, eggs, milk</p></td>
</tr>
<tr class="even">
<td><p><a href="https://en.wikipedia.org/wiki/Vitamin_C">Vitamin C</a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Ascorbic_acid">Ascorbic acid</a></p></td>
<td><p>Water</p></td>
<td><p>90 mg/75 mg</p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Scurvy">Scurvy</a></p></td>
<td><p>Stomach Pain, Diarrhoea and Flatulence.</p></td>
<td><p>Many fruits and vegetables, liver</p></td>
</tr>
<tr class="odd">
<td><p><a href="https://en.wikipedia.org/wiki/Vitamin_D">Vitamin D</a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Cholecalciferol">Cholecalciferol</a> (D3), <a href="https://en.wikipedia.org/wiki/Ergocalciferol">Ergocalciferol</a> (D2)</p></td>
<td><p>Fat</p></td>
<td><p>15 µg/15 µg</p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Rickets">Rickets</a> and <a href="https://en.wikipedia.org/wiki/osteomalacia">osteomalacia</a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Hypervitaminosis_D">Hypervitaminosis D</a></p></td>
<td><p>Eggs, liver, certain fish species such as <a href="https://en.wikipedia.org/wiki/sardine">sardines</a>, certain mushroom species such as <a href="https://en.wikipedia.org/wiki/shiitake">shiitake</a></p></td>
</tr>
<tr class="even">
<td><p><a href="https://en.wikipedia.org/wiki/Vitamin_E">Vitamin E</a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Tocopherol">Tocopherols</a>, <a href="https://en.wikipedia.org/wiki/Tocotrienol">Tocotrienols</a></p></td>
<td><p>Fat</p></td>
<td><p>15 mg/15 mg</p></td>
<td><p>Deficiency is very rare; mild <a href="https://en.wikipedia.org/wiki/hemolytic_anemia">hemolytic anemia</a> in newborn infants</p></td>
<td><p>Possible increased incidence of congestive heart failure.</p></td>
<td><p>Many fruits and vegetables, nuts and seeds, and seed oils</p></td>
</tr>
<tr class="odd">
<td><p><a href="https://en.wikipedia.org/wiki/Vitamin_K">Vitamin K</a></p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Phylloquinone">Phylloquinone</a>, <a href="https://en.wikipedia.org/wiki/Menaquinone">Menaquinones</a></p></td>
<td><p>Fat</p></td>
<td><p>AI: 110 µg/120 µg</p></td>
<td><p><a href="https://en.wikipedia.org/wiki/Bleeding_diathesis">Bleeding diathesis</a></p></td>
<td><p>Decreased anticoagulation effect of <a href="https://en.wikipedia.org/wiki/warfarin">warfarin</a>.</p></td>
<td><p>Leafy green vegetables such as spinach; egg yolks; liver</p></td>
</tr>
</tbody>
</table>
<h1 id="glycolysis"><a class="header" href="#glycolysis">Glycolysis</a></h1>
<h1 id="pyruvate-pathways--metabolism"><a class="header" href="#pyruvate-pathways--metabolism">Pyruvate Pathways &amp; Metabolism</a></h1>
<h1 id="tcacitric-acid-krebs-cycle"><a class="header" href="#tcacitric-acid-krebs-cycle">TCA/Citric Acid (Krebs) Cycle</a></h1>
<h1 id="electron-transport-chain-oxidative-phosphorylation"><a class="header" href="#electron-transport-chain-oxidative-phosphorylation">Electron Transport Chain (Oxidative Phosphorylation)</a></h1>
<h1 id="hmp-shunt-pentose-pathway"><a class="header" href="#hmp-shunt-pentose-pathway">HMP Shunt (Pentose Pathway)</a></h1>
<h1 id="catecholamine-synthesis"><a class="header" href="#catecholamine-synthesis">Catecholamine Synthesis</a></h1>
<h1 id="amino-acids"><a class="header" href="#amino-acids">Amino Acids</a></h1>
<h1 id="urea-cycle"><a class="header" href="#urea-cycle">Urea Cycle</a></h1>
<h1 id="fatty-acid-synthesis"><a class="header" href="#fatty-acid-synthesis">Fatty Acid Synthesis</a></h1>
<h1 id="fatty-acid-beta-oxidation"><a class="header" href="#fatty-acid-beta-oxidation">Fatty Acid (Beta) Oxidation</a></h1>
<h1 id="ketone-body-synthesis"><a class="header" href="#ketone-body-synthesis">Ketone Body Synthesis</a></h1>
<h1 id="glutathione-pathways"><a class="header" href="#glutathione-pathways">Glutathione Pathways</a></h1>
<h1 id="metabolic-fuel--starvation"><a class="header" href="#metabolic-fuel--starvation">Metabolic Fuel &amp; Starvation</a></h1>
<h1 id="lipid-transport"><a class="header" href="#lipid-transport">Lipid Transport</a></h1>
<h1 id="familial-dyslipidemias"><a class="header" href="#familial-dyslipidemias">Familial Dyslipidemia’s</a></h1>
<h1 id="glycogen-storage-diseases"><a class="header" href="#glycogen-storage-diseases">Glycogen Storage Diseases</a></h1>
<h1 id="fructose-metabolism"><a class="header" href="#fructose-metabolism">Fructose Metabolism</a></h1>
<h1 id="galactose-metabolism"><a class="header" href="#galactose-metabolism">Galactose Metabolism</a></h1>
<h1 id="lysosomal-storage-diseases"><a class="header" href="#lysosomal-storage-diseases">Lysosomal Storage Diseases</a></h1>
<h1 id="alcohol-metabolism"><a class="header" href="#alcohol-metabolism">Alcohol Metabolism</a></h1>
<h1 id="types-of-collagen"><a class="header" href="#types-of-collagen">Types of Collagen</a></h1>
<h1 id="pharmacology"><a class="header" href="#pharmacology">Pharmacology</a></h1>
<h1 id="high-yield-usmle"><a class="header" href="#high-yield-usmle">High Yield USMLE</a></h1>
<h2 id="a-hrefhttpsenwikipediaorgwikiantiarrhythmic_agentantiarrhythmic-agentsa"><a class="header" href="#a-hrefhttpsenwikipediaorgwikiantiarrhythmic_agentantiarrhythmic-agentsa"><a href="https://en.wikipedia.org/wiki/Antiarrhythmic_agent">Antiarrhythmic agents</a></a></h2>
<p><img src="pharmacology/../media/pharmacology/dmed01.webp" alt="" /></p>
<h2 id="a-hrefhttpsenwikipediaorgwikigestational_hypertensiongestational-hypertensiona"><a class="header" href="#a-hrefhttpsenwikipediaorgwikigestational_hypertensiongestational-hypertensiona"><a href="https://en.wikipedia.org/wiki/Gestational_hypertension">Gestational hypertension</a></a></h2>
<p><img src="pharmacology/../media/pharmacology/dmed02.webp" alt="" /></p>
<h2 id="side-effects"><a class="header" href="#side-effects">Side Effects</a></h2>
<p><img src="pharmacology/../media/pharmacology/dmed03.webp" alt="" />
<img src="pharmacology/../media/pharmacology/dmed04.webp" alt="" />
<img src="pharmacology/../media/pharmacology/dmed05.webp" alt="" />
<img src="pharmacology/../media/pharmacology/dmed06.webp" alt="" />
<img src="pharmacology/../media/pharmacology/dmed07.webp" alt="" />
<img src="pharmacology/../media/pharmacology/dmed08.webp" alt="" />
<img src="pharmacology/../media/pharmacology/dmed09.webp" alt="" />
<img src="pharmacology/../media/pharmacology/dmed10.webp" alt="" />
<img src="pharmacology/../media/pharmacology/dmed11.webp" alt="" />
<img src="pharmacology/../media/pharmacology/dmed12.webp" alt="" />
<img src="pharmacology/../media/pharmacology/dmed13.webp" alt="" />
<img src="pharmacology/../media/pharmacology/dmed14.webp" alt="" />
<img src="pharmacology/../media/pharmacology/dmed15.webp" alt="" /></p>
<h2 id="a-hrefhttpsenwikipediaorgwikituberculosis_managementtuberculosis-managementa"><a class="header" href="#a-hrefhttpsenwikipediaorgwikituberculosis_managementtuberculosis-managementa"><a href="https://en.wikipedia.org/wiki/Tuberculosis_management">Tuberculosis management</a></a></h2>
<p><img src="pharmacology/../media/pharmacology/dmed16.webp" alt="" /></p>
<h2 id="a-hrefhttpsenwikipediaorgwikialcoholismalcoholisma"><a class="header" href="#a-hrefhttpsenwikipediaorgwikialcoholismalcoholisma"><a href="https://en.wikipedia.org/wiki/Alcoholism">Alcoholism</a></a></h2>
<p><img src="pharmacology/../media/pharmacology/dmed17.webp" alt="" /></p>
<h2 id="a-hrefhttpsenwikipediaorgwikimonoclonal_antibodymonoclonal-antibodya"><a class="header" href="#a-hrefhttpsenwikipediaorgwikimonoclonal_antibodymonoclonal-antibodya"><a href="https://en.wikipedia.org/wiki/Monoclonal_antibody">Monoclonal antibody</a></a></h2>
<h4 id="a-hrefhttpsenwikipediaorgwikilist_of_therapeutic_monoclonal_antibodieslist-of-therapeutic-monoclonal-antibodiesa"><a class="header" href="#a-hrefhttpsenwikipediaorgwikilist_of_therapeutic_monoclonal_antibodieslist-of-therapeutic-monoclonal-antibodiesa"><a href="https://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies">List of therapeutic monoclonal antibodies</a></a></h4>
<p><img src="pharmacology/../media/pharmacology/dmed18.webp" alt="" /></p>
<h1 id="a-hrefhttpsenwikipediaorgwikipharmacodynamicspharmacodynamicsa-and-weak-a-hrefhttpsenwikipediaorgwikiacidacidsa-and-a-hrefhttpsenwikipediaorgwikibase_chemistrybasesa"><a class="header" href="#a-hrefhttpsenwikipediaorgwikipharmacodynamicspharmacodynamicsa-and-weak-a-hrefhttpsenwikipediaorgwikiacidacidsa-and-a-hrefhttpsenwikipediaorgwikibase_chemistrybasesa"><a href="https://en.wikipedia.org/wiki/Pharmacodynamics">Pharmacodynamics</a> and Weak <a href="https://en.wikipedia.org/wiki/Acid">Acids</a> and <a href="https://en.wikipedia.org/wiki/Base_(chemistry)">Bases</a></a></h1>
<h2 id="a-hrefpharmacologya"><a class="header" href="#a-hrefpharmacologya"><a href="pharmacology/"></a></a></h2>
<p><img src="pharmacology/../media/pharmacology/pharmacodynamics-and-weak-acids-and-bases01.webp" alt="" /></p>
<h2 id="a-hrefpharmacologya-1"><a class="header" href="#a-hrefpharmacologya-1"><a href="pharmacology/"></a></a></h2>
<p><img src="pharmacology/../media/pharmacology/pharmacodynamics-and-weak-acids-and-bases02.webp" alt="" /></p>
<h2 id="a-hrefpharmacologya-2"><a class="header" href="#a-hrefpharmacologya-2"><a href="pharmacology/"></a></a></h2>
<p><img src="pharmacology/../media/pharmacology/pharmacodynamics-and-weak-acids-and-bases03.webp" alt="" /></p>
<h2 id="a-hrefpharmacologya-3"><a class="header" href="#a-hrefpharmacologya-3"><a href="pharmacology/"></a></a></h2>
<p><img src="pharmacology/../media/pharmacology/pharmacodynamics-and-weak-acids-and-bases04.webp" alt="" /></p>
<h2 id="a-hrefpharmacologya-4"><a class="header" href="#a-hrefpharmacologya-4"><a href="pharmacology/"></a></a></h2>
<p><img src="pharmacology/../media/pharmacology/pharmacodynamics-and-weak-acids-and-bases05.webp" alt="" /></p>
<h2 id="a-hrefpharmacologya-5"><a class="header" href="#a-hrefpharmacologya-5"><a href="pharmacology/"></a></a></h2>
<p><img src="pharmacology/../media/pharmacology/pharmacodynamics-and-weak-acids-and-bases06.webp" alt="" /></p>
<h2 id="a-hrefpharmacologya-6"><a class="header" href="#a-hrefpharmacologya-6"><a href="pharmacology/"></a></a></h2>
<p><img src="pharmacology/../media/pharmacology/pharmacodynamics-and-weak-acids-and-bases07.webp" alt="" /></p>
<h2 id="a-hrefpharmacologya-7"><a class="header" href="#a-hrefpharmacologya-7"><a href="pharmacology/"></a></a></h2>
<p><img src="pharmacology/../media/pharmacology/pharmacodynamics-and-weak-acids-and-bases08.webp" alt="" /></p>
<h1 id="a-hrefhttpsenwikipediaorgwikiadmeadmea-and-a-hrefhttpsenwikipediaorgwikipharmacokineticspharmacokineticsa"><a class="header" href="#a-hrefhttpsenwikipediaorgwikiadmeadmea-and-a-hrefhttpsenwikipediaorgwikipharmacokineticspharmacokineticsa"><a href="https://en.wikipedia.org/wiki/ADME">ADME</a> and <a href="https://en.wikipedia.org/wiki/Pharmacokinetics">Pharmacokinetics</a></a></h1>
<h1 id="antibiotics-cell-wall-inhibitors"><a class="header" href="#antibiotics-cell-wall-inhibitors">Antibiotics, Cell Wall Inhibitors</a></h1>
<h2 id="antibiotics-big-picture"><a class="header" href="#antibiotics-big-picture">Antibiotics Big Picture</a></h2>
<ul>
<li><strong>Inhibit New base synthesis</strong>
<ul>
<li>Inhibit folate synthesis: <a href="https://en.wikipedia.org/wiki/Trimethoprim/sulfamethoxazole">Sulfamethoxazole-Trimethoprim</a> &amp; <a href="https://en.wikipedia.org/wiki/Dapsone">Dapsone</a></li>
</ul>
</li>
<li><strong>Alter DNA</strong>
<ul>
<li>Inhibit DNA Over/Underwinding: <a href="https://en.wikipedia.org/wiki/Fluoroquinolone">Fluoroquinolones</a></li>
<li>Alter DNA integrity: <a href="https://en.wikipedia.org/wiki/Metronidazole">Metronidazole</a></li>
</ul>
</li>
<li><strong>Inhibit Transcription</strong>
<ul>
<li>Inhibit mRNA synthesis: <a href="https://en.wikipedia.org/wiki/Rifampin">Rifampin</a></li>
</ul>
</li>
<li><strong>Inhibit Translation-Protein synthesis</strong>
<ul>
<li>Inhibit Ribosome
<ul>
<li>30S Subunit: <a href="https://en.wikipedia.org/wiki/Aminoglycoside">Aminoglycosides</a>, <a href="https://en.wikipedia.org/wiki/Tetracycline">Tetracyclines</a>, <a href="https://en.wikipedia.org/wiki/Tigecycline">Tigecycline</a></li>
<li>508 subunit: <a href="https://en.wikipedia.org/wiki/Chloramphenicol">Chloramphenicol</a>, <a href="https://en.wikipedia.org/wiki/Clindamycin">Clindamycin</a>, <a href="https://en.wikipedia.org/wiki/Linezolid">Linezolid</a>, <a href="https://en.wikipedia.org/wiki/Macrolide">Macrolides</a></li>
</ul>
</li>
</ul>
</li>
<li><strong>Inhibit Bacterial Cell Wall</strong>
<ul>
<li>Inhibit building blocks (Peptidoglycans) synthesis: <a href="https://en.wikipedia.org/wiki/Vancomycin">Vancomycin</a>, <a href="https://en.wikipedia.org/wiki/Bacitracin">Bacitracin</a></li>
<li>Inhibit Peptidoglycans cross linking (Beta Lactams): <a href="https://en.wikipedia.org/wiki/Penicillin">Penicillins</a>, <a href="https://en.wikipedia.org/wiki/Cephalosporin">Cephalosporins</a>, <a href="https://en.wikipedia.org/wiki/Carbapenem">Carbapenems</a>, <a href="https://en.wikipedia.org/wiki/Monobactam">Monobactams</a></li>
</ul>
</li>
<li><strong>Disrupt cell membrane</strong>: <a href="https://en.wikipedia.org/wiki/Daptomycin">Daptomycin</a></li>
</ul>
<h2 id="some-important-bacterial-enzymes"><a class="header" href="#some-important-bacterial-enzymes">Some Important Bacterial Enzymes</a></h2>
<ul>
<li>Bacterial cell wall
<ul>
<li>Peptidoglycan (Sugar) linked with amino acids</li>
<li>S. Aureus: Linked by D-alanine</li>
</ul>
</li>
<li><strong>Transpeptidase</strong> (PCN Binding Proteins)
<ul>
<li>Cross links Peptidoglycan chains to form a rigid wall</li>
<li><strong>Inhibited by all PCNs</strong></li>
</ul>
</li>
<li>Penicillinase (Beta-Lactamase)
<ul>
<li>Breaks down the beta lactam ring of PCN abx</li>
<li><strong>Mechanism of bacterial resistance</strong></li>
<li><strong>Inhibited by beta-lactamase inhibitors (i.e. clavulanic acid)</strong></li>
</ul>
</li>
</ul>
<h2 id="penicillins"><a class="header" href="#penicillins">Penicillins</a></h2>
<p><strong>Side Effect for all PCN</strong></p>
<ul>
<li>Hypersensitivity allergic reaction
<ul>
<li>Type I (IgE - urticaria &amp; anaphylaxis)</li>
<li>Type II (IgG mediated hemolytic anemia)</li>
<li>Type III (serum sickness like)</li>
</ul>
</li>
</ul>
<h3 id="original-pcn"><a class="header" href="#original-pcn">Original PCN</a></h3>
<p><strong>PCN G, PCN V</strong></p>
<ul>
<li>MOA:
<ul>
<li>D-Alanine structural analogue</li>
<li>Binds <strong>Transpeptidase</strong> (Penicillin binding proteins) and <strong>block crosslinking of peptidoglycan</strong> in bacterial cell wall</li>
</ul>
</li>
<li>Spectrum:
<ul>
<li>Gram +ve (Strep mostly)</li>
<li>Gram -ve (Neisseria)</li>
<li>Spirochetes (Treponema)</li>
</ul>
</li>
<li>Uses:
<ul>
<li>Strep Pharyngitis</li>
<li>Syphilis</li>
<li>Dental infections</li>
</ul>
</li>
<li>Side Effects:
<ul>
<li><strong>Direct Coombs +ve Hemolytic Anemia</strong></li>
</ul>
</li>
</ul>
<h3 id="penicillinase-sensitive"><a class="header" href="#penicillinase-sensitive">Penicillinase Sensitive</a></h3>
<p><strong>Amoxicillin (PO) &amp; Ampicillin (PO/IV)</strong></p>
<ul>
<li>MOA: Same as PCN</li>
<li>Spectrum:
<ul>
<li>Same as PCN</li>
<li>Plus H. Influenzae, H. Pylori, E. Coli, Listeria, Proteus, Salmonella, Shigella, Bnterococci</li>
</ul>
</li>
<li>Use
<ul>
<li><strong>Amoxicillin</strong>
<ul>
<li>Strep Pharyngitis</li>
<li>H. Pylori</li>
</ul>
</li>
<li><strong>Ampicillin</strong>
<ul>
<li>Listeria Meningitis (Elderly/Neonates)</li>
<li>Group B Strep Meningitis Neonates</li>
<li>Group B Strep Px in pregnancy</li>
</ul>
</li>
</ul>
</li>
<li>SE
<ul>
<li><strong>Allergic reaction</strong></li>
<li>C. Diff Colitis</li>
</ul>
</li>
</ul>
<h3 id="penicillinase-resistant"><a class="header" href="#penicillinase-resistant">Penicillinase Resistant</a></h3>
<p><strong>Dicloxacillin &amp; Nafcillin &amp; Oxacillin</strong></p>
<ul>
<li>MOA: Same as PCN</li>
<li>Spectrum: Narrow
<ul>
<li>MSSA</li>
<li>Group A Strep (S. Pyogenes)</li>
</ul>
</li>
<li>Use
<ul>
<li><strong>MSSA Infections</strong></li>
<li>Mastitis
<ul>
<li>Dicloxacillin</li>
</ul>
</li>
</ul>
</li>
<li>SE
<ul>
<li><strong><strong>Interstitial Nephritis</strong></strong></li>
</ul>
</li>
</ul>
<h3 id="beta-lactamase-inhibitors"><a class="header" href="#beta-lactamase-inhibitors">Beta-Lactamase Inhibitors</a></h3>
<p><strong><a href="https://en.wikipedia.org/wiki/Clavulanic_acid">Clavulanic acid</a> &amp; Sulbactam &amp; Tazobactam</strong></p>
<ul>
<li>MOA
<ul>
<li>Protect PCN antibiotic from destruction by inhibiting bacterial Penicillinase (Beta-Lactamase) enzyme</li>
</ul>
</li>
<li>Use
<ul>
<li>Amoxicillin/Clavulanate</li>
<li>Piperacillin/Tazobactam</li>
<li>Ampicillln/SuIbactam</li>
<li>Ticarcillin/Clavulanate</li>
</ul>
</li>
</ul>
<h3 id="antipseudomonal--penicillins"><a class="header" href="#antipseudomonal--penicillins">Antipseudomonal  Penicillins</a></h3>
<p><strong>Piperacillin &amp; Ticarcillin</strong></p>
<ul>
<li>Spectrum
<ul>
<li>Broad spectrum</li>
<li>Gram +ve (No MRSA)</li>
<li><strong>Gram -ve Pseudomonas</strong> &amp; Nosocomial organisms</li>
</ul>
</li>
<li><strong>Combined with beta-lactamase inhibitors</strong></li>
<li>Use
<ul>
<li>Pseudomonas infections</li>
</ul>
</li>
<li>SE
<ul>
<li><em><strong>C. Diff Colitis</strong></em></li>
</ul>
</li>
</ul>
<h2 id="cephalosporins"><a class="header" href="#cephalosporins">Cephalosporins</a></h2>
<h3 id="general-principles"><a class="header" href="#general-principles">General Principles</a></h3>
<ul>
<li>5 Generations of Cephalosporins</li>
<li>Spectrum Principles
<ul>
<li>Generations 1-4:
<ul>
<li><strong>1-&gt; 4 = Increase gram -ve spectrum of activity</strong></li>
</ul>
</li>
<li>Generation 5:
<ul>
<li>Broad spectrum including <strong>MRSA</strong></li>
</ul>
</li>
</ul>
</li>
<li>MOA:
<ul>
<li><strong>Same as PCN</strong></li>
<li>Less susceptible to breakdown by Penicillinase</li>
</ul>
</li>
<li>Side Effects:
<ul>
<li>Hypersensitivity (Low cross reactivity with PCN)</li>
<li>Hemolytic Anemia</li>
</ul>
</li>
</ul>
<h3 id="specific-drugs"><a class="header" href="#specific-drugs">Specific Drugs</a></h3>
<ul>
<li>1st Generation: <strong>Cefazolin IV &amp; Cephalexin PO</strong></li>
<li>2nd Generation: <strong>Cefoxitin IV</strong></li>
<li>3rd Generation: <strong>Ceftriaxone IV/IM &amp; Ceftazidime IV</strong></li>
<li>4th Generation: <strong>Cefepime IV</strong></li>
<li>5th Generation: <strong>Ceftaroline IV</strong></li>
</ul>
<h3 id="cephalosporin-uses"><a class="header" href="#cephalosporin-uses">Cephalosporin Uses</a></h3>
<p><em>1st Generation</em>
<strong>Cefazolin</strong></p>
<ul>
<li>Spectrum: Gram +ve cocci (<strong>MSSA</strong>), Proteus, <strong>E.Coli</strong>, Klebsiella</li>
<li>Uses: <strong>Skin infections, UTI</strong></li>
<li>Skin px prior to surgery: Cefazolin</li>
</ul>
<p><em>2nd Generation</em>
<strong>Cefotaxime</strong></p>
<ul>
<li>Spectrum: Above plus Neisseria, Serratia</li>
<li>Uses: Abdominal infections &amp; Pneumonia</li>
</ul>
<p><em>3rd Generation</em>
<strong>Ceftriaxone &amp; Ceftazidime</strong></p>
<ul>
<li>Spectrum: Same as 2nd plus <strong>Nosocomial organisms</strong></li>
<li>Crosses BBB</li>
<li><strong>Ceftriaxone: Meningitis, Gonorrhea</strong></li>
<li><strong>Ceftazidime: Pseudomonas</strong></li>
</ul>
<p><em>4th Generation</em>
<strong>Cefepime</strong></p>
<ul>
<li>Spectrum: Same as 3rd plus <strong>Pseudomonas</strong></li>
</ul>
<p><em>5th Generation</em>
<strong>Ceftaroline</strong></p>
<ul>
<li><strong>MRSA</strong>, Enterococcus, Listeria</li>
<li><strong>No Pseudomonas</strong></li>
</ul>
<h2 id="aztreonam"><a class="header" href="#aztreonam">Aztreonam</a></h2>
<ul>
<li>MOA
<ul>
<li>Same as PCN</li>
<li><strong>Own class</strong> - 1 beta lactam ring</li>
</ul>
</li>
<li>Spectrum
<ul>
<li>Gram -ve rods only (Pseudomonas)</li>
<li>No Gram +ve or Anaerobes</li>
</ul>
</li>
<li>Use
<ul>
<li><strong>Penicillin allergic patients</strong></li>
<li>Does not cross react with PCNs</li>
</ul>
</li>
</ul>
<h2 id="carbapenems-imipenem--carbapenem"><a class="header" href="#carbapenems-imipenem--carbapenem">Carbapenems (Imipenem &amp; Carbapenem)</a></h2>
<ul>
<li>Suffix <strong>-penem</strong></li>
<li>MOA
<ul>
<li>Same as PCN</li>
</ul>
</li>
<li>Spectrum: Broad &amp; Heavy duty
<ul>
<li>Gram +ve (but no MRSA)</li>
<li>Gram -ve rods (Including pseudomonas)</li>
<li>Anaerobes</li>
</ul>
</li>
<li>Use
<ul>
<li>Life threatening gram -ve infections</li>
</ul>
</li>
<li>SE
<ul>
<li><strong><strong>Seizures</strong></strong>
<ul>
<li><strong>Meropenem</strong> has lowest risk</li>
</ul>
</li>
</ul>
</li>
<li>Notes
<ul>
<li>Imipenem combined with <strong>Cilastatin</strong> (which inhibits its renal degradation)</li>
</ul>
</li>
</ul>
<h2 id="vancomycin"><a class="header" href="#vancomycin">Vancomycin</a></h2>
<ul>
<li>MOA
<ul>
<li><strong>Bind to D-ala D-ala</strong> inhibiting <strong>peptidoglycan synthesis</strong> inhibiting cell wall</li>
</ul>
</li>
<li>Spectrum: Gram +ve only</li>
<li>Use
<ul>
<li>IV: <strong>MRSA</strong>, S. Epidermidis, Enterococcus</li>
<li>PO: C. Diff Colitis</li>
</ul>
</li>
<li>SE
<ul>
<li><strong>Nephrotoxicity</strong></li>
<li>Thrombophlebitis</li>
<li><strong><strong>Red Man Syndrome</strong></strong>
<ul>
<li>Erythematous rash</li>
<li>Nonspecific mast cell degranulation</li>
<li>Tx: Antihistamines, slow infusion</li>
</ul>
</li>
</ul>
</li>
</ul>
<h2 id="daptomycin"><a class="header" href="#daptomycin">Daptomycin</a></h2>
<ul>
<li>MOA
<ul>
<li>Create <strong>transmembrane channels disrupting cell membranes</strong>
<ul>
<li>Cells can't maintain <strong>lons flow</strong> and membrane potential</li>
</ul>
</li>
</ul>
</li>
<li>Spectrum: Gram +ve only</li>
<li>Use
<ul>
<li><strong>MRSA</strong> Skin, bacteremia, Endocarditis</li>
<li><strong>VRE</strong></li>
<li><strong>Inactivated in lungs</strong> (Not for Pneumonia)</li>
</ul>
</li>
<li>SE
<ul>
<li><strong>Rhabdomyolysis - Elevated CK</strong></li>
<li>Punches holes in the human muscle cells??</li>
</ul>
</li>
</ul>
<h2 id="protein-synthesis-inhibitors"><a class="header" href="#protein-synthesis-inhibitors">Protein-synthesis inhibitors</a></h2>
<p><strong>How can one inhibit ribosomal function?</strong></p>
<ul>
<li><strong>Inhibit Initiation Complex Formation</strong> (30S &amp; 50S)
<ul>
<li>Linezolid &amp; Aminoglycosides</li>
</ul>
</li>
<li>Inhibit <strong>Peptide Elongation</strong> (50S)
<ul>
<li>Chloramphenicol</li>
</ul>
</li>
<li>Inhibit <strong>Peptide Translocation</strong> (50S)
<ul>
<li>Macrolides and Clindamycin</li>
</ul>
</li>
<li>Inhibit introduction of <strong>New Aminoacyl-tRNA</strong> (30S)
<ul>
<li>Tetracycline</li>
</ul>
</li>
</ul>
<h3 id="aminoglycosides-30s"><a class="header" href="#aminoglycosides-30s">Aminoglycosides (30S)</a></h3>
<p><strong>Gentamicin &amp; Neomycin &amp; Amikacin Tobramycin &amp; Streptomycin</strong></p>
<ul>
<li>MOA:
<ul>
<li><strong>Primarily</strong> Binds 30S subunit &amp; Irreversible inhibits initiation complex
<ul>
<li>Additionally, <strong>misreading of mRNA and blocks translocation</strong></li>
</ul>
</li>
<li><strong>Require O2 for uptake; therefore ineffective against anaerobes</strong></li>
</ul>
</li>
<li>Spectrum:
<ul>
<li><strong>Primarily Gram (-) including Pseudomonas</strong></li>
<li><strong>Synergy for Gram (+)</strong> (staph, strep, enterococcus — variable)</li>
</ul>
</li>
<li>Side Effects:
<ul>
<li><strong>Nephrotoxicity</strong> — acute tubular necrosis
<ul>
<li>Reversible</li>
</ul>
</li>
<li>Ototoxicity — loss of hearing. High frequency lost first
<ul>
<li><strong>NOT REVERSIBLE</strong></li>
<li>Another example is Loop diuretics</li>
</ul>
</li>
<li>Neuromuscular blockade</li>
<li><strong>Teratogen</strong></li>
</ul>
</li>
</ul>
<h3 id="tetracyclines-30s"><a class="header" href="#tetracyclines-30s">Tetracyclines (30S)</a></h3>
<p><strong>Tetracycline &amp; Doxycycline &amp; Minocycline</strong></p>
<ul>
<li>MOA:
<ul>
<li>Bind to <strong>30S</strong> and <strong>prevent attachment of aminoacyl-tRNA to A site</strong></li>
<li>Especially effective against intracellular pathogens</li>
</ul>
</li>
<li>Uses:
<ul>
<li><strong>Borrelia burgdorferi, M pneumoniae, rickettsia and chlamydia,</strong> acne</li>
<li><strong>Many zoonotics</strong></li>
<li>Doxycycline effective against MRSA (Community Acquired)</li>
</ul>
</li>
<li>Side Effects
<ul>
<li>Gl distress, <strong>discoloration of teeth in children, inhibition of bone growth in children, photosensitivity</strong></li>
<li>Contraindicated in pregnancy</li>
<li>Chelates with antacids</li>
</ul>
</li>
</ul>
<h4 id="glycylcyclines"><a class="header" href="#glycylcyclines">Glycylcyclines</a></h4>
<p><strong>Tigecycline</strong></p>
<p>MOA: Tetracycline derivative
Uses: Broad-spectrum anaerobic, gram - , and gram + coverage. <strong>Multidrug-resistant (MRSA &amp; VRE)</strong></p>
<h3 id="chloramphenicol--clindamycin-50s"><a class="header" href="#chloramphenicol--clindamycin-50s">Chloramphenicol &amp; Clindamycin (50S)</a></h3>
<p><strong>Chloramphenicol</strong></p>
<ul>
<li>MOA: Blocks <strong>Peptidyl Transferase</strong> at 50S ribosomal subunit and Prevent <strong>protein chain elongation</strong></li>
<li>Uses</li>
<li>H.influenzae, N. meningitidis, S. pneumoniae, Rickettsia rickettsii.</li>
<li>Side Effects:</li>
<li><strong>Aplastic Anemia</strong></li>
<li><strong>Gray baby syndrome</strong></li>
<li>Premature infants lack liver UDP-glucuronyltransferase therefore can’t metabolize drug</li>
<li>Avoid in pregnancy</li>
</ul>
<p><strong>Clindamycin</strong></p>
<ul>
<li>MOA: Binds to <strong>50S and Blocks Translocation</strong>
<ul>
<li>Movement of newly made peptide chain into the P site from A site</li>
</ul>
</li>
<li>Uses:
<ul>
<li><strong>Anaerobic infections</strong> (eg, Bacteroides spp., Clostridium perfringens )</li>
<li>Aspiration pneumonia, lung abscesses, and oral infections</li>
<li>Group A strep</li>
</ul>
</li>
<li>Side Effects:
<ul>
<li><strong><strong>Pseudomembranous colitis (C diff)</strong></strong></li>
</ul>
</li>
</ul>
<h3 id="linezolid-50s"><a class="header" href="#linezolid-50s">Linezolid (50S)</a></h3>
<ul>
<li>MOA: Bind 50S and <strong>prevent formation of initiation complex</strong>
<ul>
<li>Uses: <strong>Vancomycin resistant Enterococcus (VRE) &amp; MRSA</strong></li>
</ul>
</li>
<li>Side Effects:
<ul>
<li>Bope marrow suppression (especially thrombocytopenia)</li>
<li><strong><strong>Serotonin syndrome</strong></strong>
<ul>
<li>Weak MAO Inhibitor</li>
</ul>
</li>
</ul>
</li>
</ul>
<p><em>Serotonin Syndrome</em></p>
<ul>
<li>Cause: Any drugs causing increase in serotonin</li>
<li>Symptoms
<ul>
<li>Hyperreflexia</li>
<li>Diaphoresis, Diarrhea</li>
<li>Agitation</li>
</ul>
</li>
<li><strong>Treatment</strong>
<ul>
<li>Serotonin antagonist (Cyproheptadine)</li>
</ul>
</li>
</ul>
<h3 id="macrolides-50s"><a class="header" href="#macrolides-50s">Macrolides (50S)</a></h3>
<p><strong>Azithromycin &amp; clarithromycin &amp; &amp; erythromycin</strong></p>
<ul>
<li>MOA:
<ul>
<li>Binds to the 23S rRNA of the 50S</li>
<li>Blocks Translocation</li>
<li>Movement of Newly made peptide chain into the P site from A site</li>
</ul>
</li>
<li>Uses:
<ul>
<li><strong>Atypical pneumonias</strong> (Mycoplasma, Chlamydia, Legionella )</li>
<li><strong>STis</strong> (Chlamydia)</li>
<li>gram + cocci (streptococcal infections in patients allergic to penicillin)</li>
<li>B. pertussis</li>
</ul>
</li>
<li>Side Effects:
<ul>
<li><strong>Gastrointestinal Motility</strong></li>
<li><strong><strong>QT Prolongation</strong></strong></li>
</ul>
</li>
</ul>
<h2 id="misc-antibiotics"><a class="header" href="#misc-antibiotics">Misc Antibiotics</a></h2>
<h3 id="sulfonamides"><a class="header" href="#sulfonamides">Sulfonamides</a></h3>
<p><strong>Sulfamethoxazole (SMX) &amp; Sulfadiazine</strong></p>
<ul>
<li>MOA: Inhibit folate synthesis via blocking <strong>Dihydropteroate Synthase</strong></li>
<li>Uses
<ul>
<li>Gram + &amp; Gram -</li>
<li><strong>Nocardia</strong></li>
<li><strong>Simple UTI</strong></li>
<li><strong>PCP/PJP</strong> Treatment and prophylaxis</li>
</ul>
</li>
<li>Side Effects
<ul>
<li>Hypersensitivity reactions</li>
<li><strong>Hemolysis</strong>
<ul>
<li><strong>G6PD deficiency</strong></li>
</ul>
</li>
<li><strong>Photosensitivity</strong></li>
<li><strong>Stevens-Johnson syndrome</strong></li>
<li><strong>Kernicterus (Jaundice baby)</strong>
<ul>
<li>Displaces bilirubin bound to albumin</li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="anti-folate-drugs"><a class="header" href="#anti-folate-drugs">Anti-Folate Drugs</a></h3>
<p><strong>Trimethoprim</strong></p>
<ul>
<li>MOA
<ul>
<li>Inhibits <strong>Bacterial Dihydrofolate Reductase</strong></li>
</ul>
</li>
<li>Use
<ul>
<li><strong>In combination with sulfonamides</strong>-Trimethoprim-sulfametho xazole (TMP/SMX) - Bactrim</li>
<li><strong>Synergy</strong></li>
<li>UTls, Shigella, Salmonella, Pneumocystis jirovecii pneumonia treatment and prophylaxis, toxoplasmosis prophylaxis.</li>
</ul>
</li>
</ul>
<h3 id="fluoroquinolones"><a class="header" href="#fluoroquinolones">Fluoroquinolones</a></h3>
<p><strong>Ciprofloxacin &amp; Levofloxacin</strong> &amp; Suffix <strong>-Floxacin</strong></p>
<ul>
<li>MOA: Inhibit prokaryotic <strong>Topoisomerase II (DNA Gyrase) and topoisomerase IV</strong></li>
<li>Use
<ul>
<li>Gram - rods of urinary and Gl tracts (Pseudomonas)</li>
<li>Some gram + organisms</li>
</ul>
</li>
<li>SE
<ul>
<li><strong><strong>Achilles Tendonitis or tendon rupture</strong></strong>
<ul>
<li>Contraindicated in Elderly and Children</li>
</ul>
</li>
<li>Prolong QT interval</li>
</ul>
</li>
<li>Clinical Pearls
<ul>
<li>No antacids (Chelation)</li>
</ul>
</li>
</ul>
<h3 id="metronidazole"><a class="header" href="#metronidazole">Metronidazole</a></h3>
<ul>
<li>MOA:
<ul>
<li>Forms toxic free radicals
<ul>
<li>Damages bacterial cell DNA</li>
</ul>
</li>
</ul>
</li>
<li>Uses:
<ul>
<li><strong>Protozoa</strong>: Giardia, Entamoeba, Trichomonas, Gardnerella vaginalis</li>
<li><strong>Anaerobes</strong> (Bacteroides, C difficile)</li>
</ul>
</li>
<li>Side Effects:
<ul>
<li><strong>Disulfiram-like reaction</strong>
<ul>
<li>Severe flushing with alcohol</li>
</ul>
</li>
<li><strong>Metallic taste</strong></li>
</ul>
</li>
</ul>
<h3 id="nitrofurantoin--rifampin"><a class="header" href="#nitrofurantoin--rifampin">Nitrofurantoin &amp; Rifampin</a></h3>
<p><strong>Nitrofurantoin</strong></p>
<ul>
<li>MOA: Not understood</li>
<li>Use: E. Coli, Uncomplicated UTI
<ul>
<li>Concentrates in urine</li>
</ul>
</li>
<li>SE
<ul>
<li>Turns urine brown color (Harmless)</li>
<li><strong><strong>Pulmonary Fibrosis</strong></strong></li>
</ul>
</li>
</ul>
<p><strong>Rifampin</strong></p>
<ul>
<li>MOA: inhibits <strong>bacterial DNA-dependent RNA polymerase</strong></li>
<li>Use:
<ul>
<li>Mycobacteria (TB, Leprosy)</li>
<li>Haemophilus influenza B Prophylaxis</li>
<li>Neisseria Meningitis Prophylaxis</li>
</ul>
</li>
<li>Side Effects:
<ul>
<li>Heme: Thrombocytopenia, leukopenia, anemia</li>
<li>Renal: Nephritis and proteinuria</li>
<li><strong>Red-orange color excreted fluids</strong> (urine, sweat, tears)</li>
<li><strong>Induce CYP 450 - decreases effectiveness of PO contraceptives</strong></li>
</ul>
</li>
</ul>
<h2 id="antibiotic-spectrum-overview"><a class="header" href="#antibiotic-spectrum-overview">Antibiotic Spectrum Overview</a></h2>
<p><strong>Penicillins</strong></p>
<ul>
<li><strong>PCN V Narrow spectrum</strong>
<ul>
<li>Strep, Syphilis, Actinomycosis</li>
</ul>
</li>
<li><strong>Amp/Amox</strong>
<ul>
<li>Strep, Gram -ve rods (E. Coli, Proteus, Salmonella, Shigella), Listeria, H. Pylori</li>
</ul>
</li>
<li><strong>Nafcillin/Oxacillin</strong>
<ul>
<li>Methicillin sensitive S. Aureus (MSSA)</li>
</ul>
</li>
<li><strong>Pip/Tazo - Broad spectrum</strong>
<ul>
<li>Pseudomonas &amp; Nosocomials</li>
</ul>
</li>
<li><strong>Carbapenems - Very Broad</strong>
<ul>
<li>Gram +ve &amp; Pseudomonas</li>
</ul>
</li>
<li><strong>Aztreonam</strong>
<ul>
<li>Pseudomonas</li>
</ul>
</li>
</ul>
<p><strong>Cephalosporins</strong></p>
<ul>
<li><strong>1st Gen - Cefazolin &amp; Cephalexin</strong>
<ul>
<li>Gram +ve cocci (MSSA, Strep) and some Gram -ve rods (E.Coli, klebsiella)</li>
</ul>
</li>
<li><strong>2nd Gen - Cefoxitin:</strong>
<ul>
<li>Above + Neisseria &amp; Serratia</li>
</ul>
</li>
<li><strong>3rd Gen - Greater Gram -ve coverage</strong>
<ul>
<li><strong>Ceftriaxone</strong>
<ul>
<li>Used for Meningitis/Gonorrhea/PNA</li>
</ul>
</li>
<li><strong>Ceftazidime</strong>
<ul>
<li>Gram +ve plus <strong>Pseudomonas</strong></li>
</ul>
</li>
</ul>
</li>
<li><strong>4th Gen - Cefepime</strong>
<ul>
<li>Gram +ve and Gram -ve including <strong>Pseudomonas</strong></li>
</ul>
</li>
<li><strong>5th Gen - Ceftaroline</strong>
<ul>
<li><strong>MRSA</strong> and Gram -ve but <strong>No Pseudomonas</strong></li>
</ul>
</li>
</ul>
<p><strong>Protein Synthesis inhibitors</strong></p>
<ul>
<li>50S Inhibitors
<ul>
<li><strong>Aminoglycosides</strong>
<ul>
<li><strong>Gram -ve</strong> including <strong>Pseudomonas</strong></li>
<li>Used with PCNs (<strong>Synergy</strong>) for <strong>Gram +ve</strong></li>
</ul>
</li>
<li><strong>Tetracyclines</strong>
<ul>
<li>Zoonotics, intracellular organisms, atypicals, CA MRSA</li>
</ul>
</li>
<li><strong>Tigecycline</strong>
<ul>
<li><strong>Very Broad Spectrum</strong></li>
<li>Gram +ve including MRSA &amp; VRE, Gram -ve (Except Pseudomonas), and anaerobic</li>
</ul>
</li>
</ul>
</li>
<li>30S Inhibitors
<ul>
<li><strong>Clindamycin</strong>
<ul>
<li><strong>Anaerobes</strong> above the waist &amp; <strong>CA MRSA</strong></li>
</ul>
</li>
<li><strong>Linezolid</strong>
<ul>
<li>Gram +ve including <strong>MRSA &amp; VRE</strong></li>
</ul>
</li>
<li><strong>Macrolides</strong>
<ul>
<li>Intracellular organisms, <strong>atypicals</strong>, Strep, MAC</li>
</ul>
</li>
</ul>
</li>
</ul>
<p><strong>Miscellaneous Agents</strong></p>
<ul>
<li><strong>Vancomycin</strong>
<ul>
<li><strong>IV used for MRSA, PO used for C. Diff</strong></li>
</ul>
</li>
<li><strong>Daptomycin</strong>
<ul>
<li>Gram +ve <strong>(MRSA &amp; VRE)</strong></li>
</ul>
</li>
<li><strong>Fluoroquinolones</strong>
<ul>
<li><strong>Gram -ve</strong> including pseudomonas, Mycobacteria, and atypicals</li>
</ul>
</li>
<li><strong>Metronidazole</strong>
<ul>
<li><strong>Protozoa, Anaerobes below the waist, C. Diff,</strong> H. Pylori</li>
</ul>
</li>
<li><strong>SMX/TMP</strong>
<ul>
<li>Some Gram +ve (<strong>Nocardia</strong>), Gram -ve (E. Coli), <strong>PCP/PJP</strong>, Toxoplasma prophylaxis</li>
</ul>
</li>
</ul>
<p><strong>MRSA &amp; Pseudomonas Agents</strong></p>
<ul>
<li><strong>MRSA</strong>
<ul>
<li>Community Acquired:
<ul>
<li>TMP-SMX</li>
<li>Doxycycline</li>
<li>Clindamycin</li>
</ul>
</li>
<li>Healthcare Associated:
<ul>
<li>Vancomycin</li>
<li>Daptomycin</li>
<li>Linezolid</li>
<li>Tigecycline</li>
<li>Ceftaroline
<ul>
<li>5th Generation Cephalosporin</li>
<li>Only one with MRSA coverage</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li><strong>Pseudomonas</strong>
<ul>
<li>Piperacillin/Tazobactam (Zosyn)</li>
<li>Aminoglycosides</li>
<li>Aztreonam</li>
<li>Ceftazidime (3rd Gen Cephalosporin)</li>
<li>Cefepime (4th Gen Cephalosporin)</li>
<li>Carbapenems
<ul>
<li>Meropenem, Imipenem, Etc.</li>
</ul>
</li>
<li>Fluoroquinolones
<ul>
<li>Ciprofloxacin, Levofloxacin, Etc.</li>
</ul>
</li>
</ul>
</li>
</ul>
<h2 id="antibiotic-resistance"><a class="header" href="#antibiotic-resistance">Antibiotic Resistance</a></h2>
<ul>
<li><strong>Penicillins</strong>
<ul>
<li>Penicillinase (beta-lactamase)
<ul>
<li>Cleaves b-lactamase ring</li>
<li><strong>Original PCN &amp; Amoxicillin</strong></li>
</ul>
</li>
<li>Altered Peplidase (PCN BindingLPro(ein)
<ul>
<li><strong>PCNs &amp; Cephalosporins</strong></li>
</ul>
</li>
<li>Mutated Porin
<ul>
<li>Drugs can not diffuse into cell</li>
</ul>
</li>
</ul>
</li>
<li><strong>Vancomycin</strong>
<ul>
<li>Mutated Peptidoglycan cell wall
<ul>
<li>Bacteria uses D-Ala D-Lac instead of D-Ala D-Ala</li>
</ul>
</li>
<li>Impaired influx / Increased efflux</li>
</ul>
</li>
<li><strong>Quinolones</strong>
<ul>
<li>Mutated DNA Gyrase (Chromosome)</li>
<li>Efflux pump (Plasmid)</li>
</ul>
</li>
<li><strong>Aminoglycosides</strong>
<ul>
<li>Mutated Ribosomes</li>
<li>Aminoglycosides modifying enzymes (Acetylation, phosphorylation, adenylation)</li>
</ul>
</li>
<li><strong>Chloramphenicol</strong>
<ul>
<li>Inactivation by plasmid encoded acetyltransferase</li>
</ul>
</li>
<li><strong>Linezolid</strong>
<ul>
<li>Point mutation of ribosomal RNA</li>
</ul>
</li>
<li><strong>Macrolides</strong>
<ul>
<li>Decreased binding due to 23s rRNA methylation</li>
</ul>
</li>
<li><strong>Tetracyclines</strong>
<ul>
<li>Decreased uptake / Increased efflux</li>
</ul>
</li>
<li><strong>Rifamycins</strong>
<ul>
<li>Mutated RNA Polymerase</li>
</ul>
</li>
<li><strong>Anti Folates</strong>
<ul>
<li>Mutated or Increased folate synthesis enzymes</li>
</ul>
</li>
</ul>
<h1 id="antibiotics-protein-synthesis-inhibitors"><a class="header" href="#antibiotics-protein-synthesis-inhibitors">Antibiotics, Protein Synthesis Inhibitors</a></h1>
<h1 id="antibiotics-misc"><a class="header" href="#antibiotics-misc">Antibiotics, MISC</a></h1>
<h1 id="anti-fungal-agents"><a class="header" href="#anti-fungal-agents">Anti-Fungal Agents</a></h1>
<ul>
<li><a href="pharmacology/07.html#antifungals-general-principles">Antifungals General Principles</a>
<ul>
<li><a href="pharmacology/07.html#fungus">Fungus</a></li>
<li><a href="pharmacology/07.html#how-to-kill-fungus">How to kill fungus?</a></li>
</ul>
</li>
<li><a href="pharmacology/07.html#fungus-overview">Fungus Overview</a>
<ul>
<li><a href="pharmacology/07.html#systemic-fungus">Systemic Fungus</a></li>
<li><a href="pharmacology/07.html#cutaneous-fungus">Cutaneous Fungus</a></li>
<li><a href="pharmacology/07.html#opportunistic">Opportunistic</a></li>
</ul>
</li>
<li><a href="pharmacology/07.html#azoles">Azoles</a>
<ul>
<li><a href="pharmacology/07.html#azoles---specific-side-effects">Azoles - Specific Side Effects</a></li>
</ul>
</li>
<li><a href="pharmacology/07.html#echinocandins">Echinocandins</a></li>
<li><a href="pharmacology/07.html#amphotericin-b">Amphotericin B</a></li>
<li><a href="pharmacology/07.html#nystatin">Nystatin</a></li>
<li><a href="pharmacology/07.html#flucytosine">Flucytosine</a></li>
<li><a href="pharmacology/07.html#griseofulvin">Griseofulvin</a></li>
<li><a href="pharmacology/07.html#terbinafine">Terbinafine</a></li>
</ul>
<h2 id="antifungals-general-principles"><a class="header" href="#antifungals-general-principles">Antifungals General Principles</a></h2>
<h3 id="fungus"><a class="header" href="#fungus">Fungus</a></h3>
<ul>
<li>Special Fungal Characteristics</li>
<li>Cell Membrane: <strong>Ergosterol (Cholesterol-like)</strong>
<ul>
<li>Sequence of synthesis: Squalene-Squalene epoxide-Lanosterol-Ergosterol</li>
</ul>
</li>
<li>Cell Wall: <strong>Glucans (Glucose polymers)</strong></li>
</ul>
<h3 id="how-to-kill-fungus"><a class="header" href="#how-to-kill-fungus">How to kill fungus?</a></h3>
<ul>
<li>Inhibit <strong>Cell MEMBRANE</strong> synthesis
<ul>
<li>Inhibit <strong>Lanosterol</strong> synthesis: Terbinafine</li>
<li>Inhibit <strong>Ergosterol</strong> synthesis: Azoles</li>
</ul>
</li>
<li>Inhibit <strong>Cell WALL</strong> synthesis
<ul>
<li>Inhibit <strong>B-Glucans</strong> synthesis: Echinocandins (-Fungins)</li>
</ul>
</li>
<li><strong>Punch holes in Ergosterol</strong>: Amphotericin, Nystatin</li>
<li>Inhibit <strong>DNA/RNA</strong> synthesis: Flucytosine</li>
<li>Inhibit <strong>Mitosis</strong>: Griseofulvin</li>
</ul>
<h2 id="fungus-overview"><a class="header" href="#fungus-overview">Fungus Overview</a></h2>
<h3 id="systemic-fungus"><a class="header" href="#systemic-fungus">Systemic Fungus</a></h3>
<ul>
<li>Histoplasmosis, Blastomycosis , Coccidioidomycosis, Paracoccidioidomycosis</li>
<li><strong>Treatment: Azoles &amp; Amphotericin for severe infections</strong></li>
</ul>
<h3 id="cutaneous-fungus"><a class="header" href="#cutaneous-fungus">Cutaneous Fungus</a></h3>
<ul>
<li>Malassezia Furfur</li>
<li>Dermatophytes (Tinea)</li>
<li>Sporothrix</li>
<li><strong>Treatment: Topical Azoles, Terbinafine, Griseofulvin, Potassium lodide</strong></li>
</ul>
<h3 id="opportunistic"><a class="header" href="#opportunistic">Opportunistic</a></h3>
<ul>
<li>Candida</li>
<li>Aspergillus</li>
<li>Cryptococcus</li>
<li>Mucormycosis</li>
<li>Pneumocystis Jiroveci (PCP)</li>
<li><strong>Treatment</strong>
<ul>
<li><strong>Azoles, Echinocandins, Amphotericin, Nystatin, Flucytosine</strong></li>
<li><strong>PCP - SMX/TMP or Dapsone</strong></li>
</ul>
</li>
</ul>
<h2 id="azoles"><a class="header" href="#azoles">Azoles</a></h2>
<p><strong>Clotrimazole &amp; Fluconazole &amp; Itraconazole &amp; Ketoconazole &amp; Miconazole &amp; Voriconazole &amp;</strong>
Suffix <strong>-Azole</strong></p>
<p><strong>MOA</strong>:</p>
<ul>
<li>Inhibits <strong>14-a-demethylase</strong></li>
<li>Converts Lanosterol to Ergosterol (Cell Membrane)</li>
</ul>
<p><strong>Uses</strong>:</p>
<ul>
<li><strong>Local and less severe fungal infections</strong></li>
<li>Topical - 1st line for Dermatophytes</li>
<li><strong>Fluconazole</strong> - Chronic cryptococcal meningitis (AIDs) &amp; most candidal infections</li>
<li><strong>ltraconazole</strong> - Blasto, Coccidio, Histo</li>
<li><strong>Clotrimazole</strong> and <strong>Miconazole</strong> - Topical</li>
<li><strong>Voriconazole</strong> - Aspergillus and Invasive Candida</li>
</ul>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Testosterone synthesis inhibition</li>
<li><strong>Gynecomastia -&gt; Ketoconazole</strong></li>
<li><strong>Liver Dysfunction</strong></li>
<li>14-a-demethylase is a CYP450-like enzyme!</li>
</ul>
<h3 id="azoles---specific-side-effects"><a class="header" href="#azoles---specific-side-effects">Azoles - Specific Side Effects</a></h3>
<p><strong>Ketoconazole</strong></p>
<ul>
<li>Side Effects:
<ul>
<li><strong>Gynecomastia</strong>, decreased libido, ED, menstrual irrggularities</li>
<li><strong>Inhibition of adrenal steroidogenesis</strong></li>
<li><strong>Hepatotoxic</strong></li>
</ul>
</li>
</ul>
<p><strong>Fluconazole</strong></p>
<ul>
<li><strong>Least CYP interactions &amp; Lowest range of activity</strong></li>
<li>CSF penetration</li>
<li><strong><strong>Safest Azole</strong></strong></li>
<li>Side Effects:
<ul>
<li>QT Prolongation</li>
</ul>
</li>
</ul>
<p><strong>Itraconazole</strong></p>
<ul>
<li>Side Effects:
<ul>
<li>Hepatotoxic</li>
<li><strong>Visual disturbances</strong></li>
</ul>
</li>
</ul>
<p><strong>Voriconazole</strong></p>
<ul>
<li>Side Effects:
<ul>
<li><strong>Visual disturbances</strong>, SJS, Hepatotoxic, Hallucinations, Confusion</li>
</ul>
</li>
</ul>
<h2 id="echinocandins"><a class="header" href="#echinocandins">Echinocandins</a></h2>
<p><strong>Caspofungin &amp; Micafungin</strong> &amp; Suffix <strong>-fungin</strong></p>
<p><strong>MOA</strong>: Inhibits B-glucan synthesis (Cell wall)</p>
<p><strong>Uses</strong>: Invasive Aspergillosis &amp; Candida</p>
<p><strong>Side Effects:</strong> Gl upset &amp; flushing</p>
<h2 id="amphotericin-b"><a class="header" href="#amphotericin-b">Amphotericin B</a></h2>
<p><strong>MOA</strong>: Binds <strong>ergosterol</strong> and <strong>forms holes (pores) in membrane</strong></p>
<ul>
<li>Allows for electrolyte leakage</li>
</ul>
<p><strong>Use</strong>: Serious systemic &amp; opportunistic mycoses</p>
<p><strong>Infusion reactions</strong></p>
<ul>
<li>Fevers, chills, muscles spasms, hypotension</li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li>Renal: <strong><strong>Nephrotoxic, Low K, Low Mg</strong></strong></li>
<li>Infusion related: Fever &amp; pain</li>
<li>Others: Increased LFTs, anemia, thrombocytopenia, leukopenia</li>
</ul>
<p><strong>Liposomal formulation</strong></p>
<ul>
<li>Less infusion reaction</li>
<li>Less Nephrotoxicity</li>
</ul>
<p>Can use in <strong>pregnancy</strong></p>
<h2 id="nystatin"><a class="header" href="#nystatin">Nystatin</a></h2>
<p><strong>MOA</strong>: Same as Amphotericin</p>
<p><strong>Use</strong>:</p>
<ul>
<li>Oral Candida (Swish and Swallow)</li>
<li>Diaper rash/Vaginal Candida (Topical)</li>
</ul>
<h2 id="flucytosine"><a class="header" href="#flucytosine">Flucytosine</a></h2>
<p><strong>MOA</strong></p>
<ul>
<li>Converted to 5 FU by cytosine deaminase</li>
<li>5FU incorporated into DNA/RNA, leads to chain termination, inhibiting DNA/RNA synthesis</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li><strong>Cryptococcal Meningitis</strong> (Combined with Amphotericin B)</li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li><strong>Bone marrow suppression</strong></li>
</ul>
<h2 id="griseofulvin"><a class="header" href="#griseofulvin">Griseofulvin</a></h2>
<p><strong>MOA</strong></p>
<ul>
<li>Inhibit Microtubules inhibiting mitosis</li>
<li>Deposits in ko:atin tissues (Nails)</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>Superficial dermatophytes mainly Tinea Capitis</li>
<li>Rarely used 2/2 SE</li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li>Teratogenic</li>
<li><strong><strong>Induce CYP450</strong></strong>
<ul>
<li><strong>Decrease warfarin, OCP levels</strong></li>
</ul>
</li>
</ul>
<p><em>Side note</em> <strong>Drugs that inhibit Microtubules</strong></p>
<ul>
<li>Griseofulvin</li>
<li>Mebendazole</li>
<li>Colchicine</li>
<li>Vincristine/Vinblastine</li>
<li>Paclitaxel</li>
</ul>
<h2 id="terbinafine"><a class="header" href="#terbinafine">Terbinafine</a></h2>
<p><strong>MOA</strong></p>
<ul>
<li><strong>Inhibit squalene epoxide</strong> inhibiting ergosterol synthesis <strong>inhibiting cell membrane synthesis</strong></li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>Dermatophytes</li>
<li>1st line for Onychomycosis</li>
</ul>
<p><em>Note: Azole is the 1st line for topical dermatophytes</em></p>
<p><strong>SE</strong></p>
<ul>
<li><strong><strong>Hepatotoxicity</strong></strong></li>
</ul>
<h1 id="anti-tuberculosis-drugs"><a class="header" href="#anti-tuberculosis-drugs">Anti-Tuberculosis Drugs</a></h1>
<ul>
<li><a href="pharmacology/08.html#anti-mycobacterial-agents-general-principles">Anti-Mycobacterial Agents General Principles</a></li>
<li><a href="pharmacology/08.html#anti-mycobacterial-tb">Anti-Mycobacterial TB</a>
<ul>
<li><a href="pharmacology/08.html#rifampin--rifabutin">Rifampin &amp; Rifabutin</a></li>
<li><a href="pharmacology/08.html#isoniazid-inh">Isoniazid (INH)</a></li>
<li><a href="pharmacology/08.html#pyrazinamide">Pyrazinamide</a></li>
<li><a href="pharmacology/08.html#ethambutol">Ethambutol</a></li>
<li><a href="pharmacology/08.html#2nd-line-agents">2nd line Agents</a></li>
<li><a href="pharmacology/08.html#3rd-line-agents">3rd line Agents</a></li>
</ul>
</li>
<li><a href="pharmacology/08.html#anti-mycobacterium-leprae--mycobacterium-avium-complex-agents">Anti-Mycobacterium Leprae &amp; Mycobacterium Avium Complex Agents</a>
<ul>
<li><a href="pharmacology/08.html#mycobacterium-leprae-leprosy">Mycobacterium Leprae (Leprosy)</a></li>
<li><a href="pharmacology/08.html#mycobacterium-avium-complex-mac">Mycobacterium Avium Complex (MAC)</a></li>
</ul>
</li>
<li><a href="pharmacology/08.html#disease-summary---mycobacteria">Disease Summary - Mycobacteria</a>
<ul>
<li><a href="pharmacology/08.html#active-mycobacterium-tuberculosis">Active Mycobacterium Tuberculosis</a></li>
<li><a href="pharmacology/08.html#mycobacterium-avium-complex-mac-1">Mycobacterium Avium Complex (MAC)</a></li>
<li><a href="pharmacology/08.html#mycobacterium-leprae-leprosy-1">Mycobacterium Leprae (Leprosy)</a></li>
</ul>
</li>
</ul>
<h2 id="anti-mycobacterial-agents-general-principles"><a class="header" href="#anti-mycobacterial-agents-general-principles">Anti-Mycobacterial Agents General Principles</a></h2>
<ul>
<li>3 Important organisms
<ul>
<li>Mycobacteria Tuberculosis</li>
<li>Mycobacterium Avium Complex</li>
<li>Mycobacterium Leprae</li>
</ul>
</li>
<li>How is Mycobacteria different?
<ul>
<li>Cell wall
<ul>
<li>Mycolic acid (Long chain fatty acids)</li>
<li>Arabinogalactan</li>
<li>Peptidoglycan</li>
</ul>
</li>
</ul>
</li>
<li>How to kill Mycobacteria?
<ul>
<li><strong>Inhibit Cell wall synthesis</strong>
<ul>
<li><strong>Inhibit Mycolic acid synthesis</strong>: Isoniazid</li>
<li><strong>Inhibit Arabinogalactan polymerization</strong>: Ethambutol</li>
</ul>
</li>
<li><strong>Inhibit Transcription</strong>
<ul>
<li><strong>Inhibit mRNA synthesis</strong>: Rifampin</li>
</ul>
</li>
<li><strong>Inhibit Protein Synthesis</strong>: Aminoglycosides (Streptomycin)</li>
<li><strong>Inhibit new base synthesis</strong>
<ul>
<li><strong>Inhibit folic acid synthesis</strong>: SMX-TMP, Dapsone</li>
</ul>
</li>
<li><strong>Inhibit DNA unwinding</strong>: Fluoroquinolone</li>
<li>Unknown: Pyrazinamide</li>
</ul>
</li>
</ul>
<h2 id="anti-mycobacterial-tb"><a class="header" href="#anti-mycobacterial-tb">Anti-Mycobacterial TB</a></h2>
<h3 id="rifampin--rifabutin"><a class="header" href="#rifampin--rifabutin">Rifampin &amp; Rifabutin</a></h3>
<p><strong>MOA</strong>: inhibits <strong>bacterial DNA-dependent RNA polymerase</strong></p>
<p><strong>Use</strong>:</p>
<ul>
<li>Mycobacteria (TB, Leprosy)</li>
<li>Haemophilus influenza B Prophylaxis</li>
<li>Neisseria Meningitis Prophylaxis</li>
</ul>
<p><strong>Rifabutin</strong>: Cousin with less Drug interactions- Preferred in HIV patients</p>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Heme: Thrombocytopenia, leukopenia, anemia. Hyperbilirubinemia</li>
<li>Renal: Nephritis and proteinuria</li>
<li><strong>Red-orange color excreted fluids</strong> (urine sweat, tears)</li>
<li><strong>Induce CYP 450 - decreases effectiveness of PO contraceptives</strong></li>
</ul>
<p><strong>Resistance</strong>: Mutations in binding to RNA Polymerase</p>
<h3 id="isoniazid-inh"><a class="header" href="#isoniazid-inh">Isoniazid (INH)</a></h3>
<p><strong>MOA</strong>: Inhibits mycolic acid synthesis</p>
<p><strong>Use</strong>:TB</p>
<p><strong>Metabolism</strong></p>
<ul>
<li><strong>&quot;Histone Acetylation&quot;</strong></li>
<li>Patients can be slow or fast Acetylators</li>
</ul>
<p><strong>Side Effects:</strong></p>
<ul>
<li><strong>B6 Neuropathy</strong></li>
<li>Seizures (related to B6 Deficiency)</li>
<li><strong>Sideroblastic Anemia</strong></li>
<li><strong>Hepatotoxicity</strong></li>
<li><strong>Anion gap metabolic acidosis</strong> (MUD PIILES)</li>
<li><strong>Drug induced Lupus - Anti-Histone antibodies</strong></li>
</ul>
<p><strong>Resistance</strong></p>
<ul>
<li>INH is processed by <strong>intracellular catalase peroxidase</strong>
<ul>
<li>Resistance is decreased activity of this enzyme</li>
</ul>
</li>
</ul>
<p><em>Side Note: Drug Induced Lupus (Hydralazine, Isoniazid, Procainamide)</em></p>
<h3 id="pyrazinamide"><a class="header" href="#pyrazinamide">Pyrazinamide</a></h3>
<p><strong>MOA</strong>: Unknown - Works in acidic environment (Phagolysosomes)</p>
<p><strong>Use</strong>: Part of RIPE</p>
<p><strong>Side Effects</strong>: Hepatotoxic</p>
<h3 id="ethambutol"><a class="header" href="#ethambutol">Ethambutol</a></h3>
<p><strong>MOA</strong>: <strong>Inhibit Arabinosyl transferase</strong> which polymerizes <strong>arabinogalactan</strong> (Carbohydrate Part of TB cell wall)</p>
<p><strong>Use</strong>: Part of RIPE</p>
<p><strong>Side Effects</strong>: <strong>Optic Neuropathy - Red/Green color blindness</strong></p>
<h3 id="2nd-line-agents"><a class="header" href="#2nd-line-agents">2nd line Agents</a></h3>
<ul>
<li>Aminoglycosides (Streptomycin)</li>
<li>Fluoroquinolones (Ciprofloxacin, Levofloxacin)</li>
</ul>
<h3 id="3rd-line-agents"><a class="header" href="#3rd-line-agents">3rd line Agents</a></h3>
<ul>
<li>P-Aminosalicylic acid (Blocks folic acid)</li>
<li>Ethionamide (Blocks mycolic acid)</li>
<li>Cycloserine (Inhibits cell wall)</li>
</ul>
<h2 id="anti-mycobacterium-leprae--mycobacterium-avium-complex-agents"><a class="header" href="#anti-mycobacterium-leprae--mycobacterium-avium-complex-agents">Anti-Mycobacterium Leprae &amp; Mycobacterium Avium Complex Agents</a></h2>
<h3 id="mycobacterium-leprae-leprosy"><a class="header" href="#mycobacterium-leprae-leprosy">Mycobacterium Leprae (Leprosy)</a></h3>
<p><strong>Dapsone</strong>
<strong>MOA</strong>:</p>
<ul>
<li>Folic acid antagonist</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li><strong>Leprosy</strong> both types</li>
<li><strong>PCP if patient has sulfa allergy</strong></li>
</ul>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Hemolysis with G6PD deficiency</li>
</ul>
<p><strong>Other Drugs used for Leprosy</strong></p>
<ul>
<li>Rifampin</li>
<li>Clofazimine</li>
</ul>
<h3 id="mycobacterium-avium-complex-mac"><a class="header" href="#mycobacterium-avium-complex-mac">Mycobacterium Avium Complex (MAC)</a></h3>
<p>AIDS defining illness</p>
<p>Need to <strong>prophylax HIV patients if CD4&lt; 50</strong></p>
<p>Drugs used for MAC</p>
<ul>
<li><strong>Multi drug treatment</strong></li>
<li><strong>Azithromycin 1st line</strong></li>
<li>Clarithromycin</li>
<li>Ethambutol</li>
<li>Rifaputin</li>
</ul>
<h2 id="disease-summary---mycobacteria"><a class="header" href="#disease-summary---mycobacteria">Disease Summary - Mycobacteria</a></h2>
<h3 id="active-mycobacterium-tuberculosis"><a class="header" href="#active-mycobacterium-tuberculosis">Active Mycobacterium Tuberculosis</a></h3>
<ul>
<li>Be Aware of Directly Observed Treatment (DOT)</li>
<li><strong>1st line</strong>
<ul>
<li>RIPE</li>
</ul>
</li>
<li><strong>MDR</strong>
<ul>
<li>High dose RIPE</li>
<li>Aminoglycosides X</li>
<li>Fluoroquinolone</li>
</ul>
</li>
<li><strong>XDR (Extra resistant)</strong>
<ul>
<li>Ethionamide</li>
<li>Cycloserine</li>
<li>P-Aminosalicylic acid</li>
</ul>
</li>
</ul>
<h3 id="mycobacterium-avium-complex-mac-1"><a class="header" href="#mycobacterium-avium-complex-mac-1">Mycobacterium Avium Complex (MAC)</a></h3>
<ul>
<li>1st: Azithromycin</li>
<li>2nd: Ethambutol, Rifabutin</li>
</ul>
<h3 id="mycobacterium-leprae-leprosy-1"><a class="header" href="#mycobacterium-leprae-leprosy-1">Mycobacterium Leprae (Leprosy)</a></h3>
<ul>
<li><strong>Tuberculoid type (Th1)</strong>
<ul>
<li><em>Dapsone</em> + Rifampin</li>
</ul>
</li>
<li><strong>Lepromatous type (Th2)</strong>
<ul>
<li>Dapsone + Rifampin + Clofazimine</li>
</ul>
</li>
</ul>
<h1 id="malaria"><a class="header" href="#malaria">Malaria</a></h1>
<h1 id="misc-parasites"><a class="header" href="#misc-parasites">Misc Parasites</a></h1>
<h1 id="anti-virals--hiv"><a class="header" href="#anti-virals--hiv">Anti-virals &amp; HIV</a></h1>
<ul>
<li><a href="pharmacology/11.html#antivirals">Antivirals</a>
<ul>
<li><a href="pharmacology/11.html#antivirals-general-principles">Antivirals General Principles</a>
<ul>
<li><a href="pharmacology/11.html#goal-prevent-viral-replication">Goal: Prevent viral replication</a></li>
<li><a href="pharmacology/11.html#nucleoside-vs-nucleotide">Nucleoside vs. Nucleotide</a></li>
<li><a href="pharmacology/11.html#how">How?</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#herpesvaricella-zostercmv">Herpes/Varicella Zoster/CMV</a>
<ul>
<li><a href="pharmacology/11.html#acyclovir--valaciclovir">Acyclovir &amp; VALAciclovir</a></li>
<li><a href="pharmacology/11.html#ganciclovir--valgancciclovir">Ganciclovir &amp; VALGANCciclovir</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#viral-respiratory-infections">Viral Respiratory Infections</a>
<ul>
<li><a href="pharmacology/11.html#oseltamivir--zanamivir">Oseltamivir &amp; Zanamivir</a></li>
<li><a href="pharmacology/11.html#ribavirin">Ribavirin</a></li>
<li><a href="pharmacology/11.html#amantadine">Amantadine</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#hepatitis">Hepatitis</a>
<ul>
<li><a href="pharmacology/11.html#interferon-alpha">Interferon Alpha</a></li>
<li><a href="pharmacology/11.html#ribavirin-1">Ribavirin</a></li>
<li><a href="pharmacology/11.html#ledipasivir--sofosbuvir-harvoni--ledipasivir--simeprevir">Ledipasivir / Sofosbuvir (Harvoni) &amp; Ledipasivir / Simeprevir</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#antivirals-summary">Antivirals Summary</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#hiv-treatment">HIV Treatment</a>
<ul>
<li><a href="pharmacology/11.html#hiv-treatment-general-principles">HIV Treatment General Principles</a>
<ul>
<li><a href="pharmacology/11.html#goal-prevent-viral-replication-1">Goal: Prevent viral replication</a></li>
<li><a href="pharmacology/11.html#how-1">How?</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#nucleoside-reverse-transcriptase-inhibitors-nrtis">Nucleoside Reverse Transcriptase Inhibitors (NRTIs)</a>
<ul>
<li><a href="pharmacology/11.html#emtricitabine--abacavir--lamivudine--zidovudine">Emtricitabine &amp; Abacavir &amp; Lamivudine &amp; Zidovudine</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#nucleotide-reverse-transcriptase-inhibitors-ntrti">Nucleotide Reverse Transcriptase Inhibitors (NtRTI)</a>
<ul>
<li><a href="pharmacology/11.html#tenofovir">Tenofovir</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#non-nucleoside-reverse-transcriptase-inhibitors-nnrti">Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)</a>
<ul>
<li><a href="pharmacology/11.html#efavirenz-rilpivirine-etravirine">Efavirenz, Rilpivirine, Etravirine</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#protease-inhibitors">Protease Inhibitors</a>
<ul>
<li><a href="pharmacology/11.html#atazanavir--lopinavir--ritonavir--suffix--navir">Atazanavir &amp; Lopinavir &amp; Ritonavir &amp;** Suffix **-navir</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#integrase-inhibitors">Integrase Inhibitors</a>
<ul>
<li><a href="pharmacology/11.html#raltegravir-suffix--gravir">Raltegravir (Suffix -gravir)</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#fusion-inhibitors">Fusion Inhibitors</a>
<ul>
<li><a href="pharmacology/11.html#enfuvirtide">Enfuvirtide</a></li>
<li><a href="pharmacology/11.html#maraviroc">Maraviroc</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#hiv-summary">HIV Summary</a>
<ul>
<li><a href="pharmacology/11.html#who-gets-treated">Who gets treated?</a></li>
<li><a href="pharmacology/11.html#regimens">Regimens</a></li>
</ul>
</li>
<li><a href="pharmacology/11.html#prophylaxis-in-hiv-patients">Prophylaxis in HIV Patients</a></li>
</ul>
</li>
</ul>
<h1 id="antivirals"><a class="header" href="#antivirals">Antivirals</a></h1>
<h2 id="antivirals-general-principles"><a class="header" href="#antivirals-general-principles">Antivirals General Principles</a></h2>
<h3 id="goal-prevent-viral-replication"><a class="header" href="#goal-prevent-viral-replication">Goal: Prevent viral replication</a></h3>
<h3 id="nucleoside-vs-nucleotide"><a class="header" href="#nucleoside-vs-nucleotide">Nucleoside vs. Nucleotide</a></h3>
<ul>
<li>Nucleoside: Base + Sugar</li>
<li>Nucleotide: Base + Sugar + Phosphate</li>
</ul>
<h3 id="how"><a class="header" href="#how"><strong>How?</strong></a></h3>
<ul>
<li><strong>Terminate replicating chain- Inhibit viral DNA Polymerase</strong>
<ul>
<li><strong>NucleoSIDE analogue</strong>: Acyclovir, Ganciclovir, Trifluridine</li>
<li><strong>NucleoTIDE analogue</strong>: Cidofovir</li>
</ul>
</li>
<li><strong>Directly inhibit DNA/RNA Polymerase</strong>
<ul>
<li>Foscarnet</li>
</ul>
</li>
<li><strong>Inhibit new base synthesis X</strong>
<ul>
<li>Ribavirin</li>
</ul>
</li>
<li><strong>Inhibit virion release from cells</strong>
<ul>
<li>Oseltamivir</li>
</ul>
</li>
<li><strong>Inhibit viral uncoating</strong>
<ul>
<li>Amantadine</li>
</ul>
</li>
</ul>
<h2 id="herpesvaricella-zostercmv"><a class="header" href="#herpesvaricella-zostercmv">Herpes/Varicella Zoster/CMV</a></h2>
<h3 id="acyclovir--valaciclovir"><a class="header" href="#acyclovir--valaciclovir">Acyclovir &amp; VALAciclovir</a></h3>
<p><strong>MOA</strong></p>
<ul>
<li>Guanosine analogue (NucleoSIDE)- Phosphorylated by <strong>viral thymidine Kinase</strong>, inhibits viral DNA polymerase by chain termination.</li>
<li>Prefers viral cells</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li><strong>HSV</strong> Encephalitis and Ulcers</li>
<li><strong>VZV</strong></li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li>Concentrates in kidneys - <strong>Acute renal failure if dehydrated</strong></li>
</ul>
<h3 id="ganciclovir--valgancciclovir"><a class="header" href="#ganciclovir--valgancciclovir">Ganciclovir &amp; VALGANCciclovir</a></h3>
<p><strong>MOA</strong></p>
<ul>
<li>Guanosine analogue (NucleoSIDE), phosphorylated by <strong>CMV viral kinase</strong>, inhibits DNA polymerase</li>
<li>Goes into viral and human cells</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li><strong>CMV</strong>
<ul>
<li>Retinitis, systemic, prophylaxis in transplant patients</li>
</ul>
</li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li>More toxic than acyclovir</li>
<li><strong>Bone marrow suppression (Neutropenia)</strong></li>
<li>Renal failure</li>
</ul>
<h2 id="viral-respiratory-infections"><a class="header" href="#viral-respiratory-infections">Viral Respiratory Infections</a></h2>
<h3 id="oseltamivir--zanamivir"><a class="header" href="#oseltamivir--zanamivir">Oseltamivir &amp; Zanamivir</a></h3>
<p><strong>MOA</strong>: <strong>Neuraminidase Inhibitor</strong></p>
<ul>
<li>Influenza virus attaches to host cell using hemagglutinin via sialic acid</li>
<li>Neuraminidase cleaves sialic acid and allows virus to be release</li>
<li><strong>Drug inhibit viral progeny release from host cells by inhibiting Neuraminidase enzyme</strong></li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>Influenza A &amp; B</li>
<li>Use within 48 hours of sx</li>
<li>Shortens duration of iliness</li>
<li>Can be used as prophylaxis</li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li>Zanamivir- Inhaled-Bronchospasm</li>
</ul>
<h3 id="ribavirin"><a class="header" href="#ribavirin">Ribavirin</a></h3>
<p><strong>MOA</strong></p>
<ul>
<li>Inhibits <strong>IMP dehydrogenase</strong></li>
<li>Leading to <strong>inhibiting guanine nucleotide synthesis</strong></li>
<li>Leading to <strong>inhibiting viral mRNA synthesis</strong></li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>Aerosol - <strong>RSV in children</strong></li>
<li>Oral - <strong>Hepatitis B&amp; C</strong></li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li>Anemia</li>
<li><strong><strong>Teratogenic</strong></strong></li>
</ul>
<h3 id="amantadine"><a class="header" href="#amantadine">Amantadine</a></h3>
<p><strong>MOA</strong> Inhibits M2 protein used for viral uncoating</p>
<p>Not used for Flu anymore - Used for PD</p>
<h2 id="hepatitis"><a class="header" href="#hepatitis">Hepatitis</a></h2>
<h3 id="interferon-alpha"><a class="header" href="#interferon-alpha">Interferon Alpha</a></h3>
<p><strong>MOA</strong></p>
<ul>
<li>Interferes with viral protein synthesis</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>Hepatiis B/ C + Ribavirin - <strong>NOT CURATIVE</strong></li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li><strong>Depression</strong></li>
<li>Myopathy</li>
<li><strong>Neutropenia</strong></li>
</ul>
<p><em>Side note</em></p>
<ul>
<li>Interferon <em>Alpha</em> - Tx viral and cancer stuff</li>
<li>Interferon <em>Beta</em> - Tx Multiple Sclerosis</li>
<li>Interferon <em>Gamma</em> - Chronic Granulomatous Disease</li>
</ul>
<h3 id="ribavirin-1"><a class="header" href="#ribavirin-1">Ribavirin</a></h3>
<ul>
<li>Hepatitis B &amp; C with interferon</li>
</ul>
<h3 id="ledipasivir--sofosbuvir-harvoni--ledipasivir--simeprevir"><a class="header" href="#ledipasivir--sofosbuvir-harvoni--ledipasivir--simeprevir">Ledipasivir / Sofosbuvir (Harvoni) &amp; Ledipasivir / Simeprevir</a></h3>
<p><strong>MOA</strong></p>
<ul>
<li><strong>Ledipasivir</strong>
<ul>
<li>Inhibit NSSA (involved in viral replication)</li>
</ul>
</li>
<li><strong>Sofosbuvir</strong>
<ul>
<li>Incorporated into RNA and acts as chain terminator</li>
<li>Inhibit RNA dependent DNA polymerase</li>
</ul>
</li>
<li><strong>Simeprevir</strong>
<ul>
<li>HCV protease inhibitor</li>
</ul>
</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>Hepatitic C</li>
<li><strong>Harvoni - Curative in Combo</strong></li>
</ul>
<p><strong>Cost</strong></p>
<ul>
<li>$100,000 for 12 weeks</li>
<li>$1000 per pill</li>
</ul>
<h2 id="antivirals-summary"><a class="header" href="#antivirals-summary">Antivirals Summary</a></h2>
<p><strong>Viruses AND Drugs</strong></p>
<ul>
<li><strong>HSV</strong>= Acyclovir- Foscarnet-Trifluridine</li>
<li><strong>VZV</strong>= Acyclovir</li>
<li><strong>CMV</strong>= Ganciclovir- Foscarnet- Cidofovir</li>
<li><strong>Influenza</strong>= Oseltamivir, Amantadine</li>
<li><strong>RSV</strong>= Ribavirin</li>
<li><strong>HBV</strong>
<ul>
<li>Tenofovir + Lamivudine</li>
<li>Interferon + Ribavirin (Not prefered)</li>
</ul>
</li>
<li><strong>HCV</strong>
<ul>
<li>Curative = Ledipasvir/Sofosbuvir +/- Ribavirin</li>
</ul>
</li>
</ul>
<h1 id="hiv-treatment"><a class="header" href="#hiv-treatment">HIV Treatment</a></h1>
<h2 id="hiv-treatment-general-principles"><a class="header" href="#hiv-treatment-general-principles">HIV Treatment General Principles</a></h2>
<h3 id="goal-prevent-viral-replication-1"><a class="header" href="#goal-prevent-viral-replication-1">Goal: Prevent viral replication</a></h3>
<h3 id="how-1"><a class="header" href="#how-1">How?</a></h3>
<ul>
<li><strong>Inhibit HIV fusion into host cells</strong>
<ul>
<li><em>Prevent docking</em>: Maraviroc</li>
<li><em>Prevent fusion and entry</em>: Enfuvirtide</li>
</ul>
</li>
<li><strong>Inhibit reverse transcriptase</strong>
<ul>
<li><em>Via nucleoSIDES</em>: NRTI (Emtricitabine/Abacavir/Lamivudine/Zidovudine)</li>
<li><em>Via nucleoTIDES</em>: NtRTI (Tenofovir)</li>
<li><em>Via non-nucleosides</em>: NNRTI (Efavirenz)</li>
</ul>
</li>
<li><strong>Inhibit HIV integration into host cell genome</strong>
<ul>
<li><em>Integrase inhibitors</em> (Suffix-gravir)</li>
</ul>
</li>
<li><strong>Inhibit new virus maturation</strong>
<ul>
<li><em>Protease Inhibitors</em>: (Suffix-navir)</li>
</ul>
</li>
</ul>
<h2 id="nucleoside-reverse-transcriptase-inhibitors-nrtis"><a class="header" href="#nucleoside-reverse-transcriptase-inhibitors-nrtis">Nucleoside Reverse Transcriptase Inhibitors (NRTIs)</a></h2>
<h3 id="emtricitabine--abacavir--lamivudine--zidovudine"><a class="header" href="#emtricitabine--abacavir--lamivudine--zidovudine">Emtricitabine &amp; Abacavir &amp; Lamivudine &amp; Zidovudine</a></h3>
<p><strong>MOA</strong></p>
<ul>
<li>Inhibit nucleotide binding to reverse transcriptase - Terminate DNA chain</li>
<li>Need to be phosphorylated</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li><strong>Backbone of HAART</strong></li>
<li>Lamivudine= HIV + Hepatitis B</li>
<li><em><strong>Zidovudine</strong></em>
<ul>
<li><strong>Pregnant HIV mothers</strong></li>
<li><strong>Prophylaxis for infants @ risk</strong></li>
</ul>
</li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li><strong>Abacavir - Hypersensitivity if HLA-B5701 mutation</strong></li>
<li>Zidovudine - Myelosuppression, Lipodystrophy</li>
<li>Didanosine - <strong><strong>Pancreatitis</strong></strong></li>
</ul>
<h2 id="nucleotide-reverse-transcriptase-inhibitors-ntrti"><a class="header" href="#nucleotide-reverse-transcriptase-inhibitors-ntrti">Nucleotide Reverse Transcriptase Inhibitors (NtRTI)</a></h2>
<h3 id="tenofovir"><a class="header" href="#tenofovir">Tenofovir</a></h3>
<p><strong>MOA</strong></p>
<ul>
<li>Terminate DNA chain by inhibiting reverse transcriptase</li>
<li>Does not need to be phosphorylated</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li><strong>Mainly used to boost levels of protease inhibitors (Booster)</strong>
<ul>
<li>Tenofovir inhibits CYP 450</li>
<li>Protease inhibitors are metabolized via CYP 450</li>
</ul>
</li>
<li>Active against Hepatitis B</li>
</ul>
<h2 id="non-nucleoside-reverse-transcriptase-inhibitors-nnrti"><a class="header" href="#non-nucleoside-reverse-transcriptase-inhibitors-nnrti">Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)</a></h2>
<h3 id="efavirenz-rilpivirine-etravirine"><a class="header" href="#efavirenz-rilpivirine-etravirine">Efavirenz, Rilpivirine, Etravirine</a></h3>
<p><strong>MOA</strong></p>
<ul>
<li>Inhibit reverse transcriptase @ site different than NRTI</li>
<li>Do not need phosphorylation</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>HAART</li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li>Vivid dreams</li>
<li>Contraindicated in pregnancy</li>
</ul>
<p><strong>Drug interactions</strong></p>
<ul>
<li>Decrease levels of barbiturates and anticonvulsants</li>
<li>Efavirenz levels will be decreased by Rifampin</li>
</ul>
<h2 id="protease-inhibitors"><a class="header" href="#protease-inhibitors">Protease Inhibitors</a></h2>
<h3 id="atazanavir--lopinavir--ritonavir--suffix--navir"><a class="header" href="#atazanavir--lopinavir--ritonavir--suffix--navir">Atazanavir &amp; Lopinavir &amp; Ritonavir &amp;** Suffix **-navir</a></h3>
<p><strong>MOA</strong></p>
<ul>
<li><strong>Inhibit HIV 1 protease which cleaves HIV polypeptide products into functional parts</strong></li>
<li>Prevent maturation of new viruses</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>HAART</li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li><strong>Lipodystrophy</strong></li>
<li>Hyperglycemia and Dyslipidemia</li>
</ul>
<p>LOTS of drug interactions</p>
<ul>
<li><strong>Ritonavir is used to boost levels of Pls</strong></li>
</ul>
<h2 id="integrase-inhibitors"><a class="header" href="#integrase-inhibitors">Integrase Inhibitors</a></h2>
<h3 id="raltegravir-suffix--gravir"><a class="header" href="#raltegravir-suffix--gravir">Raltegravir (Suffix -gravir)</a></h3>
<p><strong>MOA</strong></p>
<ul>
<li>Inhibit <strong>HIV integrase</strong> thus inhibiting HIV genome htegration into host cell chromosomes</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>HAART</li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li>Increase Creatine kinase</li>
</ul>
<h2 id="fusion-inhibitors"><a class="header" href="#fusion-inhibitors">Fusion Inhibitors</a></h2>
<p><em>Basics</em>: HIV uses gp proteins to bind to host cells</p>
<ul>
<li><em>Gp-120</em>: <strong>attaches</strong> to CCRS5 receptor on macrophages, CXCR4 on T cells</li>
<li><em>Gp-41</em>: required for <strong>fusion and entry</strong></li>
</ul>
<h3 id="enfuvirtide"><a class="header" href="#enfuvirtide">Enfuvirtide</a></h3>
<p><strong>MOA</strong>: Binds <strong>gp-41</strong> (block entry)
<strong>Use</strong>: Subcutaneous in HAART
<strong>SE</strong>: Injection site rxn</p>
<h3 id="maraviroc"><a class="header" href="#maraviroc">Maraviroc</a></h3>
<p><strong>MOA</strong>: Binds CCRS5 - Inhibit attachment/Docking</p>
<h2 id="hiv-summary"><a class="header" href="#hiv-summary">HIV Summary</a></h2>
<h3 id="who-gets-treated"><a class="header" href="#who-gets-treated">Who gets treated?</a></h3>
<ul>
<li>HIV diagnosis regardless of CD4 count</li>
<li>Especially if CD4 &lt; 500</li>
<li>AIDS defining illness</li>
<li>Pregnant mothers, infants @ risk: <strong>Zidovudine</strong></li>
</ul>
<h3 id="regimens"><a class="header" href="#regimens">Regimens</a></h3>
<ul>
<li>Combo to prevent resistance - usually 3 medications</li>
<li>Backbone is <strong>2 NRTI (Efavirenz, Emtricitabine or Abacavir)</strong></li>
<li>Plus one of the following
<ul>
<li>Protease inhibitors</li>
<li>Integrase inhibitors</li>
<li>Fusion inhibitors</li>
<li>NNRTI</li>
</ul>
</li>
</ul>
<h2 id="prophylaxis-in-hiv-patients"><a class="header" href="#prophylaxis-in-hiv-patients">Prophylaxis in HIV Patients</a></h2>
<ul>
<li><em>Pneumocystis Jiroveci Pneumonia (PJP/PCP)</em>
<ul>
<li><strong>CD4&lt;200</strong></li>
<li>Prophylaxis
<ul>
<li><strong>SMX/TMP</strong></li>
<li><em><strong>Dapsone/Pentamidine</strong></em> for Sulfa allergy</li>
</ul>
</li>
</ul>
</li>
<li><em>Toxoplasmosis</em>
<ul>
<li><strong>CD4&lt;100</strong></li>
<li>Prophylaxis
<ul>
<li><strong>SMX/TMP</strong></li>
<li>Dapsone for Sulfa allergy</li>
</ul>
</li>
</ul>
</li>
<li><em>Mycobacterium Avium Complex</em>
<ul>
<li><strong>CD4&lt;50</strong>
<ul>
<li>Prophylaxis
<ul>
<li><strong>Azithromycin</strong> or clarithromycin</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h1 id="immunosuppressants"><a class="header" href="#immunosuppressants">Immunosuppressants</a></h1>
<h1 id="anti-neoplastics"><a class="header" href="#anti-neoplastics">Anti-Neoplastics</a></h1>
<h1 id="anticoagulants--antiplatelets"><a class="header" href="#anticoagulants--antiplatelets">Anticoagulants &amp; Antiplatelets</a></h1>
<ul>
<li><a href="pharmacology/14.html#hemostasis-big-picture">Hemostasis Big Picture</a>
<ul>
<li><a href="pharmacology/14.html#high-pressure-circuits">High Pressure Circuits</a></li>
<li><a href="pharmacology/14.html#low-pressure-circuits">Low Pressure Circuits</a></li>
</ul>
</li>
<li><a href="pharmacology/14.html#anticoagulants-big-picture">Anticoagulants Big Picture</a>
<ul>
<li><a href="pharmacology/14.html#how-to-prevent-formation-of-fibrin-clot">How to prevent formation of fibrin clot?</a></li>
<li><a href="pharmacology/14.html#how-to-break-down-fibrin-clot">How to break down fibrin clot?</a></li>
</ul>
</li>
<li><a href="pharmacology/14.html#anticoagulants">Anticoagulants</a>
<ul>
<li><a href="pharmacology/14.html#warfarin">Warfarin</a></li>
<li><a href="pharmacology/14.html#heparin">Heparin</a></li>
<li><a href="pharmacology/14.html#factor-xa-inhibitors">Factor Xa Inhibitors</a></li>
<li><a href="pharmacology/14.html#thrombin-inhibitors">Thrombin Inhibitors</a></li>
<li><a href="pharmacology/14.html#fibrinolytics-and-their-inhibitors">Fibrinolytics and their inhibitors</a>
<ul>
<li><a href="pharmacology/14.html#fibrinolytics">Fibrinolytics</a></li>
<li><a href="pharmacology/14.html#inhibitors">Inhibitors</a></li>
</ul>
</li>
<li><a href="pharmacology/14.html#antiplatelets-big-picture">Antiplatelets Big Picture</a>
<ul>
<li><a href="pharmacology/14.html#platelet-receptors">Platelet receptors</a></li>
<li><a href="pharmacology/14.html#how-to-inhibit-platelet-aggregation">How to inhibit platelet aggregation?</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="pharmacology/14.html#antiplatelets">Antiplatelets</a>
<ul>
<li><a href="pharmacology/14.html#aspirin">Aspirin</a></li>
<li><a href="pharmacology/14.html#adp-inhibitors">ADP Inhibitors</a></li>
<li><a href="pharmacology/14.html#direct-gplibilla-inhibitors">Direct GplIb/IllA Inhibitors</a></li>
<li><a href="pharmacology/14.html#camp-inhibitors">cAMP Inhibitors</a></li>
</ul>
</li>
<li><a href="pharmacology/14.html#myocardial-infarction-treatment">Myocardial Infarction Treatment</a>
<ul>
<li><a href="pharmacology/14.html#acute-phase-of-ml">Acute Phase of Ml</a></li>
<li><a href="pharmacology/14.html#subacute-phase-of-mi--medical-management">Subacute Phase of MI- Medical Management</a></li>
</ul>
</li>
<li><a href="pharmacology/14.html#stroke-treatment">Stroke Treatment</a>
<ul>
<li><a href="pharmacology/14.html#ischemic-stroke">Ischemic Stroke</a></li>
<li><a href="pharmacology/14.html#hemorrhagic-stroke-intraparenchymal-bleed-or-subarachnoid-hemorrhage">Hemorrhagic Stroke (Intraparenchymal bleed or Subarachnoid hemorrhage)</a></li>
</ul>
</li>
<li><a href="pharmacology/14.html#dvtpe-treatment">DVT/PE Treatment</a>
<ul>
<li><a href="pharmacology/14.html#acute-dvtpe">Acute DVT/PE</a></li>
<li><a href="pharmacology/14.html#acute-saddle-pe-affecting-hemodynamics">Acute Saddle PE affecting Hemodynamics</a></li>
<li><a href="pharmacology/14.html#chronic-dvtpe">Chronic DVT/PE</a></li>
<li><a href="pharmacology/14.html#dvt-prophylaxis-for-high-risk-patients">DVT Prophylaxis for high risk patients</a></li>
</ul>
</li>
</ul>
<h2 id="hemostasis-big-picture"><a class="header" href="#hemostasis-big-picture">Hemostasis Big Picture</a></h2>
<h3 id="high-pressure-circuits"><a class="header" href="#high-pressure-circuits">High Pressure Circuits</a></h3>
<ul>
<li>Disorders: Ischemic Stroke, Early phase of Myocardial Infarction, Peripheral Vascular Disease</li>
<li><strong>Main clotting player: Platelets</strong></li>
<li>Use Antiplatelets (i.e. Aspirin)</li>
</ul>
<h3 id="low-pressure-circuits"><a class="header" href="#low-pressure-circuits">Low Pressure Circuits</a></h3>
<ul>
<li>Disorders: DVT, PE, Atrial Fibrillation, Dural Sinus Thrombosis, Late phase Myocardial Infarction</li>
<li><strong>Main clotting player: Coagulation factors leading to fibrin clot</strong></li>
<li>Use Anticoagulants (i.e. Heparin, Warfarin)</li>
</ul>
<h2 id="anticoagulants-big-picture"><a class="header" href="#anticoagulants-big-picture">Anticoagulants Big Picture</a></h2>
<h3 id="how-to-prevent-formation-of-fibrin-clot"><a class="header" href="#how-to-prevent-formation-of-fibrin-clot">How to prevent formation of fibrin clot?</a></h3>
<ul>
<li>Inhibit <strong>Factor 10,9,7,2,C, S</strong>
<ul>
<li>Warfarin</li>
</ul>
</li>
<li><strong>Activate Antithrombin decreasing the action of Thrombin (Factor 2) and Factor 10</strong>
<ul>
<li>Heparin</li>
</ul>
</li>
<li>Inhibit <strong>Factor Xa</strong>
<ul>
<li>Oral: Apixaban, Rivaroxaban</li>
<li>|V/SC: Enoxaparin, Fondaparinux</li>
</ul>
</li>
<li>Inhibit <strong>Thrombin (Factor 2)</strong>
<ul>
<li>Bivalirudin IV, Argatroban IV, Dabigatran PO</li>
</ul>
</li>
</ul>
<h3 id="how-to-break-down-fibrin-clot"><a class="header" href="#how-to-break-down-fibrin-clot">How to <strong>break down fibrin clot?</strong></a></h3>
<ul>
<li><strong>Activate plasmin which breaks down fibrin clot</strong>: Alteplase, Streptokinase</li>
</ul>
<h2 id="anticoagulants"><a class="header" href="#anticoagulants">Anticoagulants</a></h2>
<h3 id="warfarin"><a class="header" href="#warfarin">Warfarin</a></h3>
<p><strong>MOA</strong>: Inhibits carboxylation of vitamin K dependent factors, 10, 9, 7, 2, Protein C, Protein S</p>
<ul>
<li>Effect on extrinsic pathway</li>
<li>Prolongs <strong>PT/INR</strong></li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>DVT/PE</li>
<li>A Fib</li>
</ul>
<p><strong>Notes</strong></p>
<ul>
<li>Pharmacogenomics differences in metabolism</li>
<li>Metabolized via CYP enzymes- Prolonged half life ~ 5 days</li>
<li><strong>Multiple drug-drug interactions</strong></li>
<li>Advise patients on stable amount of greens containing vitamin K</li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li>Bleeding</li>
<li>Teratogenic</li>
<li><strong>Warfarin induced tissue necrosis</strong></li>
<li>Warfarin inhibits Protein C,S in addition to 10, 9, 7,2</li>
<li>Protein C,S which have anticoagulant properties have half life than 10,9,7,2</li>
<li>Hypercoagulability state resulting in microthrombi and skin necrosis</li>
<li>Tx: Bridge with heparin in the initial phase to inhibit factors 10,2</li>
</ul>
<p><strong>Warfarin Reversal</strong></p>
<ul>
<li>Prothrombin Concentrate (2,9.10)-Quick</li>
<li>FFP (VitK factors + Factor V)-Quick</li>
<li>Vitamin K-Takes time</li>
</ul>
<h3 id="heparin"><a class="header" href="#heparin">Heparin</a></h3>
<p><strong>MOA</strong>: Activates Antithrombin which lowers the activity of thrombin (2) and factor 10</p>
<ul>
<li>Affects the intrinsic pathway</li>
<li>Monitor using PTT</li>
</ul>
<p><em>Heparin has a short half life</em></p>
<p><strong>Use</strong></p>
<ul>
<li>Acute DVT/PE</li>
<li>Acute Coronary Syndrome (Ml)</li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li>Bleeding</li>
<li><em><strong>Heparin induced thrombocytopenia</strong></em>
<ul>
<li>IgG antibodies against heparin bound platelet factor (PF4)</li>
<li>Antibody complexes with platelets</li>
<li>Thrombosis and thrombocytopenia</li>
</ul>
</li>
</ul>
<p><strong>Reversal</strong></p>
<ul>
<li>Protamine
<ul>
<li>Binds to Heparin</li>
</ul>
</li>
</ul>
<h3 id="factor-xa-inhibitors"><a class="header" href="#factor-xa-inhibitors">Factor Xa Inhibitors</a></h3>
<p><em>Parenteral</em>: <strong>Enoxaparin, Fondaparinux</strong></p>
<p><strong>MOA</strong>: Inhibit Factor Xa</p>
<p><em>Longer half life than unfractionated heparin</em></p>
<p><strong>Use</strong></p>
<ul>
<li>Same as heparin</li>
<li>DVT/PE</li>
<li>AFib</li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li>Less incidence of HIT</li>
<li>Fondaparinux sometimes used in patients with HIT allergy</li>
<li>No Reversal</li>
</ul>
<p><em>Oral</em>: <strong>Apixaban, Rivaroxaban</strong></p>
<p><strong>MOA</strong>: Inhibit Factor Xa</p>
<p><em>No need for monitoring</em></p>
<p><strong>Use</strong></p>
<ul>
<li>Chronic DVT/PE</li>
<li>A.Fib</li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li><strong>Bleeding not easily reversible</strong></li>
</ul>
<h3 id="thrombin-inhibitors"><a class="header" href="#thrombin-inhibitors">Thrombin Inhibitors</a></h3>
<p><strong>Bivalirudin IV, Argatroban IV, Dabigatran PO</strong></p>
<p><strong>MOA</strong>: Directly inhibit activity of free and clotted thrombin</p>
<p><strong>Use</strong></p>
<ul>
<li><strong>Dabigatran</strong>: DVT, A. fib</li>
<li><strong>Argatroban</strong>: HIT allergic patients</li>
<li><strong>Bivalirudin</strong>: Patients undergoing percutaneous coronary stenting- prevent stent thrombosis</li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li>Bleeding
<ul>
<li>Reverse Dabigatran with idarucizumab</li>
</ul>
</li>
</ul>
<h3 id="fibrinolytics-and-their-inhibitors"><a class="header" href="#fibrinolytics-and-their-inhibitors">Fibrinolytics and their inhibitors</a></h3>
<h4 id="fibrinolytics"><a class="header" href="#fibrinolytics">Fibrinolytics</a></h4>
<p><strong>Altepase, Streptokinase</strong></p>
<p><strong>MOA</strong>:</p>
<ul>
<li>Altepase is naturally occurring enzyme</li>
<li>Converts plasminogen to plasmin which cleaves thrombin and fibrin clots</li>
</ul>
<p><strong>Indications</strong></p>
<ul>
<li>MIif no PCI Available</li>
<li>Early Ischemic stroke</li>
<li>Large Saddle PE</li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li>Severe bleeding
<ul>
<li>Reversal with antifibrinolytics</li>
</ul>
</li>
</ul>
<h4 id="inhibitors"><a class="header" href="#inhibitors">Inhibitors</a></h4>
<p><strong>Aminocaproic Acid, Tranexamic Acid</strong>
<strong>MOA</strong>: Inhibits plasminogen activation</p>
<p><strong>Use:</strong></p>
<ul>
<li>Bleeding from fibrinolytics</li>
<li>Bleeding from surgery</li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li>Thrombosis</li>
</ul>
<h3 id="antiplatelets-big-picture"><a class="header" href="#antiplatelets-big-picture">Antiplatelets Big Picture</a></h3>
<h4 id="platelet-receptors"><a class="header" href="#platelet-receptors">Platelet receptors</a></h4>
<ul>
<li><strong>Gplib/llla</strong>
<ul>
<li>Binds platelets together using <strong>fibrinogen</strong></li>
</ul>
</li>
<li><strong>Gp1b</strong>
<ul>
<li>Binds endothelial surfaces using <strong>vW factor</strong></li>
</ul>
</li>
</ul>
<h4 id="how-to-inhibit-platelet-aggregation"><a class="header" href="#how-to-inhibit-platelet-aggregation">How to inhibit <em>platelet aggregation</em>?</a></h4>
<ul>
<li>Inhibit <strong>TXA2 synthesis</strong>: Aspirin</li>
<li><strong>Decrease cAMP expression</strong>: Cilostazol, Dipyridamole,</li>
<li><strong>Inhibit exposure of Gpllb/llla on surface of receptors</strong>: Clopidogrel, Prasugrel, Ticlopidine</li>
<li><strong>Directly inhibit Gplib/llla receptors</strong>: Abciximab, Eptifibatide</li>
</ul>
<h2 id="antiplatelets"><a class="header" href="#antiplatelets">Antiplatelets</a></h2>
<h3 id="aspirin"><a class="header" href="#aspirin">Aspirin</a></h3>
<p><strong>MOA</strong></p>
<ul>
<li><strong>Irreversibly</strong> inhibit COX 1 inhibiting synthesis of TXA2 inhibiting platelet aggregation</li>
<li>Inhibition lasts the half life of platelets ~5-7 days</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>Primary prevention of MI</li>
<li>Acute M|</li>
<li>Ischemic stroke/TIA prevention and treatment</li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li>Discussed previously</li>
<li>Bleeding</li>
</ul>
<h3 id="adp-inhibitors"><a class="header" href="#adp-inhibitors">ADP Inhibitors</a></h3>
<p><strong>Clopidogrel, Prasugrel, Ticagrelor</strong></p>
<p><strong>MOA</strong></p>
<ul>
<li>Irreversibly block P2Y12 subtype of ADP receptor</li>
<li>ADP responsible for expression of Gpllb/llla</li>
<li>Gbllb/llla binds fibrin and causes platelet aggregation and thrombus</li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>Myocardial infarction, decrease thrombosis of coronary stents, Recurrent ischemic thrombotic stroke</li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li>Bleeding</li>
</ul>
<h3 id="direct-gplibilla-inhibitors"><a class="header" href="#direct-gplibilla-inhibitors">Direct GplIb/IllA Inhibitors</a></h3>
<p><strong>Abciximab, Eptifibatide</strong></p>
<p><strong>MOA</strong>: Direct inhibitors of Gpllb/llla on activated platelets preventing aggregation</p>
<p><strong>Use</strong></p>
<ul>
<li>Percutaneous coronary angioplasty</li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li>Thrombocytopenia</li>
</ul>
<h3 id="camp-inhibitors"><a class="header" href="#camp-inhibitors">cAMP Inhibitors</a></h3>
<p><strong>Cilostazol, Dipyridamole</strong></p>
<p><strong>MOA</strong>: Phosphodiesterase inhibitors- Inhibiting breakdown of cAMP leading to decrease in platelet aggregation</p>
<p><strong>Use</strong></p>
<ul>
<li><strong>Peripheral vascular disease- Cilostazol</strong></li>
<li>Prevention of stroke/TIA- Dipyridamole + Aspirin</li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li>Bleeding</li>
<li>Facial flushing</li>
<li>Hypotension</li>
</ul>
<h2 id="myocardial-infarction-treatment"><a class="header" href="#myocardial-infarction-treatment">Myocardial Infarction Treatment</a></h2>
<h3 id="acute-phase-of-ml"><a class="header" href="#acute-phase-of-ml">Acute Phase of Ml</a></h3>
<ul>
<li>Initial Treatment (MONA)
<ul>
<li><strong>Morphine</strong>: Pain &amp; Vasodilator</li>
<li><strong>02</strong>: Vasodilator</li>
<li><strong>Nitroglycerin</strong>: Decreases myocardial demand</li>
<li><strong>Aspirin</strong>: Decreases further thrombus propagation</li>
<li><strong>+/- Heparin/Enoxaparin</strong>: Prevent further thrombus propagation</li>
</ul>
</li>
<li>Reperfusion</li>
<li>1st line: <strong>Coronary Balloon Angiography and stent</strong> (Cath Lab)</li>
<li>2nd line: <strong>Alteplase</strong> (Fibrinolytic) if no cath lab available</li>
</ul>
<h3 id="subacute-phase-of-mi--medical-management"><a class="header" href="#subacute-phase-of-mi--medical-management">Subacute Phase of MI- Medical Management</a></h3>
<ul>
<li><strong>Antiplatelet</strong>: Aspirin &amp; Clopidogrel (to prevent stent occlusion)</li>
<li><strong>Beta Blocker &amp; ACE Inhibitor</strong>: <strong><strong>Proven mortality benefit</strong></strong></li>
<li><strong>High Intensity Statin</strong>: Decrease atherosclerosis</li>
</ul>
<h2 id="stroke-treatment"><a class="header" href="#stroke-treatment">Stroke Treatment</a></h2>
<h3 id="ischemic-stroke"><a class="header" href="#ischemic-stroke">Ischemic Stroke</a></h3>
<ul>
<li>Acute phase
<ul>
<li>Thrombolysis using <strong>Altepase</strong> (tPA) if meets certain criteria</li>
</ul>
</li>
<li>Subacute phase
<ul>
<li><strong>Antiplatelets</strong>
<ul>
<li><strong>Aspirin</strong> for first Stroke and/or TIA</li>
<li><strong>Clopidogrel</strong> for recurrent strokes</li>
</ul>
</li>
<li><strong>High intensity statin</strong></li>
<li><strong>Anticoagulant</strong> if cardioembolic source (i.e. atrial fibrillation)
<ul>
<li>Warfarin or Xa inhibitors</li>
</ul>
</li>
<li><strong>BP Control</strong></li>
</ul>
</li>
</ul>
<h3 id="hemorrhagic-stroke-intraparenchymal-bleed-or-subarachnoid-hemorrhage"><a class="header" href="#hemorrhagic-stroke-intraparenchymal-bleed-or-subarachnoid-hemorrhage">Hemorrhagic Stroke (Intraparenchymal bleed or Subarachnoid hemorrhage)</a></h3>
<ul>
<li><strong>BP Control</strong> to prevent more bleeding</li>
<li><strong>Nimodipine</strong> for SAH: Prevent cerebral vasospasm</li>
</ul>
<h2 id="dvtpe-treatment"><a class="header" href="#dvtpe-treatment">DVT/PE Treatment</a></h2>
<h4 id="acute-dvtpe"><a class="header" href="#acute-dvtpe">Acute DVT/PE</a></h4>
<ul>
<li>Heparin/Enoxaparin/Fondaparinux: Prevent further thrombus propagation</li>
</ul>
<h4 id="acute-saddle-pe-affecting-hemodynamics"><a class="header" href="#acute-saddle-pe-affecting-hemodynamics">Acute Saddle PE affecting Hemodynamics</a></h4>
<ul>
<li>Altepase</li>
</ul>
<h4 id="chronic-dvtpe"><a class="header" href="#chronic-dvtpe">Chronic DVT/PE</a></h4>
<ul>
<li>Warfarin</li>
<li>Oral Anti-Xa Inhibitors</li>
<li>Dabigatran</li>
<li>Enoxaparin, Heparin in pregnant patients</li>
</ul>
<h4 id="dvt-prophylaxis-for-high-risk-patients"><a class="header" href="#dvt-prophylaxis-for-high-risk-patients">DVT Prophylaxis for high risk patients</a></h4>
<ul>
<li>Enoxaparin/Heparin</li>
<li>Oral Anti-Xa inhibitors</li>
</ul>
<h1 id="hematinics"><a class="header" href="#hematinics">Hematinics</a></h1>
<ul>
<li><a href="pharmacology/15.html#anemia-overview">Anemia Overview</a></li>
<li><a href="pharmacology/15.html#iron">Iron</a>
<ul>
<li><a href="pharmacology/15.html#ferrous-sulfate-oral">Ferrous Sulfate (Oral)</a></li>
<li><a href="pharmacology/15.html#iron-dextran-intervenous">Iron Dextran (Intervenous)</a></li>
</ul>
</li>
<li><a href="pharmacology/15.html#iron-overload">Iron Overload</a></li>
<li><a href="pharmacology/15.html#b12--folate">B12 &amp; Folate</a>
<ul>
<li><a href="pharmacology/15.html#b12--cyanocobalamin">B12- Cyanocobalamin</a></li>
<li><a href="pharmacology/15.html#folic-acid-b9">Folic Acid (B9)</a></li>
</ul>
</li>
<li><a href="pharmacology/15.html#growth-factors">Growth Factors</a>
<ul>
<li><a href="pharmacology/15.html#erythropoietin-rbc">Erythropoietin: RBC</a></li>
<li><a href="pharmacology/15.html#filgrastim-wbc">Filgrastim: WBC</a></li>
<li><a href="pharmacology/15.html#oprelvekin-interleukin-11-platelets">Oprelvekin (Interleukin 11): Platelets</a></li>
</ul>
</li>
</ul>
<h2 id="anemia-overview"><a class="header" href="#anemia-overview">Anemia Overview</a></h2>
<p><img src="https://d3uigcfkiiww0g.cloudfront.net/wordpress/blog/pics-en/uploads/types-of-anemia.png" alt="Anemia Overview" /></p>
<p><strong>Hematinics</strong>: Agents that increase Hemoglobin</p>
<p><strong>Anemia</strong></p>
<ul>
<li>Microcytic</li>
<li>Normocytic</li>
<li>Macrocytic</li>
</ul>
<p><strong>Pharmacologic Treatment</strong></p>
<ul>
<li>Correct deficiency
<ul>
<li>Fe deficiency microcytic: Fe</li>
<li>Megaloblastic macrocytic : B12 &amp; Folate</li>
</ul>
</li>
<li>Stimulate bone marrow production of RBC: Erythropoietin
<ul>
<li>Anemia of Chronic Disease</li>
</ul>
</li>
</ul>
<h2 id="iron"><a class="header" href="#iron">Iron</a></h2>
<h3 id="ferrous-sulfate-oral"><a class="header" href="#ferrous-sulfate-oral">Ferrous Sulfate (Oral)</a></h3>
<p><strong>Use</strong>: Fe deficiency microcytic anemia</p>
<p><strong>Bioavailability</strong></p>
<ul>
<li>25% orally</li>
<li>Fe+2 better absorbed</li>
<li>Ascorbic acid (Vitamin C) aids absorption- Reduces Fe+3 to Fe+2</li>
</ul>
<p><strong>Duration of tx</strong>: 3-6 months after correcting cause of Fe deficiency</p>
<p><strong>SE</strong></p>
<ul>
<li>Gl Discomfort</li>
<li><em><strong>Constipation</strong></em>*</li>
<li><em><strong>Black stools</strong></em>
<ul>
<li>Can mimic or mask Gl bleed</li>
</ul>
</li>
</ul>
<h3 id="iron-dextran-intervenous"><a class="header" href="#iron-dextran-intervenous">Iron Dextran (Intervenous)</a></h3>
<p><strong>Use</strong></p>
<ul>
<li>Patients who cannot tolerate oral iron</li>
<li>Severe Iron deficiency anemia</li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li>Risk of anaphylaxis</li>
<li>Can use a small test dose initially</li>
</ul>
<h2 id="iron-overload"><a class="header" href="#iron-overload">Iron Overload</a></h2>
<p><strong>Causes of Iron overload</strong></p>
<ul>
<li>Accidental ingestion by children- Iron poisoning</li>
<li>Hemochromatosis</li>
<li>Repeated blood transfusions (i.e. sickle cell)</li>
</ul>
<p><strong>Mechanism of injury</strong></p>
<ul>
<li>Cell death due to peroxidation of membrane lipids</li>
</ul>
<p><strong>Symptoms of Iron poisoning</strong></p>
<ul>
<li>Nausea, vomiting, Gl bleed, Gl obstruction, anion gap metabolic acidosis</li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li>Chelate and bind free iron</li>
<li>IV Deferoxamine</li>
<li>Oral Deferasirox</li>
</ul>
<h2 id="b12--folate"><a class="header" href="#b12--folate">B12 &amp; Folate</a></h2>
<h3 id="b12--cyanocobalamin"><a class="header" href="#b12--cyanocobalamin">B12- Cyanocobalamin</a></h3>
<p>Absorbed in <strong>lleum</strong></p>
<p><strong>Causes of deficiency</strong></p>
<ul>
<li>lleum malabsorption: Pernicious anemia, Crohn'’s, surgical resection</li>
<li>Vegan diet</li>
</ul>
<p><strong>Symptoms of Deficiency</strong></p>
<ul>
<li>Macrocytic megaloblastic anemia</li>
<li>Hypersegmented PMNs</li>
<li><strong>Paresthesias</strong></li>
<li><strong>Subacute combined degeneration</strong></li>
<li><strong>Increased homocysteine</strong></li>
<li><strong>Increased Methylmalonic acid</strong></li>
</ul>
<h3 id="folic-acid-b9"><a class="header" href="#folic-acid-b9">Folic Acid (B9)</a></h3>
<p>Absorbed in <strong>Jejunum</strong></p>
<p><strong>Causes of deficiency</strong></p>
<ul>
<li>Drugs: phenytoin, sulfa, MTX</li>
<li>Alcoholism</li>
<li>Pregnancy</li>
</ul>
<p><strong>Symptoms of deficiency</strong></p>
<ul>
<li>Macrocytic megaloblastic anemia</li>
<li>Hypersegmented PMNs</li>
<li>No Neuro sx</li>
<li><strong>Increased Homocysteine</strong></li>
<li><strong>Normal Methylmalonic acid</strong></li>
</ul>
<h2 id="growth-factors"><a class="header" href="#growth-factors">Growth Factors</a></h2>
<h3 id="erythropoietin-rbc"><a class="header" href="#erythropoietin-rbc">Erythropoietin: RBC</a></h3>
<p><strong>Use</strong></p>
<ul>
<li>Anemia of chronic disease</li>
<li>CKD</li>
<li>Malignancy induced</li>
</ul>
<p><strong>SE</strong></p>
<ul>
<li>Hypertension</li>
<li>Thrombosis</li>
<li>Increased risk of CV events if Hgb &gt; 12</li>
</ul>
<h3 id="filgrastim-wbc"><a class="header" href="#filgrastim-wbc">Filgrastim: WBC</a></h3>
<p><strong>Granulocyte Colony Stimulating factor</strong>
<strong>Use</strong>: Neutropenia 2/2 chemotherapy
<strong>SE</strong>: Bone pain</p>
<h3 id="oprelvekin-interleukin-11-platelets"><a class="header" href="#oprelvekin-interleukin-11-platelets">Oprelvekin (Interleukin 11): Platelets</a></h3>
<p><strong>Megakaryocyte Growth Factor</strong>
Use: Thrombocytopenia that does not respond to platelet transfusion</p>
<h1 id="anti-hyperlipidemia-agents"><a class="header" href="#anti-hyperlipidemia-agents">Anti-Hyperlipidemia Agents</a></h1>
<ul>
<li><a href="pharmacology/16.html#lipid-lowering-agents">Lipid Lowering Agents</a>
<ul>
<li><a href="pharmacology/16.html#hmg-coa-reductase-inhibitors">HMG CoA Reductase Inhibitors</a></li>
<li><a href="pharmacology/16.html#fibrates">Fibrates</a></li>
<li><a href="pharmacology/16.html#bile-acid-binding-resins">Bile Acid Binding Resins</a></li>
<li><a href="pharmacology/16.html#niacin-nicotinic-acid">Niacin (Nicotinic Acid)</a></li>
<li><a href="pharmacology/16.html#cholesterol-absorption-inhibitors">Cholesterol Absorption Inhibitors</a></li>
<li><a href="pharmacology/16.html#pcsk9-inhibitors">PCSK9 Inhibitors</a></li>
</ul>
</li>
<li><a href="pharmacology/16.html#big-picture---lipid-lowering-agents">Big Picture - Lipid Lowering Agents</a></li>
<li><a href="pharmacology/16.html#hyperlipidemia---when-do-you-start-a-statin">Hyperlipidemia - When do you start a statin?</a></li>
</ul>
<h2 id="lipid-lowering-agents"><a class="header" href="#lipid-lowering-agents">Lipid Lowering Agents</a></h2>
<h3 id="hmg-coa-reductase-inhibitors"><a class="header" href="#hmg-coa-reductase-inhibitors">HMG CoA Reductase Inhibitors</a></h3>
<p><em>High Intensity</em> - Atorvastatin &amp; Rosuvastatin,
<em>Medium / Low Intensity</em> - Lovastatin &amp; Pravastatin &amp; Simvastatin &amp; Fluvastatin</p>
<p><strong>MOA</strong>: Inhibition of HMG CoA reductase</p>
<ul>
<li>↑ hepatic expression of LDL receptors &amp; ↓ increased clearance of LDL from blood</li>
<li><strong>↓ LDL(Max) &amp; ↑ HDL</strong></li>
</ul>
<p><strong>Uses</strong>: Hypercholesterolemia, ACS, CAD, <strong>status post CVA, eta</strong></p>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Increases Liver Function Tests (ALT &amp; AST &gt; x3 D/C Statin)</li>
<li><strong>MYOPATHIES -&gt; Rhabdomyolysis!</strong> Especially when mixed with <strong>Fibrates</strong>!</li>
</ul>
<h3 id="fibrates"><a class="header" href="#fibrates">Fibrates</a></h3>
<p><strong>Fenofibrate &amp; Gemfibrozil</strong></p>
<p><strong>MOA</strong>:</p>
<ul>
<li>PPARa -&gt; increases Lipoprotein lipase</li>
</ul>
<p><strong>Uses</strong>:</p>
<ul>
<li>Primarily known for reducing Triglycerides</li>
<li>Patient with TG 600 and / or Pancreatitis</li>
</ul>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Myopathies</li>
</ul>
<p><strong>Drug interactions with Statins!</strong></p>
<ul>
<li>Gemfibrozil &amp; Simvastatin are <strong>CONTRAINDICATION</strong></li>
</ul>
<h3 id="bile-acid-binding-resins"><a class="header" href="#bile-acid-binding-resins">Bile Acid Binding Resins</a></h3>
<p><strong>Cholestyramine &amp; Colesevelam &amp; Colestipol</strong></p>
<p><strong>MOA</strong>:</p>
<ul>
<li>Bile Acid Sequestrants</li>
<li>Increase the clearance of bile acids by binding them in GUT</li>
</ul>
<p><strong>Absorption Drug Interactions</strong></p>
<ul>
<li><em>1 hour before</em> and <em>2 hours after</em></li>
</ul>
<p><strong>Side Effects</strong>: Gi Disturbance (flatulence, bloating, and constipation)</p>
<h3 id="niacin-nicotinic-acid"><a class="header" href="#niacin-nicotinic-acid">Niacin (Nicotinic Acid)</a></h3>
<p><strong>MOA</strong>:</p>
<ul>
<li><strong>Vitamin B3</strong></li>
<li><strong>Increases HDL</strong></li>
</ul>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Causing flushing &amp; pruritus (treat w/ ASA)</li>
<li>May lead to glucose intolerance</li>
</ul>
<p><em>No mortality benefit</em></p>
<h3 id="cholesterol-absorption-inhibitors"><a class="header" href="#cholesterol-absorption-inhibitors">Cholesterol Absorption Inhibitors</a></h3>
<p><strong>Ezetimibe</strong></p>
<p><strong>MOA</strong>: Inhibits cholesterol absorption in GIT</p>
<p><strong>Uses</strong>
o Adjunct to statin for hypercholesterolemia
o Not indicated for monotherapy</p>
<h3 id="pcsk9-inhibitors"><a class="header" href="#pcsk9-inhibitors">PCSK9 Inhibitors</a></h3>
<p><strong>Alirocumab &amp; Evolocumab</strong></p>
<p><strong>MOA</strong>:</p>
<ul>
<li>Inhibits the degradation of LDL receptors</li>
<li>LDL receptors recycled in Liver</li>
</ul>
<p><strong>Uses</strong></p>
<ul>
<li><strong>Familial Hypercholesterolemia (absent or defective LDL receptor)</strong></li>
<li>Pts w/ Hypercholesterolemia not controlled by High intensity statin</li>
</ul>
<h2 id="big-picture---lipid-lowering-agents"><a class="header" href="#big-picture---lipid-lowering-agents">Big Picture - Lipid Lowering Agents</a></h2>
<p><strong>How to Lower and Raise Lipids</strong></p>
<ul>
<li><strong>LDLs</strong>
<ul>
<li>Strongest - Statins &amp; PCSK9 Inhibitors</li>
<li>Moderate - Ezetimibe &amp; Bile acid resins &amp; Niacin</li>
</ul>
</li>
<li><strong>TGs</strong> - Fibrates</li>
<li><strong>Raising HDLs</strong> - Niacin</li>
</ul>
<h2 id="hyperlipidemia---when-do-you-start-a-statin"><a class="header" href="#hyperlipidemia---when-do-you-start-a-statin">Hyperlipidemia - When do you start a statin?</a></h2>
<ul>
<li>Patients with clinical atherosclerotic heart disease</li>
<li>LDL &gt; 190 mg/dL</li>
<li>Diabetes and age 40 to 75 years.</li>
<li>Patients age 40 to 75 years with LDL 70 to 189 mg/dL...</li>
</ul>
<p><strong>10-year cardiovascular risk determines if a statin is appropriate</strong></p>
<h1 id="diuretics"><a class="header" href="#diuretics">Diuretics</a></h1>
<ul>
<li><a href="pharmacology/17.html#diuretics-site-of-action">Diuretics Site of Action</a></li>
<li><a href="pharmacology/17.html#loop-diuretics">Loop Diuretics</a></li>
<li><a href="pharmacology/17.html#thiazide-diuretics">Thiazide Diuretics</a></li>
<li><a href="pharmacology/17.html#potassium-sparing-diuretics">Potassium-sparing Diuretics</a>
<ul>
<li><a href="pharmacology/17.html#mineralocorticoid-receptor-antagonist">Mineralocorticoid receptor antagonist</a></li>
<li><a href="pharmacology/17.html#epithelial-sodium-channel-inhibitor">Epithelial Sodium Channel Inhibitor</a></li>
</ul>
</li>
</ul>
<h2 id="diuretics-site-of-action"><a class="header" href="#diuretics-site-of-action">Diuretics Site of Action</a></h2>
<p><img src="https://d1yboe6750e2cu.cloudfront.net/i/2ad75181990046f158d01bec58943ab356fa3c50" alt="Diuretics Site of Action" /></p>
<h2 id="loop-diuretics"><a class="header" href="#loop-diuretics">Loop Diuretics</a></h2>
<p><strong>Furosemide &amp; Bumetanide &amp; Torsemide &amp; Ethacrynic Acid</strong></p>
<p><strong>MOA</strong>: Inhibit of Na+ / K+ / 2Cl- symporter in ascending LOH</p>
<p>Used primarily for <strong>edema in heart failure:</strong></p>
<ul>
<li><strong>Furosemide</strong> - first line</li>
<li><strong>Torsemide</strong> - next step after Furosemide</li>
<li><strong>Ethacrynic Acid</strong> - Sulfa Allergy</li>
<li><strong>Bumetanide</strong> - Ascites -&gt; cirrhosis</li>
</ul>
<p><strong>Side Effects:</strong> <strong>HYPOKALEMIA</strong> , Hypocalcemia, Hypomagnesemia and <strong>Ototoxicity</strong> at higher doses</p>
<h2 id="thiazide-diuretics"><a class="header" href="#thiazide-diuretics">Thiazide Diuretics</a></h2>
<p><strong>Hydrochlorothiazide &amp; Chlorothiazide &amp; Metolazone &amp; Indapamide &amp; Chlorthalidone</strong></p>
<p><strong>MOA</strong>:</p>
<ul>
<li>Inhibit of Na+ / Cl- symporter in the DCT</li>
</ul>
<p>Used primarily for <strong>HTN</strong> and Adjunct in HF</p>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Increased cholesterol, glucose, uric acid, calcium</li>
<li>Decreased K+, Na+, Mg2+</li>
</ul>
<h2 id="potassium-sparing-diuretics"><a class="header" href="#potassium-sparing-diuretics">Potassium-sparing Diuretics</a></h2>
<h3 id="mineralocorticoid-receptor-antagonist"><a class="header" href="#mineralocorticoid-receptor-antagonist">Mineralocorticoid receptor antagonist</a></h3>
<p><strong>Spironolactone &amp; Eplerenone</strong></p>
<p><strong>MOA:</strong></p>
<ul>
<li>Inhibits Aldosterone</li>
</ul>
<p><strong>Uses</strong></p>
<ul>
<li><strong>CHF</strong> &amp; 1 and 2 hyperaldosteronism</li>
</ul>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Cause <strong>Hyperkalemia</strong> and <strong>Gynecomastia</strong> (S &gt; E) and Metabolic acidosis</li>
</ul>
<h3 id="epithelial-sodium-channel-inhibitor"><a class="header" href="#epithelial-sodium-channel-inhibitor">Epithelial Sodium Channel Inhibitor</a></h3>
<p><strong>Amiloride &amp; Triamterene</strong></p>
<p><strong>MOA</strong>:</p>
<ul>
<li>Blocks Na+ channels and DCT and collecting duct inhibiting sodium reabsorption</li>
<li><strong>No Aldosterone Effects</strong></li>
</ul>
<p><strong>Uses</strong></p>
<ul>
<li>HTN</li>
</ul>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Causes <strong>Hyperkalemia</strong>, and Hypernatremia</li>
<li>No Gynecomastia</li>
</ul>
<h1 id="anti-hypertensives"><a class="header" href="#anti-hypertensives">Anti-Hypertensives</a></h1>
<h1 id="anti-arrhythmics"><a class="header" href="#anti-arrhythmics">Anti-Arrhythmics</a></h1>
<h1 id="inotropes-heart-failure-and-anti-angina"><a class="header" href="#inotropes-heart-failure-and-anti-angina">Inotropes, Heart Failure, and Anti-Angina</a></h1>
<h1 id="toxicology"><a class="header" href="#toxicology">Toxicology</a></h1>
<ul>
<li><a href="pharmacology/21.html#toxicology-basic-principles">Toxicology Basic Principles</a></li>
<li><a href="pharmacology/21.html#toxins">Toxins</a>
<ul>
<li><a href="pharmacology/21.html#cholinergic-toxidrome-increased-ach">Cholinergic Toxidrome (Increased Ach)</a></li>
<li><a href="pharmacology/21.html#anticholinergic-decreased-ach">Anticholinergic (Decreased Ach)</a></li>
<li><a href="pharmacology/21.html#autonomic-toxidrome-sympathomimetic">Autonomic Toxidrome-Sympathomimetic</a></li>
<li><a href="pharmacology/21.html#narcotics">Narcotics</a></li>
<li><a href="pharmacology/21.html#sedatives-increased-gaba">Sedatives (Increased GABA)</a></li>
<li><a href="pharmacology/21.html#acetaminophen-apap">Acetaminophen (APAP)</a></li>
<li><a href="pharmacology/21.html#synthetic-marijuana-k2-spice">Synthetic Marijuana (K2 Spice)</a></li>
<li><a href="pharmacology/21.html#seafood-toxins">Seafood Toxins</a>
<ul>
<li><a href="pharmacology/21.html#toxin-ciguatoxin">Toxin: Ciguatoxin</a></li>
<li><a href="pharmacology/21.html#toxin-scombroid-histamine">Toxin: Scombroid (Histamine)</a></li>
<li><a href="pharmacology/21.html#tetrodotoxin-ttx">Tetrodotoxin (TTX)</a></li>
<li><a href="pharmacology/21.html#heavy-metals">Heavy Metals</a>
<ul>
<li><a href="pharmacology/21.html#lead-divalent-lon---pb">Lead (Divalent lon - Pb)</a></li>
<li><a href="pharmacology/21.html#mercury-hg">Mercury (Hg)</a></li>
<li><a href="pharmacology/21.html#arsenic">Arsenic</a></li>
<li><a href="pharmacology/21.html#copper">Copper</a></li>
<li><a href="pharmacology/21.html#iron">Iron</a></li>
<li><a href="pharmacology/21.html#cesiumthallium">Cesium/Thallium</a></li>
</ul>
</li>
<li><a href="pharmacology/21.html#solvents">Solvents</a>
<ul>
<li><a href="pharmacology/21.html#halogenated-aliphatic-hydrocarbons">Halogenated Aliphatic Hydrocarbons</a></li>
<li><a href="pharmacology/21.html#aromatic-hydrocarbons">Aromatic Hydrocarbons</a></li>
</ul>
</li>
<li><a href="pharmacology/21.html#hemoglobin-modification">Hemoglobin Modification</a>
<ul>
<li><a href="pharmacology/21.html#methemoglobin-fe3">Methemoglobin (Fe3+)</a></li>
<li><a href="pharmacology/21.html#carbon-monoxide">Carbon Monoxide</a></li>
<li><a href="pharmacology/21.html#cyanide">Cyanide</a></li>
</ul>
</li>
<li><a href="pharmacology/21.html#chelators-general-principles">Chelators general principles</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<h1 id="toxicology-basic-principles"><a class="header" href="#toxicology-basic-principles">Toxicology Basic Principles</a></h1>
<ul>
<li>Airway</li>
<li>Breathing</li>
<li>Circulation</li>
<li>Decontamination
<ul>
<li>Early presentation (Within 1 hour)</li>
<li>Patient must have protected airway (risk of vomit and aspiration)</li>
<li>Activated Charcoal
<ul>
<li>Binds to medications/toxins- Patient must have normal peristalsis to use (risk of obstruction)</li>
</ul>
</li>
<li>Gastric Lavage: Cleaning the stomach- NG tube with fluids in and out
<ul>
<li>Useful if poison is a metal</li>
</ul>
</li>
<li>Whole Bowel irmgation: Giving osmotic agent (Polyethylene glycol) to flush out G tract
<ul>
<li>Use if poison is caustic agent (acid or alkaline poisons) or metal</li>
<li>Need normal persitalsis</li>
</ul>
</li>
</ul>
</li>
<li>DON'T Combo (Dextrose, Oxygen, Naloxone, Thiamine)</li>
<li>Enhanced Elimination
<ul>
<li>Dialysis</li>
<li>Manipulate urinary pH: Acidify urine for bases poisons, alkaline urine for acidic poisons</li>
</ul>
</li>
<li>Focused therapy</li>
</ul>
<h1 id="toxins"><a class="header" href="#toxins">Toxins</a></h1>
<h2 id="cholinergic-toxidrome-increased-ach"><a class="header" href="#cholinergic-toxidrome-increased-ach">Cholinergic Toxidrome (Increased Ach)</a></h2>
<p><strong>Sx</strong>: Lots of <strong>Secretions (SLUDGE), hyperactive bowel sounds, Bradycardia, Miosis, Sweaty Skin</strong></p>
<p><strong>Toxins</strong></p>
<ul>
<li>Acetylcholinesterase inhibitors
<ul>
<li>Insecticides: Organophosphates (Farmers, gardening)</li>
<li>Donepezil (Dementia/Alzheimer's)</li>
<li>Physostigmine (Myasthenia)</li>
</ul>
</li>
<li>Cholinergic agonists: Bethanechol (used for Urinary retention)</li>
<li>Nicotine</li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li>Anticholinergic agent: <strong>Atropine</strong></li>
<li><strong>Plus Pralidoxime (PAM) for Organophosphates</strong> (Regenerates AChE)</li>
</ul>
<h2 id="anticholinergic-decreased-ach"><a class="header" href="#anticholinergic-decreased-ach">Anticholinergic (Decreased Ach)</a></h2>
<p><strong>Sx</strong>: <strong>“Too dry” Flushed dry skin, mental confusion, hyperthermia, Mydriasis, tachycardia</strong></p>
<p><strong>Toxins</strong></p>
<ul>
<li>TCA (Depressed patient OD)</li>
<li>Antihistamines (diphenhydramine, Elderly pt)</li>
<li>Benztropine (PD pt)</li>
<li>Antipsychotics</li>
<li>Baclofen</li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li>Increase Ach- Physostigmine (AchE inhibitor)</li>
<li>Sx management</li>
</ul>
<h2 id="autonomic-toxidrome-sympathomimetic"><a class="header" href="#autonomic-toxidrome-sympathomimetic">Autonomic Toxidrome-Sympathomimetic</a></h2>
<p><strong>Sx:</strong> <strong>Flushed Sweaty skin, Mydriasis, Tachycardia</strong></p>
<p><strong>Toxins:</strong></p>
<ul>
<li>Street: Cocaine, Methamphetamine, MDMA</li>
<li>Amphetamines (ADHD)</li>
<li>MAO Inhibitors</li>
</ul>
<p><strong>Treatment:</strong></p>
<ul>
<li>BZD (Sx management)</li>
<li>Cocaine-avoid Beta blockers</li>
</ul>
<h2 id="narcotics"><a class="header" href="#narcotics">Narcotics</a></h2>
<p><strong>Sx</strong>: <strong>CNS depression, Resp depression</strong>, absent bowel sounds, <strong>Miosis</strong></p>
<p><strong>Toxins</strong>: Opioids, heroin</p>
<p><strong>Treatment</strong></p>
<ul>
<li>Respiratory support</li>
<li>Naloxone (Will ppt withdrawal and agitation)</li>
</ul>
<h2 id="sedatives-increased-gaba"><a class="header" href="#sedatives-increased-gaba">Sedatives (Increased GABA)</a></h2>
<p><strong>Sx: CNS/Resp depression, normal pupils</strong></p>
<p><strong>Toxins</strong></p>
<ul>
<li>BZD</li>
<li>Barbiturates</li>
<li>ETOH</li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li>Respiratory support</li>
<li><strong>Flumazenil for BZD OD</strong> (PPT withdrawal and seizures)</li>
<li>ETOH: Sx support (BZD) and Thiamine</li>
</ul>
<h2 id="acetaminophen-apap"><a class="header" href="#acetaminophen-apap">Acetaminophen (APAP)</a></h2>
<p><strong>Mechanism of injury</strong></p>
<ul>
<li>NAPQI (APAP metabolite) depletes glutathione- forms toxic byproducts in liver</li>
<li><strong>Centrilobular necrosis</strong></li>
</ul>
<p><strong>Sx:</strong></p>
<ul>
<li>Depressed patient with OD/suicide</li>
<li>0-12 hours: Nausea/vomiting</li>
<li>12-48 hours: abd pain, RUQ pain</li>
<li>48-96 hours: Jaundice, encephalopathy</li>
<li>96 hours: Fulminant liver failure</li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li>N-Acetylcysteine
<ul>
<li>Regenerates glutathione</li>
<li>|V or oral</li>
<li>Best if given with 8 hours</li>
</ul>
</li>
</ul>
<h2 id="synthetic-marijuana-k2-spice"><a class="header" href="#synthetic-marijuana-k2-spice">Synthetic Marijuana (K2 Spice)</a></h2>
<p><strong>MOA</strong></p>
<ul>
<li>Full cannabinoid agonist (CB1)</li>
<li>100 x more potent than Marijuana (THC)</li>
</ul>
<p><strong>Sx</strong></p>
<ul>
<li>Conjunctival injection</li>
<li>Increased appetite</li>
<li>Visual hallucinations</li>
<li>Coagulopathy similar to coumadin</li>
</ul>
<p>Treatment: Supportive</p>
<h2 id="seafood-toxins"><a class="header" href="#seafood-toxins">Seafood Toxins</a></h2>
<h3 id="toxin-ciguatoxin"><a class="header" href="#toxin-ciguatoxin">Toxin: Ciguatoxin</a></h3>
<p>Where? - Dinoflagellate (<strong>Reef Fish</strong>)</p>
<p>MOA: Hold open voltage gated Na channels</p>
<p>Sx: <strong>Reversal of sensation (Cold feels hot and hot feels cold)</strong></p>
<p>Tx: Supportive</p>
<h3 id="toxin-scombroid-histamine"><a class="header" href="#toxin-scombroid-histamine">Toxin: Scombroid (Histamine)</a></h3>
<p>Where? - <strong>Fish left out in the sun</strong></p>
<p>MOA: Histamine</p>
<p>Sx: Histamine effects; rash, wheezing, bronchospasm; mimics food allergy</p>
<p>Tx: Histamine blockers H1/H2 &amp; Epinephrine if severe</p>
<h3 id="tetrodotoxin-ttx"><a class="header" href="#tetrodotoxin-ttx">Tetrodotoxin (TTX)</a></h3>
<p>Where? - <strong>Puffer fish</strong></p>
<p>MOA: Blocks Na channels</p>
<p>Sx: Paralysis, Cardiac and respiratory collapse</p>
<p>Tx: Supportive</p>
<h3 id="heavy-metals"><a class="header" href="#heavy-metals">Heavy Metals</a></h3>
<h4 id="lead-divalent-lon---pb"><a class="header" href="#lead-divalent-lon---pb">Lead (Divalent lon - Pb)</a></h4>
<p>Enzyme inhibitor</p>
<p><strong>MOA:</strong></p>
<ul>
<li>Inhibits Ferrochelatase and ALA dehydratase (2nd step and last step of Heme synthesis)</li>
<li>Inhibits rRNA degradation (Basophilic stippling)</li>
<li>Interferes with cations actions (Unique)</li>
</ul>
<p><strong>Causes</strong></p>
<ul>
<li><strong>Kids: swallowing lead-old houses/paint</strong></li>
<li><strong>Adults: Batteries/Bullets</strong></li>
</ul>
<p><strong>Effects</strong></p>
<ul>
<li>Lead lines on Gingiva/Metaphysis of long bones</li>
<li><strong>Microcytic anemia with basophilic stippling</strong></li>
<li><strong>Encephalopathy</strong></li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li>EDTA</li>
<li>Dimercaprol</li>
<li>Succimer for Kids</li>
</ul>
<h4 id="mercury-hg"><a class="header" href="#mercury-hg">Mercury (Hg)</a></h4>
<p>Enzyme Inhibitor</p>
<p><strong>MOA</strong> Binds functional groups (Unique to Hg)</p>
<p><strong>Causes</strong> Lots of Fish</p>
<p><strong>Effects</strong></p>
<ul>
<li><strong>Gingivostomatitis</strong></li>
<li><strong>Tremor</strong></li>
<li>Neuropsychiatric illness</li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li>Succimer-1st line</li>
<li>Dimercaprol-2nd line</li>
</ul>
<h4 id="arsenic"><a class="header" href="#arsenic">Arsenic</a></h4>
<p>Enzyme Inhibitor</p>
<p><strong>MOA</strong></p>
<ul>
<li>Replace Phos group</li>
</ul>
<p><strong>Causes</strong></p>
<ul>
<li>Contaminated H20</li>
</ul>
<p><strong>Effects</strong></p>
<ul>
<li>Delayed peripheral neuropathy</li>
<li>Rice water stools (Severe gastroenteritis)</li>
<li>QT prolongation</li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li>Dimercaprol</li>
<li>Can't use Succimer because of gastroenteritis</li>
</ul>
<h4 id="copper"><a class="header" href="#copper">Copper</a></h4>
<ul>
<li>Wilson disease</li>
<li>Tx: Penicillamine</li>
</ul>
<h4 id="iron-1"><a class="header" href="#iron-1">Iron</a></h4>
<p><strong>MOA</strong></p>
<ul>
<li>peroxidation of membrane lipids</li>
<li>DNA oxidation</li>
</ul>
<p>Causes of toxicity</p>
<ul>
<li>Accidental ingestion (kids)</li>
<li>Transfusions (Sickle Cell)</li>
<li>Hemochromalosis</li>
</ul>
<p><strong>Effects</strong></p>
<ul>
<li>Gl bleed, lethargy</li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li>IV Deferoxamine</li>
<li>PO Deferasirox</li>
<li>Dialysis</li>
</ul>
<h4 id="cesiumthallium"><a class="header" href="#cesiumthallium">Cesium/Thallium</a></h4>
<p>Antidote: Prussian blue</p>
<h3 id="solvents"><a class="header" href="#solvents">Solvents</a></h3>
<h4 id="halogenated-aliphatic-hydrocarbons"><a class="header" href="#halogenated-aliphatic-hydrocarbons">Halogenated Aliphatic Hydrocarbons</a></h4>
<p>Use: Cleaning agents</p>
<p>Cause free radical injury</p>
<p>Chloroform, Carbon tetrachloride</p>
<ul>
<li>CNS depression, cardiotoxicity, liver injury</li>
</ul>
<p>Carbon tetrachloride</p>
<ul>
<li>Dry cleaning industry</li>
<li>Liver centrilobular necrosis</li>
</ul>
<p>Treatment: Remove agent</p>
<h4 id="aromatic-hydrocarbons"><a class="header" href="#aromatic-hydrocarbons">Aromatic Hydrocarbons</a></h4>
<p>Use: Industrial solvents</p>
<p><strong>Benzene</strong></p>
<ul>
<li>Acute
<ul>
<li>Vertgo</li>
<li>Euphoria, Coma</li>
</ul>
</li>
<li>Chronic
<ul>
<li>Aplastic Anemia</li>
<li>Myelodysplastic Syndrome</li>
</ul>
</li>
</ul>
<p><strong>Toluene</strong></p>
<ul>
<li>CNS depression, skin</li>
<li>Ataxia, LOC</li>
</ul>
<p><strong>Xylene</strong></p>
<ul>
<li>CNS depression, skin</li>
</ul>
<p>Treatment: Remove agent</p>
<h3 id="hemoglobin-modification"><a class="header" href="#hemoglobin-modification">Hemoglobin Modification</a></h3>
<h4 id="methemoglobin-fe3"><a class="header" href="#methemoglobin-fe3">Methemoglobin (Fe3+)</a></h4>
<p><strong>Idea: Hgb Fe3+ hates O2 and does not bind to it</strong></p>
<p><strong>Causes</strong></p>
<ul>
<li>Nitiries from diet/poliution</li>
<li>Benzocaine</li>
</ul>
<p><strong>MOA</strong></p>
<ul>
<li>Fe+2 oxidized to Fe+3 which decreases Hgb 02 binding</li>
<li>Left Shiftin Hgb Curve</li>
</ul>
<p><strong>Sx</strong></p>
<ul>
<li>Cyanosis</li>
<li><strong>Chocolate blood</strong></li>
<li><strong>Normal PaO2</strong></li>
</ul>
<p><strong>Treatment</strong>: Methylene blue &amp; Vit C (Reduce Fe+3 1o Fe+2)</p>
<h4 id="carbon-monoxide"><a class="header" href="#carbon-monoxide">Carbon Monoxide</a></h4>
<p><strong>Idea: Oxygen can't bind to hemoglobin</strong></p>
<p><strong>Causes</strong>: Fires, car exhaust</p>
<p><strong>Carboxyhemoglobin (CO+Hgb)</strong></p>
<p><strong>MOA</strong></p>
<ul>
<li>CO binds to Hgb 200x more than 02</li>
<li>Hgb becomes more stingy and doesn't dissociate from 02</li>
<li><strong>Lef Shift in Hemoglobin curve</strong></li>
</ul>
<p><strong>Sx</strong></p>
<ul>
<li><strong>Cherry red skin</strong></li>
<li><strong>Normal Pa02</strong></li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li>100% 02</li>
<li>Hyperbaric 02</li>
</ul>
<h4 id="cyanide"><a class="header" href="#cyanide">Cyanide</a></h4>
<p><strong>Idea: Mitochondria Can't use Oxygen to make ATP</strong></p>
<p><strong>Causes</strong></p>
<ul>
<li>Smoke, Plastic burning</li>
<li>Nitroprusside</li>
</ul>
<p><strong>MOA</strong></p>
<ul>
<li><strong>Bind and decrease Cytochrome C in mitochondria, blocking ETC &amp; decrease oxidative phosphorylation</strong> o Also bind Methemoglobin</li>
</ul>
<p><strong>Sx</strong></p>
<ul>
<li>HA, Seizures</li>
<li>High Yenous 02</li>
<li>Lactic acidosis</li>
</ul>
<p><strong>Treatment</strong></p>
<ul>
<li>Induce methemoglobinema (Nitrites)</li>
<li>Thiosullate</li>
</ul>
<h3 id="chelators-general-principles"><a class="header" href="#chelators-general-principles">Chelators general principles</a></h3>
<p><strong>Edetate Calcium Disodium CaNa2 (EDTA)</strong></p>
<ul>
<li>Chelates divalent ions (<strong>Lead</strong>)</li>
<li>Notes: Excreted in kidneys (Contraindicated in anuric agents)</li>
</ul>
<p><strong>Succimer</strong> (Or Dimercaprol which is an analogue)</p>
<ul>
<li>Chelates heavy metals (Lead, Mercury, Arsenic)</li>
<li>Reverses metal induced inhibition of Cysteine containing enzymes</li>
<li>Route of administration: Succimer: Oral, Dimercaprol: IM</li>
</ul>
<p><strong>Penicillamine</strong></p>
<ul>
<li>Forms soluble complexes with targets and increase their solubility
<ul>
<li>Heavy metals (<strong>Copper</strong>, lead, mercury)</li>
<li>Cysteine: prevents cystine stones in Cystinuria</li>
<li>Rheumatoid factor: Used in RA</li>
</ul>
</li>
<li>SE: PCN allergy, Hypersensitivity reactions, <strong>Membranous nephropathy</strong></li>
</ul>
<p><strong>Deferoxamine</strong></p>
<ul>
<li>Binds <strong>free Fe+3</strong></li>
</ul>
<h1 id="alternative-medicine"><a class="header" href="#alternative-medicine">Alternative Medicine</a></h1>
<h1 id="rheumatoid-arthritis-pharmacology"><a class="header" href="#rheumatoid-arthritis-pharmacology">Rheumatoid Arthritis Pharmacology</a></h1>
<ul>
<li><a href="pharmacology/23.html#ra-big-picture">RA Big Picture</a></li>
<li><a href="pharmacology/23.html#rheumatoid-arthritis">Rheumatoid Arthritis</a></li>
<li><a href="pharmacology/23.html#nsaids">NSAIDs</a>
<ul>
<li><a href="pharmacology/23.html#aspirin">Aspirin</a></li>
<li><a href="pharmacology/23.html#ibuprofen--indomethacin--naproxen">Ibuprofen &amp; Indomethacin &amp; Naproxen</a></li>
<li><a href="pharmacology/23.html#celecoxib">Celecoxib</a></li>
</ul>
</li>
<li><a href="pharmacology/23.html#glucocorticoids">Glucocorticoids</a>
<ul>
<li><a href="pharmacology/23.html#prednisolone--prednisone--triamcinolone--methylprednisolone">Prednisolone &amp; Prednisone &amp; Triamcinolone &amp; Methylprednisolone</a></li>
</ul>
</li>
<li><a href="pharmacology/23.html#disease-modifying-anti-rheumatic-drugs---non-biologic">Disease Modifying Anti-Rheumatic Drugs - Non Biologic</a>
<ul>
<li><a href="pharmacology/23.html#methotrexate">Methotrexate</a></li>
<li><a href="pharmacology/23.html#leflunomide">Leflunomide</a></li>
<li><a href="pharmacology/23.html#hydroxychloroquine">Hydroxychloroquine</a></li>
<li><a href="pharmacology/23.html#sulfasalazine">Sulfasalazine</a></li>
<li><a href="pharmacology/23.html#azathioprine">Azathioprine</a></li>
<li><a href="pharmacology/23.html#cyclosporine">Cyclosporine</a></li>
</ul>
</li>
<li><a href="pharmacology/23.html#disease-modifying-anti-rheumatic-drugs---biologic">Disease Modifying Anti-Rheumatic Drugs - Biologic</a>
<ul>
<li><a href="pharmacology/23.html#tnf-a-inhibitors">TNF-a Inhibitors</a>
<ul>
<li><a href="pharmacology/23.html#side-effects">Side Effects:</a></li>
<li><a href="pharmacology/23.html#contraindications">Contraindications</a></li>
</ul>
</li>
<li><a href="pharmacology/23.html#cd20-antibody">CD20 Antibody</a></li>
<li><a href="pharmacology/23.html#selective-costimulation-modulor">Selective Costimulation Modulor</a></li>
<li><a href="pharmacology/23.html#interleukin-1-inhibitor">Interleukin-1 inhibitor</a>
<ul>
<li><a href="pharmacology/23.html#interleukin-6-inhibitor">Interleukin-6 inhibitor</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<h2 id="ra-big-picture"><a class="header" href="#ra-big-picture">RA Big Picture</a></h2>
<p>Problem: TNF inflammation and Rheumatoid factor made by B cells</p>
<p>How to fix it?</p>
<ul>
<li>Symptom management
<ul>
<li>Decrease non-specific inflammation acutely
<ul>
<li><strong>NSAIDs</strong> and <strong>Glucocorticoids</strong></li>
</ul>
</li>
</ul>
</li>
<li>Modify the disease progression
<ul>
<li>Prevent synthesis of DNA needed for leukocytes: <strong>MTX</strong>. <strong>Leflunomide</strong>, <strong>Azathioprine</strong></li>
<li>Decrease/modulate lymphocyte action: <strong>Hydroxychloroquine</strong>, <strong>Sulfasalazine</strong></li>
<li>Block TNF: <strong>Etanercept</strong>, <strong>Infliximab</strong>, <strong>Adalimumab</strong></li>
<li>Block B Cells: <strong>Rituximab</strong></li>
<li>Block T cell stimulation: <strong>Abatacept</strong></li>
<li>Block Interleukins
<ul>
<li>IL 1: <strong>Anakinra</strong>, <strong>Canakinumab</strong></li>
<li>IL 6: <strong>Tocilizumab</strong></li>
</ul>
</li>
</ul>
</li>
</ul>
<h2 id="rheumatoid-arthritis"><a class="header" href="#rheumatoid-arthritis">Rheumatoid Arthritis</a></h2>
<p><strong>General</strong></p>
<p>The goal of RA treatment is low disease activity or ideally, remission
Treat with disease-modifying antirheumatic drugs (DMARDs) and Anti-inflammatories</p>
<ul>
<li>Non Biologic DMARDs - Methotrexate, Leflunomide, Sulfasalazine, elc.</li>
<li>Biologic DMARDs - etanercept, infliximab, adalimumab</li>
<li>Anti Inflammatories - Corticosteroids and NSAIDs</li>
</ul>
<p>DMARDSs should be started within three months of diagnosis for most patients.</p>
<p>Treatment decisions are based on the patient's disease
activity, disease duration, prognosis, and current RA regimen.</p>
<p><strong>Acute Flair: NSAID with Corticosteroid</strong></p>
<p><strong>Chronic Treatment Progression</strong></p>
<ol>
<li><strong>Nonbiologic DMARDs</strong>
Monotherapy recommended in early disease with low
disease activity, and in early disease of moderate
activity without poor prognosis.</li>
<li><strong>Nonbiologic DMARDSs in Combination</strong>
More effective than monotherapy. Combinations
typically consist of methotrexate (the “anchor” drug)
plus one or two other DMARDs</li>
<li><strong>Biologic DMARDS</strong>
After nonbiologic DMARD failure in a patient with
poor prognosis (e.g., highly active disease, early
joint damage, rheumatoid factor, anti-citrullinated
protein antibody), or after inadequate response o
two nonbiologic DMARD regimens in a patient without
poor Prognosis.</li>
</ol>
<h2 id="nsaids"><a class="header" href="#nsaids">NSAIDs</a></h2>
<h4 id="aspirin-1"><a class="header" href="#aspirin-1">Aspirin</a></h4>
<p>MOA: <strong>Irreversible</strong> COX inhibitor</p>
<p>Uses:</p>
<ul>
<li><em>Low dose</em>: Primary and Secondary Prevention MI,</li>
<li><em>High dose</em>: Rheumatoid Arthritis (historically), Active MI, Anti-inflammatory, Anti-Pyretic</li>
</ul>
<p>SE: <strong>Gastritis</strong> (Gl ulcers &amp; Bleeding), <strong>Tinnitus</strong>, Renal failure, <strong>Reye syndrome</strong></p>
<p>Toxicity:</p>
<ul>
<li><em>Early</em>: Respiratory Alkalosis</li>
<li><em>Late</em>: Becomes Mixed Metabolic Acidosis and Respiratory Alkalosis</li>
</ul>
<h4 id="ibuprofen--indomethacin--naproxen"><a class="header" href="#ibuprofen--indomethacin--naproxen">Ibuprofen &amp; Indomethacin &amp; Naproxen</a></h4>
<p>MOA:</p>
<ul>
<li><strong>Reversible</strong> COX inhibitor</li>
<li>Amount of COX1 and COX2 blockade changes depending on the agent</li>
</ul>
<p>Uses: Fever, analgesia,and anti-inflammatory</p>
<p>SE: Gastritis (ulcers, bleeding, etc)</p>
<h4 id="celecoxib"><a class="header" href="#celecoxib">Celecoxib</a></h4>
<p>MOA:</p>
<ul>
<li><strong>Reversible</strong> COX 2 inhibitor</li>
<li>Found in inflammatory cells and and <strong>vascular endothelial</strong>. Spares gastric mucosa.</li>
</ul>
<p>Uses: RA and OA</p>
<p>SE: <strong>Sulfa allergy and increased risk of thrombosis (Ml)</strong></p>
<h2 id="glucocorticoids"><a class="header" href="#glucocorticoids">Glucocorticoids</a></h2>
<h4 id="prednisolone--prednisone--triamcinolone--methylprednisolone"><a class="header" href="#prednisolone--prednisone--triamcinolone--methylprednisolone">Prednisolone &amp; Prednisone &amp; Triamcinolone &amp; Methylprednisolone</a></h4>
<p>MOA: Inhibit Phospholipase A2, NFKB, TNF, leukocyte adhesion</p>
<p>Uses:</p>
<ul>
<li>Acute Asthma/COPD, Gout, Anaphylaxis, Crohn disease, MS, etc.</li>
<li>Oral, IV, etc.</li>
</ul>
<p><strong>SE (High Yield)</strong></p>
<ul>
<li>Cushing like syndrome</li>
<li>Hyperglycemia</li>
<li>Osteoporosis</li>
<li><strong>HPA Axis Suppression for long term &gt; 10 days- Needs tapering if longer</strong></li>
<li>Immunodeficiency</li>
<li>Glaucoma</li>
<li>Depression/Psychosis</li>
</ul>
<h2 id="disease-modifying-anti-rheumatic-drugs---non-biologic"><a class="header" href="#disease-modifying-anti-rheumatic-drugs---non-biologic">Disease Modifying Anti-Rheumatic Drugs - Non Biologic</a></h2>
<h4 id="methotrexate"><a class="header" href="#methotrexate">Methotrexate</a></h4>
<p>MOA:</p>
<ul>
<li>Dihydrofolate reductase inhibitor (DHFR)</li>
<li><strong>Drug of Choice</strong></li>
<li>Effects take 4-6 week period</li>
</ul>
<p><strong>SE:</strong></p>
<ul>
<li><strong>Bone Marrow suppression</strong></li>
<li><strong>GI: Stomatitis, Anorexia, NV</strong>
<ul>
<li>Minimized by SC or IM administration</li>
</ul>
</li>
<li><strong>Liver Toxicity (Fibrosis and Necrosis)</strong>
<ul>
<li><strong>Avoid Alcohol</strong></li>
</ul>
</li>
<li><strong>Pulmonary: Hypersensitivity Pneumonitis</strong></li>
<li><strong>Teratogenic -&gt; Neural tube defects</strong></li>
</ul>
<p><em>Antidote</em>: <strong>Leucovorin</strong> (Folinic acid)</p>
<h4 id="leflunomide"><a class="header" href="#leflunomide">Leflunomide</a></h4>
<p>MOA:</p>
<ul>
<li>Dihydroorotate dehydrogenase Inhibitor (Carbamoyl phosphate -&gt; Orolic acid)</li>
<li><strong>Pyrimidine synthesis inhibitor</strong>
Use: Monotherapy for RA (those who can't tolerate MTX / Instead of)</li>
</ul>
<p>Response in 1 month (Max Response 3-6)</p>
<p>SE:</p>
<ul>
<li>Diarrhea</li>
<li><strong>Myelosuppression</strong></li>
<li><strong>Hepatotoxicity</strong></li>
<li><strong>Contraindicated during pregnancy</strong>
<ul>
<li>Cousin of Thalidomide</li>
</ul>
</li>
</ul>
<h4 id="hydroxychloroquine"><a class="header" href="#hydroxychloroquine">Hydroxychloroquine</a></h4>
<p>MOA: Traps free radicals, Stabilizes lysosomal membranes, suppresses lymphocyte response</p>
<ul>
<li><strong>Antimalarial</strong></li>
<li><strong>Response in 3-6 months</strong></li>
</ul>
<p>Uses:</p>
<ul>
<li><strong>Mild RA (Moderate effect)</strong></li>
<li><strong>In Combo w/ MTX and Sulfasalazine</strong></li>
</ul>
<p>Side Effects</p>
<ul>
<li>Well tolerated</li>
<li>Gl</li>
<li><strong>Vision Changes</strong></li>
<li><strong>~Safe during pregnancy</strong></li>
</ul>
<h4 id="sulfasalazine"><a class="header" href="#sulfasalazine">Sulfasalazine</a></h4>
<p>MOA: ??? &amp; Anti-inflammatory effects, immunomodulatory</p>
<p>Uses:</p>
<ul>
<li><strong>Mild RA (Moderate effect)</strong></li>
<li><strong>In Combo w/ MTX and Hydroxychloroguine</strong></li>
</ul>
<p><strong>Response in 2-3 months</strong></p>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Gl anorexia, <em><strong>rash (Sulfa)</strong></em></li>
<li><strong>Can be used during pregnancy</strong></li>
</ul>
<h4 id="azathioprine"><a class="header" href="#azathioprine">Azathioprine</a></h4>
<p>MOA:</p>
<ul>
<li>Metabolized to BMP (Purine analogue) -&gt; Inhibits DNA synthesis</li>
<li><strong>Antimetabolite</strong></li>
</ul>
<p>Use:</p>
<ul>
<li>Refractory RA or systemic involvement</li>
<li>Induction, remission of mod IBD (Glucocorticoid sparing)</li>
<li><strong>Slow onset</strong> - Co-administered with MTX</li>
</ul>
<p>Side Effects: Myelosuppression, <strong>Hepatotoxicity</strong></p>
<p>DDI: <strong>Allopurinol (Inhibits Xanthine oxidase which metabolizes 6MP)</strong></p>
<h4 id="cyclosporine"><a class="header" href="#cyclosporine">Cyclosporine</a></h4>
<p>MOA:</p>
<ul>
<li>Calcineurin Inhibitor</li>
<li>Blocks T-cell proliferation by preventing IL-2 transcription</li>
</ul>
<p>Uses:</p>
<ul>
<li>RA</li>
<li>Prophylaxis of organ rejection and Treat graft-versus-host disease</li>
</ul>
<p>Side Effects:</p>
<ul>
<li><strong>Nephrotoxicity, HTN HLD</strong>, neurotoxicity, gingival hyperplasia, hirsutism.</li>
<li>Must monitor drug levels (small therapeutic window)</li>
<li>Lots of Drug-drug and Drug food interactions</li>
</ul>
<h2 id="disease-modifying-anti-rheumatic-drugs---biologic"><a class="header" href="#disease-modifying-anti-rheumatic-drugs---biologic">Disease Modifying Anti-Rheumatic Drugs - Biologic</a></h2>
<h3 id="tnf-a-inhibitors"><a class="header" href="#tnf-a-inhibitors">TNF-a Inhibitors</a></h3>
<p><strong>Etanercept</strong>
MOA: Fusion Protein. Binds TNR-a and
prevents from activating receptor</p>
<p><strong>Infliximab</strong>
MOA: Chimeric Anti TNR-a monoclonal Antibody</p>
<p><strong>Adalimumab</strong>
MOA: Humanized Anti TNR-a monoclonal Antibody</p>
<h4 id="side-effects-1"><a class="header" href="#side-effects-1">Side Effects:</a></h4>
<ul>
<li>Injection site reaction</li>
<li><strong>INFECTION (</strong>* TB <strong>, Hep b, etc.)</strong></li>
<li>Cancer</li>
<li>Allergic reaction</li>
<li>Demyelinating disease (Natalizumab -&gt; MS)</li>
<li>SLE-Like syndrome</li>
<li><strong>CHF Exacerbation</strong></li>
<li>Pancytopenia</li>
</ul>
<h4 id="contraindications"><a class="header" href="#contraindications">Contraindications</a></h4>
<ul>
<li><em><strong>History of TB or + PPD</strong></em></li>
<li>Infection (active, chronic, or recurrent)</li>
<li><strong>CHF</strong></li>
</ul>
<h3 id="cd20-antibody"><a class="header" href="#cd20-antibody">CD20 Antibody</a></h3>
<p><strong>Rituximab</strong></p>
<p>MOA:</p>
<ul>
<li>Chimeric Monoclonal antibody CD20</li>
<li><strong>B cell surface antigen</strong></li>
</ul>
<p>Uses:</p>
<ul>
<li>CLL &amp; NHL</li>
<li><strong>Combo w/ MTX + Nonbiologic DMARD</strong></li>
</ul>
<p>Side Effects:</p>
<ul>
<li><strong>Infusion reaction (Fatal)</strong></li>
<li><strong>Infection</strong></li>
<li><strong>Reactivation of Hep B</strong></li>
</ul>
<h3 id="selective-costimulation-modulor"><a class="header" href="#selective-costimulation-modulor">Selective Costimulation Modulor</a></h3>
<p><strong>Abatacept</strong></p>
<p>MOA:</p>
<ul>
<li>Fusion protein. Homologue of CD28, T cell receptor for B7</li>
<li>Interferes with T-cell Activation (Dendritic Cell / CD8/CD4)</li>
</ul>
<p>Use: <strong>Monotherapy RA</strong></p>
<p>Side Effects:</p>
<ul>
<li>Infusion reactions (HTN, HA, Anaphylaxis)</li>
<li>Increase infection risk</li>
</ul>
<h3 id="interleukin-1-inhibitor"><a class="header" href="#interleukin-1-inhibitor">Interleukin-1 inhibitor</a></h3>
<p><strong>Anakinra</strong></p>
<p>MOA: IL-1 receptor antagonist</p>
<p>Uses: monotherapy or Combo w/ MTX</p>
<ul>
<li>Considered Least effect DMARD</li>
</ul>
<p><strong>Canakinumab</strong></p>
<p>MOA: Monocional AB against IL-1B</p>
<p>Uses: Systemic Juvenile idiopathic arthritis</p>
<p>Side effects:</p>
<ul>
<li>Infections</li>
<li>Abdominal pain</li>
<li>Injection site reaction</li>
</ul>
<h4 id="interleukin-6-inhibitor"><a class="header" href="#interleukin-6-inhibitor">Interleukin-6 inhibitor</a></h4>
<p><strong>Tocilizumab</strong></p>
<p>MOA: Monoclonal antibody against IL-6</p>
<p>Uses:</p>
<ul>
<li>Patients with inadequate response to 1 or more DMARDs</li>
<li>Systemic Juvenile idiopathic arthritis</li>
</ul>
<p>Side Effects:</p>
<ul>
<li>Infections (TB, fungal, viral URI), HA, HTN, increased LFTS</li>
</ul>
<h1 id="gout-pharmacology"><a class="header" href="#gout-pharmacology">Gout Pharmacology</a></h1>
<ul>
<li><a href="pharmacology/24.html#gout-big-picture">Gout Big Picture</a>
<ul>
<li><a href="pharmacology/24.html#goals-for-acute-gout-attacks">Goals for Acute Gout Attacks</a></li>
<li><a href="pharmacology/24.html#goals-for-chronic-gout">Goals for Chronic Gout</a></li>
</ul>
</li>
<li><a href="pharmacology/24.html#inhibitors-of-uric-acid-synthesis">Inhibitors of Uric Acid synthesis</a></li>
<li><a href="pharmacology/24.html#uricosuric-agents">Uricosuric Agents</a></li>
<li><a href="pharmacology/24.html#colchicine">Colchicine</a></li>
<li><a href="pharmacology/24.html#indomethacin-nsaid">Indomethacin (NSAID)</a></li>
<li><a href="pharmacology/24.html#agents-to-increase-uric-acid-degradation">Agents to increase uric acid degradation</a></li>
</ul>
<h2 id="gout-big-picture"><a class="header" href="#gout-big-picture">Gout Big Picture</a></h2>
<p><strong>Problem</strong>: Hyperuricemia and crystals followed by neutrophil mediated inflammation</p>
<h3 id="goals-for-acute-gout-attacks"><a class="header" href="#goals-for-acute-gout-attacks">Goals for Acute Gout Attacks</a></h3>
<ul>
<li>Minimize neutrophils infiltration: <strong>Colchicine</strong></li>
<li>Decrease inflammation: <strong>Glucocorticoids (Prednisone)</strong> and <strong>NSAIDs (Indomethacin)</strong></li>
</ul>
<h3 id="goals-for-chronic-gout"><a class="header" href="#goals-for-chronic-gout">Goals for Chronic Gout</a></h3>
<ul>
<li>Decrease uric acid production: <strong>Allopurinol</strong> and <strong>Febuxostat</strong></li>
<li>Increase uric acid excretion from kidneys: <strong>Probenecid</strong></li>
<li>Make uric acid more soluble: <strong>Rasburicase &amp; Pegloticase</strong></li>
<li>Minimize hyperuricemia
<ul>
<li>Avoid- <strong>Furosemide, Thiazide diuretics, Niacin</strong>, Cyclosporine, <strong>Pyrazinamide</strong></li>
<li>Avoid- <strong>Low dose Aspirin</strong> (Inhibits uric acid secretion into urine)</li>
</ul>
</li>
</ul>
<h2 id="inhibitors-of-uric-acid-synthesis"><a class="header" href="#inhibitors-of-uric-acid-synthesis">Inhibitors of Uric Acid synthesis</a></h2>
<p><strong>Allopurinol &amp; Febuxostat</strong></p>
<p><strong>MOA</strong>: Inhibit xanthine oxidase (XO)</p>
<p><strong>Use</strong>
o Chronic gout
o Tumor lysis syndrome
o Lesch-Nyhan Syndrome</p>
<p><strong>SE</strong></p>
<ul>
<li>Allopurinol
<ul>
<li>Dose adjusted in renal failure</li>
<li><strong>Steven Johnson Syndrome</strong></li>
<li>Hepatotoxicity</li>
<li><strong>Aplastic anemia</strong></li>
<li>Drug interaction: Inhibits metabolism of 6 MP/Azathioprine by XO</li>
</ul>
</li>
<li>Febuxostat - Better lolerated than allopurinol</li>
</ul>
<h2 id="uricosuric-agents"><a class="header" href="#uricosuric-agents">Uricosuric Agents</a></h2>
<p><strong>Probenecid</strong>
<strong>MOA</strong> Inhibit urate reabsorption from proximal convoluted tubule (PCT)
<strong>Use</strong></p>
<ul>
<li>Chronic gout</li>
<li>Increase Penicillin concentration in the blood (Inhibits its secretion from PCT)
<strong>SE</strong></li>
<li><strong>Uric acid stone</strong> (increases urate urine levels- make sure pt is hydrated)</li>
<li>Sulfa allergy</li>
</ul>
<h2 id="colchicine"><a class="header" href="#colchicine">Colchicine</a></h2>
<p><strong>MOA</strong></p>
<ul>
<li>Bind and <strong>Stabilize Microtubules</strong></li>
<li>Inhibit microtubule polymerization</li>
<li><strong>Decrease neutrophil chemotaxis</strong></li>
</ul>
<p><strong>Use</strong></p>
<ul>
<li>Acute gout attacks</li>
<li>Low doses: prevent gout attacks
<strong>SE</strong></li>
<li><em><strong>Diarrhea</strong></em></li>
<li><strong>Agranulocytosis</strong></li>
<li><strong>Myopathy</strong></li>
<li>Hepatic necrosis</li>
</ul>
<h2 id="indomethacin-nsaid"><a class="header" href="#indomethacin-nsaid">Indomethacin (NSAID)</a></h2>
<p><strong>MOA</strong> Inhibit COX- Prostaglandins and neutrophil migration</p>
<p><strong>Use</strong>: Acute gout attack</p>
<p><strong>SE</strong>: Gl ulcers, fluid retention</p>
<h2 id="agents-to-increase-uric-acid-degradation"><a class="header" href="#agents-to-increase-uric-acid-degradation">Agents to increase uric acid degradation</a></h2>
<p><strong>Rasburicase &amp; Pegloticase</strong></p>
<p><strong>MOA</strong>: Recombinant Uricase: Converts uric acid to allantoin (water soluble)</p>
<p><strong>Use</strong></p>
<ul>
<li>Refractory chronic gout</li>
<li><strong>Prevent and treat Tumor Lysis Syndrome</strong>
<strong>SE</strong>: Anaphylaxis, Autoimmune antibodies</li>
</ul>
<h1 id="muscle-relaxants"><a class="header" href="#muscle-relaxants">Muscle Relaxants</a></h1>
<h1 id="dermatology"><a class="header" href="#dermatology">Dermatology</a></h1>
<h1 id="nsaids-and-prostaglandins"><a class="header" href="#nsaids-and-prostaglandins">NSAIDS and Prostaglandins</a></h1>
<h1 id="cholinergic-nervous-system"><a class="header" href="#cholinergic-nervous-system">Cholinergic Nervous System</a></h1>
<h1 id="adrenergic-nervous-system"><a class="header" href="#adrenergic-nervous-system">Adrenergic Nervous System</a></h1>
<h1 id="reproductive-pharmacology"><a class="header" href="#reproductive-pharmacology">Reproductive Pharmacology</a></h1>
<h1 id="pharmacology-asthma--copd"><a class="header" href="#pharmacology-asthma--copd">Pharmacology Asthma &amp; COPD</a></h1>
<h1 id="anti-histamines"><a class="header" href="#anti-histamines">Anti-Histamines</a></h1>
<h1 id="calcium-homeostasis"><a class="header" href="#calcium-homeostasis">Calcium Homeostasis</a></h1>
<h1 id="hypothalamic-and-pituitary-agents"><a class="header" href="#hypothalamic-and-pituitary-agents">Hypothalamic and Pituitary Agents</a></h1>
<h1 id="adrenocorticosteroids"><a class="header" href="#adrenocorticosteroids">Adrenocorticosteroids</a></h1>
<h1 id="thyroid-acting-agents"><a class="header" href="#thyroid-acting-agents">Thyroid Acting Agents</a></h1>
<h1 id="diabetes"><a class="header" href="#diabetes">Diabetes</a></h1>
<h1 id="nausea--vomiting"><a class="header" href="#nausea--vomiting">Nausea &amp; Vomiting</a></h1>
<h1 id="inflammatory-bowel-disease"><a class="header" href="#inflammatory-bowel-disease">Inflammatory Bowel Disease</a></h1>
<h1 id="constipation--diarrhea"><a class="header" href="#constipation--diarrhea">Constipation &amp; Diarrhea</a></h1>
<ul>
<li><a href="pharmacology/40.html#constipation">Constipation</a>
<ul>
<li><a href="pharmacology/40.html#laxatives">Laxatives</a>
<ul>
<li><a href="pharmacology/40.html#bulk-forming-laxative">Bulk-Forming Laxative</a></li>
<li><a href="pharmacology/40.html#stool-surfactant-agents-aka-stool-softeners">Stool surfactant agents AKA Stool softeners</a></li>
<li><a href="pharmacology/40.html#osmotic-laxatives">Osmotic Laxatives</a></li>
</ul>
</li>
<li><a href="pharmacology/40.html#stimulant-laxatives">Stimulant Laxatives</a>
<ul>
<li><a href="pharmacology/40.html#senna-exlax--bisacodyl-dulcolax">Senna (ExLax) &amp; Bisacodyl! (Dulcolax)</a></li>
<li><a href="pharmacology/40.html#lubiprostone">Lubiprostone</a></li>
<li><a href="pharmacology/40.html#methylinaltrexone-bromide">Methylinaltrexone bromide</a></li>
<li><a href="pharmacology/40.html#prucalopride">Prucalopride</a></li>
</ul>
</li>
<li><a href="pharmacology/40.html#constipation-treatment-examples">Constipation Treatment Examples</a>
<ul>
<li><a href="pharmacology/40.html#occasional-constipation">Occasional Constipation</a></li>
<li><a href="pharmacology/40.html#child-w-constipation">Child w/ Constipation</a></li>
<li><a href="pharmacology/40.html#geriatric-w-hard-stool">Geriatric w/ ‘Hard Stool’</a></li>
<li><a href="pharmacology/40.html#opioid-induced-constipation">Opioid Induced Constipation</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="pharmacology/40.html#antidiarrheal">Antidiarrheal</a>
<ul>
<li><a href="pharmacology/40.html#loperamide">Loperamide</a></li>
<li><a href="pharmacology/40.html#diphenoxylateatropine">Diphenoxylate/Atropine</a></li>
<li><a href="pharmacology/40.html#when-an-antidiarrheal-is-contraindicated">When an Antidiarrheal is Contraindicated:</a></li>
</ul>
</li>
</ul>
<h1 id="constipation"><a class="header" href="#constipation">Constipation</a></h1>
<p><strong>Goal</strong>
For the patient to have a comfortable BM</p>
<p><strong>How?</strong></p>
<ul>
<li>Stool Softeners
<ul>
<li>Docusate</li>
</ul>
</li>
<li>Bulk Forming
<ul>
<li>Psyllium &amp; methylicellulose</li>
</ul>
</li>
<li>Osmotic Agents
<ul>
<li>Magnesium hydroxide &amp; Polyethylene Glycol (PEG)</li>
</ul>
</li>
<li>Stimulant Laxatives
<ul>
<li>Senna, Bisacody! &amp; Lubiprostone</li>
</ul>
</li>
<li>Other
<ul>
<li>Methyinaltrexone bromide &amp; Prucalopride</li>
</ul>
</li>
</ul>
<h2 id="laxatives"><a class="header" href="#laxatives">Laxatives</a></h2>
<h3 id="bulk-forming-laxative"><a class="header" href="#bulk-forming-laxative">Bulk-Forming Laxative</a></h3>
<p><strong>Psyllium (Metamucil), methylcellulose, polycarbophil</strong></p>
<p><strong>MOA</strong>: Soluble fibers; draw water into gut lumen, forms liquid that promotes peristalsis</p>
<p><strong>SE</strong>: Bloating and Gas</p>
<h3 id="stool-surfactant-agents-aka-stool-softeners"><a class="header" href="#stool-surfactant-agents-aka-stool-softeners">Stool surfactant agents AKA Stool softeners</a></h3>
<p><strong>Docusate</strong></p>
<p><strong>MOA:</strong></p>
<ul>
<li>Acts like detergent (emulsification)</li>
<li>Facilitates interaction of water into stool</li>
<li>Literally make stool softer</li>
</ul>
<p><strong>SE</strong>: impair fat-soluble vitamin absorption</p>
<h3 id="osmotic-laxatives"><a class="header" href="#osmotic-laxatives">Osmotic Laxatives</a></h3>
<p><strong>Magnesium hydroxide</strong></p>
<p><strong>MOA</strong>: Nonabsorbable sugars / salts</p>
<p><strong>Use</strong>: Occasional constipation</p>
<p><strong>SE</strong>: Flatus, cramps, <strong>hypermagnesemia</strong> (in renal impairment)</p>
<p><strong>Polyethylene Glycol (PEG)</strong></p>
<p><strong>MOA</strong>: Non Absorbable osmotically active sugar</p>
<p><strong>Use</strong>: Occasional constipation, <strong>Colonic cleansing before Endoscopy</strong></p>
<p><strong>SE:</strong></p>
<ul>
<li><strong>Very safe</strong></li>
<li>Electrolyte abnormalities (long term use)</li>
</ul>
<h2 id="stimulant-laxatives"><a class="header" href="#stimulant-laxatives">Stimulant Laxatives</a></h2>
<h3 id="senna-exlax--bisacodyl-dulcolax"><a class="header" href="#senna-exlax--bisacodyl-dulcolax">Senna (ExLax) &amp; Bisacodyl! (Dulcolax)</a></h3>
<p><strong>MOA:</strong></p>
<ul>
<li>Lecture: Stimulation of enteric NS and increase electrolyte and fluid section</li>
<li>First Aid: Stimulation of enteric NS -&gt; colonic contraction</li>
</ul>
<p><strong>Uses: occasional constipation</strong></p>
<p><strong>Side effects</strong>: gastric irritation, cramps, fluid and electrolyte depletion <strong>(Bisacodyl)</strong></p>
<h3 id="lubiprostone"><a class="header" href="#lubiprostone">Lubiprostone</a></h3>
<p><strong>MOA</strong>: Stimulates Type 2 Chloride Channel -&gt; increase chloride-rich fluid secretion</p>
<p><strong>USE</strong>: IBS with constipation</p>
<p><strong>SE</strong>: Nausea</p>
<h3 id="methylinaltrexone-bromide"><a class="header" href="#methylinaltrexone-bromide">Methylinaltrexone bromide</a></h3>
<p><strong>MOA</strong>: Mu-Opioid antagonist on Gl opioid receptors</p>
<p><strong>Indications</strong>: <strong>Opioid-induced constipation</strong></p>
<p><em>Does not cross BBB</em></p>
<p><strong>SE</strong>: Stomach pain, gas, bloating, ND</p>
<h3 id="prucalopride"><a class="header" href="#prucalopride">Prucalopride</a></h3>
<p>MOA: Serotonin 5-HT4 Receptor Agonists</p>
<p>Indication: Chronic constipation</p>
<p>SE: Cardiovascular</p>
<h2 id="constipation-treatment-examples"><a class="header" href="#constipation-treatment-examples">Constipation Treatment Examples</a></h2>
<p><strong>Hard Stool -&gt; Docusate or Osmotic agent</strong></p>
<p><strong>No Peristalsis -&gt; Stimulant agent</strong></p>
<h3 id="occasional-constipation"><a class="header" href="#occasional-constipation">Occasional Constipation</a></h3>
<ul>
<li>Senna (monotherapy)</li>
<li>Bisacodyl (Monotherapy) PO or PR</li>
</ul>
<h3 id="child-w-constipation"><a class="header" href="#child-w-constipation">Child w/ Constipation</a></h3>
<ul>
<li>Poly Ethylene Glycol (PEG) daily
<ul>
<li>1 cup/ scope full</li>
</ul>
</li>
</ul>
<h3 id="geriatric-w-hard-stool"><a class="header" href="#geriatric-w-hard-stool">Geriatric w/ ‘Hard Stool’</a></h3>
<p><strong>Docusate</strong></p>
<ul>
<li>Not necessarily constipated</li>
</ul>
<h3 id="opioid-induced-constipation"><a class="header" href="#opioid-induced-constipation">Opioid Induced Constipation</a></h3>
<p><strong>“Mush” &amp; “Push”</strong></p>
<ul>
<li>Make stool softer and aid in its expulsion</li>
</ul>
<p><strong>Docusate + Senna</strong></p>
<ul>
<li>Add PEG as needed</li>
</ul>
<h1 id="antidiarrheal"><a class="header" href="#antidiarrheal">Antidiarrheal</a></h1>
<h3 id="loperamide"><a class="header" href="#loperamide">Loperamide</a></h3>
<p><strong>MOA:</strong>
o Mu-Opioid agonist (Peripherally)</p>
<p><strong>Use</strong>: Diarrhea.</p>
<p><strong>SE:</strong> Constipation and Nausea</p>
<p>New reports of patient's ODing</p>
<p><strong>Should not be used in infectious diarrhea</strong></p>
<p>Bismuth subsalicylate (See previous slides)</p>
<h3 id="diphenoxylateatropine"><a class="header" href="#diphenoxylateatropine">Diphenoxylate/Atropine</a></h3>
<p><strong>MOA:</strong></p>
<ul>
<li>Diphenoxylate -&gt; Mu- Opioid agonist (Peripherally)</li>
<li>Atropine -&gt;Abuse deterrent</li>
<li>Anticholinergic SE</li>
<li>Use: Traveler diarrhea (no fever/blood in stool)</li>
</ul>
<h3 id="when-an-antidiarrheal-is-contraindicated"><a class="header" href="#when-an-antidiarrheal-is-contraindicated">When an Antidiarrheal is Contraindicated:</a></h3>
<ul>
<li>Ulcerative Colitis</li>
<li>Acute dysentery</li>
<li>Bacterial enterocolitis</li>
<li>Pseudomembranous colitis (C. Diff)</li>
</ul>
<p><em><strong>Risk of Toxic Mega Colon</strong></em> with use of antidiarrheal</p>
<h1 id="gerd-pharmacology"><a class="header" href="#gerd-pharmacology">GERD Pharmacology</a></h1>
<h1 id="parkinsons-disease"><a class="header" href="#parkinsons-disease">Parkinson's Disease</a></h1>
<ul>
<li><a href="pharmacology/42.html#parkinsons-disease-treatment">Parkinson's Disease Treatment</a>
<ul>
<li><a href="pharmacology/42.html#carbidopalevodopa">Carbidopa/Levodopa</a></li>
<li><a href="pharmacology/42.html#dopamine-agonists">Dopamine Agonists</a>
<ul>
<li><a href="pharmacology/42.html#1st-generation---ergot-derivatives">1st Generation - Ergot Derivatives</a></li>
<li><a href="pharmacology/42.html#2nd-generation---non-ergot-derivatives">2nd Generation - Non-Ergot Derivatives</a></li>
<li><a href="pharmacology/42.html#amantadine">Amantadine</a></li>
<li><a href="pharmacology/42.html#apomorphine">Apomorphine</a></li>
</ul>
</li>
<li><a href="pharmacology/42.html#adjunct-agents-in-parkinsons">Adjunct Agents in Parkinson's</a>
<ul>
<li><a href="pharmacology/42.html#maois">MAOIs</a></li>
<li><a href="pharmacology/42.html#comt-inhibitors">COMT inhibitors</a></li>
<li><a href="pharmacology/42.html#deep-brain-stimulation">Deep Brain Stimulation</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="pharmacology/42.html#drugs-for-other-movement-disorders">Drugs for Other Movement Disorders</a>
<ul>
<li><a href="pharmacology/42.html#tourettes-syndrome">Tourette's Syndrome</a></li>
<li><a href="pharmacology/42.html#amyotrophic-lateral-sclerosis">Amyotrophic lateral sclerosis</a></li>
<li><a href="pharmacology/42.html#benign-essential-tremor">Benign essential tremor</a></li>
</ul>
</li>
<li><a href="pharmacology/42.html#antipsychotic-agents---typicals-fyi">Antipsychotic Agents - Typicals (FYI)</a>
<ul>
<li><a href="pharmacology/42.html#general-characteristics">General Characteristics</a></li>
<li><a href="pharmacology/42.html#typical-antipsychotics">Typical Antipsychotics</a></li>
</ul>
</li>
<li><a href="pharmacology/42.html#parkinsons-disease-treatment-guidelines">Parkinson’s Disease Treatment Guidelines</a></li>
</ul>
<h1 id="parkinsons-disease-treatment"><a class="header" href="#parkinsons-disease-treatment">Parkinson's Disease Treatment</a></h1>
<h2 id="carbidopalevodopa"><a class="header" href="#carbidopalevodopa">Carbidopa/Levodopa</a></h2>
<p><strong>MOA</strong>:</p>
<ul>
<li><strong>Levodopa</strong>: Dopamine precursor</li>
<li><strong>Carbidopa</strong>: Inhibits L-Dopa peripheral metabolism</li>
</ul>
<p><strong>Uses</strong>: Parkinson's</p>
<ul>
<li>Primarily bradykinesia, rigidity and tremor</li>
<li>Less effective on flat affect and shuffling gait</li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li><strong>Dyskinesia (irreversible)</strong></li>
<li><strong>Peak dosing effect</strong></li>
<li>Adrenergic:</li>
<li>Tachycardia, arrhythmias, HTN</li>
<li><strong>Behavioral</strong>:</li>
<li>Psychosis, hallucination, delusions, etc. (think excess dopamine)</li>
<li>Orthostasis</li>
<li><strong>N/V/D (Tolerance)</strong></li>
<li><strong>“Wearing off” or “on-off effects”</strong></li>
</ul>
<h2 id="dopamine-agonists"><a class="header" href="#dopamine-agonists">Dopamine Agonists</a></h2>
<h3 id="1st-generation---ergot-derivatives"><a class="header" href="#1st-generation---ergot-derivatives">1st Generation - Ergot Derivatives</a></h3>
<p><strong>Bromocriptine</strong></p>
<p><strong>MOA</strong>: D2 agonist and D1 antagonist</p>
<p><strong>Use</strong>: <strong>Adjunct</strong> to Carb/Levo</p>
<p><strong>Titrate slowly</strong></p>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Orthostasis and arrhythmias</li>
<li>Hallucinations
<strong>Pergolide</strong> (withdrawn from market - heart valve regurgitation)</li>
</ul>
<h3 id="2nd-generation---non-ergot-derivatives"><a class="header" href="#2nd-generation---non-ergot-derivatives">2nd Generation - Non-Ergot Derivatives</a></h3>
<p><strong>Pramipexole &amp; Ropinirole</strong></p>
<p><strong>MOA</strong>: D2 Agonist</p>
<p><strong>Uses</strong>:</p>
<ul>
<li>Effective monotherapy patients</li>
<li>Adjunct to reduce “on-off&quot; effects</li>
</ul>
<p><strong>Pramipexole -&gt; Longer half-life</strong></p>
<p><strong>Contraindicated in pregnancy</strong></p>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Impulse control!</li>
<li>Hallucination &amp; sleepiness</li>
</ul>
<h3 id="amantadine-1"><a class="header" href="#amantadine-1">Amantadine</a></h3>
<p><strong>MOA</strong>:</p>
<ul>
<li>Enhances DA release or blocks DA reuptake, muscarinic antagonist, NMDA receptor antagonist</li>
</ul>
<p><strong>Use</strong>:</p>
<ul>
<li>Effective <strong>Early</strong> monotherapy patients</li>
<li><strong>Adjunct to reduce motor side effects (bradykinesia &amp; rigidity)</strong></li>
</ul>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Hallucinations &amp; insomnia</li>
<li>NNV</li>
</ul>
<h3 id="apomorphine"><a class="header" href="#apomorphine">Apomorphine</a></h3>
<p><strong>MOA</strong>: Dopamine Agonist</p>
<p><strong>Use</strong>: Reduce off time in advanced disease</p>
<p><strong>Emetogenic -&gt; Must administer with antiemetic</strong></p>
<h2 id="adjunct-agents-in-parkinsons"><a class="header" href="#adjunct-agents-in-parkinsons">Adjunct Agents in Parkinson's</a></h2>
<h3 id="maois"><a class="header" href="#maois">MAOIs</a></h3>
<p><strong>Selegiline</strong>
<strong>MOA</strong>: MAOI-B inhibitor - prevents metabolism of DA</p>
<p><strong>Use</strong>:</p>
<ul>
<li>Early monotherapy</li>
<li>Adjunct with Carb/Levo</li>
</ul>
<p><strong>Reduces “Wearing off&quot; time!</strong></p>
<p><strong>Contraindications</strong> TCAs, SSRls, etc.</p>
<p><strong>Side effects:</strong> Insomina, dyskinesia, nausea, headache, cardiac arrhythmias, <strong>HTN</strong></p>
<h3 id="comt-inhibitors"><a class="header" href="#comt-inhibitors">COMT inhibitors</a></h3>
<p><strong>Tolcapone &amp; Entacapone</strong></p>
<p><strong>MOA</strong>:
o Tolcapone -&gt; CNS and peripheral COMT.
o Entacapone -&gt; Peripheral COMT</p>
<p><strong>Use</strong>: <strong>Adjunct for freezing and dyskinesia</strong></p>
<p><strong>Lower L-Dopa dose</strong></p>
<p><strong>Attenuates the wearing-off time</strong></p>
<h3 id="deep-brain-stimulation"><a class="header" href="#deep-brain-stimulation">Deep Brain Stimulation</a></h3>
<p><strong>Uses:</strong></p>
<ul>
<li>Lastline</li>
<li>Improves tremor, rigidity, and bradykinesia</li>
</ul>
<p>Able to reduce L-Dopa dose</p>
<p>Effect lasts 1-3 years</p>
<h1 id="drugs-for-other-movement-disorders"><a class="header" href="#drugs-for-other-movement-disorders">Drugs for Other Movement Disorders</a></h1>
<h3 id="tourettes-syndrome"><a class="header" href="#tourettes-syndrome">Tourette's Syndrome</a></h3>
<p><strong>Neuroleptics</strong>: Haloperidol</p>
<ul>
<li>Very effective &amp; SE
<strong>Alpha-2 agonists</strong>: Clonidine</li>
<li>Transdermal Patch</li>
<li>Rebound HTN when D/C'd</li>
</ul>
<h3 id="amyotrophic-lateral-sclerosis"><a class="header" href="#amyotrophic-lateral-sclerosis">Amyotrophic lateral sclerosis</a></h3>
<p><strong>Baclofen</strong></p>
<p><strong>MOA</strong>: GABAP agonist</p>
<p>Used for <strong>Spasticity</strong></p>
<p><strong>SE</strong>: withdrawal, abuse, overdose</p>
<p><strong>Riluzole</strong>
<strong>MOA</strong>: Decreases glutamate excitotoxicity
<strong>Use</strong>: <strong>Delay onset of ventilator-dependence</strong></p>
<h3 id="benign-essential-tremor"><a class="header" href="#benign-essential-tremor">Benign essential tremor</a></h3>
<p><strong>Anticonvulsant</strong>: Primidone</p>
<p>MOA: Barbiturate like</p>
<p><strong>B-Blockers</strong></p>
<h1 id="antipsychotic-agents---typicals-fyi"><a class="header" href="#antipsychotic-agents---typicals-fyi">Antipsychotic Agents - Typicals (FYI)</a></h1>
<h4 id="general-characteristics"><a class="header" href="#general-characteristics">General Characteristics</a></h4>
<p><strong>MOA</strong>: Block D2 receptors in Basal Ganglia, Frontal lobe, Limbic system</p>
<p><strong>Use</strong>: 2nd line for Schizophrenia after atypicals D2 SE &amp; Anticholinergic SE related to Potency</p>
<p><strong>SE</strong>:</p>
<ul>
<li><strong>D2 blockade</strong>
<ul>
<li>Motor side effects (<a href="https://en.wikipedia.org/wiki/Extrapyramidal_symptoms">EPS</a>, TD)</li>
<li>Prolactinemia (Pituitary)</li>
<li>NMS</li>
</ul>
</li>
<li>Anticholinergic: Dry mouth, constipation, Urinary retention , mydriasis</li>
<li>Alpha blockade: Orthostasis &amp; Impotence</li>
<li>Histamine blockade: Sedation</li>
<li>DAJSHT: Anti-Emetic (Gut)</li>
<li>Prolong QT</li>
</ul>
<h4 id="typical-antipsychotics"><a class="header" href="#typical-antipsychotics">Typical Antipsychotics</a></h4>
<p><strong>Chlorpromazine</strong> (Low Potency)</p>
<ul>
<li>MOA: Blocks D2, <strong>alpha 1</strong>, <strong>Histamine</strong>, Muscarinic</li>
<li>More Anticholinergic Symptoms</li>
</ul>
<p><strong>Haloperidol</strong> (High Potency)</p>
<ul>
<li>Mostly blocks D2</li>
<li>More <a href="https://en.wikipedia.org/wiki/Extrapyramidal_symptoms">EPS</a> symptoms</li>
</ul>
<h1 id="parkinsons-disease-treatment-guidelines"><a class="header" href="#parkinsons-disease-treatment-guidelines">Parkinson’s Disease Treatment Guidelines</a></h1>
<img src="https://accesspharmacy.mhmedical.com/data/books/dipi9/dipi9_c043f004.png" width="600" height="600" />
<p><strong>New Diagnosis</strong></p>
<ul>
<li>MAO-I</li>
<li>D2 agonist</li>
</ul>
<p><strong>Early Onset</strong></p>
<ul>
<li>Amantadine</li>
</ul>
<p><strong>Gold Standard</strong> Carbidopa / Levodopa</p>
<p><strong>Dyskinesia</strong></p>
<ul>
<li>MOA-I</li>
<li>COMT</li>
<li>Deep brain stimulation</li>
</ul>
<h1 id="anti-epileptic-drugs"><a class="header" href="#anti-epileptic-drugs">Anti-Epileptic Drugs</a></h1>
<ul>
<li><a href="pharmacology/43.html#anticonvulsant-overview">Anticonvulsant Overview</a>
<ul>
<li><a href="pharmacology/43.html#partial">Partial</a></li>
<li><a href="pharmacology/43.html#tonic-clonic">Tonic-Clonic</a></li>
<li><a href="pharmacology/43.html#absence">Absence</a></li>
<li><a href="pharmacology/43.html#status-epilepticus">Status Epilepticus</a></li>
</ul>
</li>
<li><a href="pharmacology/43.html#anticonvulsant-drugs">Anticonvulsant Drugs</a>
<ul>
<li><a href="pharmacology/43.html#phenytoin">Phenytoin</a></li>
<li><a href="pharmacology/43.html#carbamazepine">Carbamazepine</a></li>
<li><a href="pharmacology/43.html#valproic-acid-valproate-depakote">Valproic Acid (Valproate, Depakote)</a></li>
<li><a href="pharmacology/43.html#barbiturates">Barbiturates</a></li>
<li><a href="pharmacology/43.html#benzodiazepines">Benzodiazepines</a></li>
<li><a href="pharmacology/43.html#complementary-agents---partial-and-tonic-clonic">Complementary Agents - Partial and Tonic-Clonic</a>
<ul>
<li><a href="pharmacology/43.html#lamotrigine">Lamotrigine</a></li>
<li><a href="pharmacology/43.html#felbamate">Felbamate</a></li>
<li><a href="pharmacology/43.html#gabapentin">Gabapentin</a></li>
<li><a href="pharmacology/43.html#pregabalin">Pregabalin</a></li>
<li><a href="pharmacology/43.html#topiramate">Topiramate</a></li>
<li><a href="pharmacology/43.html#levetiracetam">Levetiracetam</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<h1 id="anticonvulsant-overview"><a class="header" href="#anticonvulsant-overview">Anticonvulsant Overview</a></h1>
<h2 id="partial"><a class="header" href="#partial">Partial</a></h2>
<p>1st Line - <strong>Carbamazepine</strong></p>
<p>2nd Line - All <strong>Except Ethosuximide</strong></p>
<h2 id="tonic-clonic"><a class="header" href="#tonic-clonic">Tonic-Clonic</a></h2>
<p>1st Line - <strong>Phenytoin and Valproic Acid</strong></p>
<p>2nd Line - Phenobarbital, Carbamazepine, Topiramate, Lamotrigine, Levetiracetam</p>
<h2 id="absence"><a class="header" href="#absence">Absence</a></h2>
<p>1st Line — <strong>Ethosuximide</strong></p>
<p>Presenting w/ Tonic-Clonic - <strong>Valproic acid</strong></p>
<p>2nd Line - Lamotrigine</p>
<h2 id="status-epilepticus"><a class="header" href="#status-epilepticus">Status Epilepticus</a></h2>
<p>1st Line - <strong>Benzodiazepines</strong></p>
<p>2nd Line - Phenytoin</p>
<h1 id="anticonvulsant-drugs"><a class="header" href="#anticonvulsant-drugs">Anticonvulsant Drugs</a></h1>
<h2 id="phenytoin"><a class="header" href="#phenytoin">Phenytoin</a></h2>
<p><strong>MOA</strong>: prolongs Na+ channel inactivation</p>
<p><strong>Uses:</strong></p>
<ul>
<li>Partial and Tonic Clonic</li>
<li>NOT absence</li>
</ul>
<p><strong>Pharmacokinetics</strong></p>
<ul>
<li><strong>Biphasic -&gt; 1st then Zero order kinetics</strong></li>
<li>IV/IIM (Fosphenytoin)</li>
</ul>
<p><em><strong>Interactions</strong></em>
o Inducers of CYP (barbiturates and carbamazepine
o Highly plasma protein bound
o Decrease effectiveness of PO contraceptives</p>
<p><strong>Therapeutic levels (Monitor blood levels)</strong></p>
<p><strong>Side Effects</strong></p>
<ul>
<li>Acute toxicity
<ul>
<li><strong>Nystagmus</strong>, diplopia and ataxia,</li>
<li>Gidisturbances, confusion, cerebellar atrophy</li>
</ul>
</li>
<li>Chronic toxicity
<ul>
<li><strong>Gingival hyperplasia &amp; hirsutism</strong></li>
<li>Vitamin D and K abnormality</li>
<li>Rash</li>
<li>Agranulocytosis</li>
<li>Megaloblastic anemia</li>
<li>Hodgkins like syndrome</li>
</ul>
</li>
</ul>
<h2 id="carbamazepine"><a class="header" href="#carbamazepine">Carbamazepine</a></h2>
<p>MOA: Prolongs Na+ channel refractory period</p>
<p><strong>Uses:</strong></p>
<ul>
<li><strong>First line Partial</strong></li>
<li>Tonic-Clonic (Not Absence)</li>
<li><strong>Trigeminal Neuralgia</strong> &amp; Bipolar</li>
</ul>
<p><strong>Drug Interactions</strong></p>
<p>Induces CYP metabolism (Phenytoin, primidone, ETX, VA, clonazepam, POC)</p>
<p>Metabolite -&gt; <strong>Oxcarbazepine</strong></p>
<ul>
<li>10,11 epoxide metabolite</li>
<li><strong>Less Potent, but better toxicity profile</strong></li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li>Acute Toxicity
<ul>
<li>Stupor and coma, convulsions, irritability and rash (Hypersensitivity)</li>
</ul>
</li>
<li>Chronic Toxicity
<ul>
<li>Diplopia and ataxia, Gl upset, unsteadiness, drowsiness, and fluid retention.</li>
<li>Aplastic Anemia and Agranulocytosis</li>
<li>Stevens-Johnson Syndrome (HLA-B*1502)</li>
</ul>
</li>
</ul>
<h2 id="valproic-acid-valproate-depakote"><a class="header" href="#valproic-acid-valproate-depakote">Valproic Acid (Valproate, Depakote)</a></h2>
<p><strong>MOA:</strong></p>
<ul>
<li>Inhibition of Na+ and T-type Ca2+ channels and GABA-T.</li>
<li>Stimulation of GAD (GABA synthesis)</li>
</ul>
<p><strong>Uses:</strong></p>
<ul>
<li>Partial Seizures, Absence and Tonic-clonic</li>
</ul>
<p><strong>Valproate &gt; Ethosuximide:</strong></p>
<ul>
<li>Patient with absence turning into tonic-clonic</li>
</ul>
<p><strong>Monitor blood levels</strong></p>
<p><strong>Pharmacokinetics</strong></p>
<ul>
<li>Metabolized in Liver</li>
<li>90% protein bound</li>
<li>Inhibits metabolism of phenytoin, carbamazepine, and phenobarbital</li>
</ul>
<p><strong>Side Effects</strong></p>
<ul>
<li>N/V, weight gain, Gl upset, sedation</li>
<li>Hepatotoxicity: (rare) Patients &lt; 2 y/o. Polypharmacy</li>
<li><strong>Birth Defects: Spina bifida, cardiovascular, orofacial defects, digital defects</strong>
<ul>
<li>Modulates folic acid</li>
</ul>
</li>
</ul>
<h2 id="barbiturates"><a class="header" href="#barbiturates">Barbiturates</a></h2>
<p><strong>Phenobarbital</strong></p>
<p><strong>MOA:</strong></p>
<ul>
<li>Inactivates VG Na+ Channel</li>
<li><em><em>GABA</em> Receptor agonist (Duration)</em>*</li>
<li>AMPA Antagonist</li>
</ul>
<p><strong>Uses:</strong></p>
<ul>
<li>Partial and Tonic-Clonic (Not Absence)</li>
<li>Young kids and Status epilepticus</li>
</ul>
<p><strong>Monitor blood levels</strong></p>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Sedation, ataxia and nystagmus, <strong>respiratory depression, rash and exacerbation of porphyria</strong></li>
<li>Tolerance -&gt; toxicity</li>
</ul>
<h2 id="benzodiazepines"><a class="header" href="#benzodiazepines">Benzodiazepines</a></h2>
<p><strong>MOA:</strong></p>
<ul>
<li>GABA&quot; Receptor Modulator</li>
<li>Increase frequency of CL- channel opening</li>
</ul>
<p><strong>SE:</strong> Sedation, tolerance, withdrawal, addiction</p>
<p><strong>Diazepam</strong></p>
<p><strong>Use</strong>: status epilepticus</p>
<p><strong>Clonazepam</strong></p>
<p><strong>Use</strong>: Absence</p>
<h2 id="complementary-agents---partial-and-tonic-clonic"><a class="header" href="#complementary-agents---partial-and-tonic-clonic">Complementary Agents - Partial and Tonic-Clonic</a></h2>
<h3 id="lamotrigine"><a class="header" href="#lamotrigine">Lamotrigine</a></h3>
<p><strong>MOA</strong>: Inhibits Na+ (some Ca2+)</p>
<p><strong>Uses:</strong></p>
<ul>
<li>Adjunct for refractory patients</li>
<li>Tonic-Clonic Kids &gt; 2 y/o</li>
</ul>
<p><strong>Side Effects: Rash</strong></p>
<h3 id="felbamate"><a class="header" href="#felbamate">Felbamate</a></h3>
<p><strong>MOA</strong>: ??? (GABA* modulator / NMDA Blocker)</p>
<p><strong>Uses:</strong></p>
<ul>
<li>Uncontrolled partial seizures</li>
<li>Adjunct for Tonic-Clonic and Partial</li>
</ul>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Aplastic anemia, severe hepatitis,</li>
</ul>
<p><em><strong>Only refractory cases</strong></em></p>
<h3 id="gabapentin"><a class="header" href="#gabapentin">Gabapentin</a></h3>
<p><strong>MOA:</strong> GABA analog &amp; Inhibits VGCa+</p>
<p><strong>Uses:</strong> Adjunct Partial Seizures &amp; Neuropathic pain</p>
<p><em>Exacerbate myoclonic seizures</em></p>
<p>Side Effects: Somnolence, dizziness, ataxia</p>
<p><strong>Renal excreted</strong></p>
<h3 id="pregabalin"><a class="header" href="#pregabalin">Pregabalin</a></h3>
<p><strong>MOA</strong>: GABA Analog</p>
<p><strong>Uses:</strong> Partial Seizures &amp; Neuropathic pain</p>
<p><strong>“Euphoria” -&gt; Actually...</strong></p>
<ul>
<li>Clinical trial found “drug liking&quot; effect...</li>
</ul>
<h3 id="topiramate"><a class="header" href="#topiramate">Topiramate</a></h3>
<p><strong>MOA:</strong> Prolongs Na+ channel refractory period &amp; AMPA antagonism, etc.</p>
<p><strong>Uses:</strong></p>
<ul>
<li>Adjunct for Tonic-Clonic and Partial</li>
<li>Headaches &amp; Migraines</li>
<li>Eating disorders</li>
<li>Etc.</li>
</ul>
<p><strong>Side Effects:</strong> <strong>Somnolence</strong>, fatigue and dizziness, <strong>cognitive slowing</strong>, psychiatric symptoms, <strong>weight loss</strong></p>
<h3 id="levetiracetam"><a class="header" href="#levetiracetam">Levetiracetam</a></h3>
<p><strong>Uses:</strong> Adjunct for Tonic-Clonic and Partial</p>
<p><strong>Side Effects:</strong></p>
<ul>
<li>Mood or behavioral changes</li>
<li>Benign side effect profile</li>
</ul>
<h1 id="headaches"><a class="header" href="#headaches">Headaches</a></h1>
<h1 id="stimulants-and-weight-loss"><a class="header" href="#stimulants-and-weight-loss">Stimulants and Weight Loss</a></h1>
<h1 id="opioids"><a class="header" href="#opioids">Opioids</a></h1>
<h1 id="local-anesthetics"><a class="header" href="#local-anesthetics">Local Anesthetics</a></h1>
<h1 id="general-anesthesia"><a class="header" href="#general-anesthesia">General Anesthesia</a></h1>
<h1 id="drugs-of-abuse--ethanol"><a class="header" href="#drugs-of-abuse--ethanol">Drugs of Abuse &amp; Ethanol</a></h1>
<h1 id="anti-anxiety--sleep-pharmacology"><a class="header" href="#anti-anxiety--sleep-pharmacology">Anti-Anxiety / Sleep Pharmacology</a></h1>
<h1 id="bipolar-lithium-pharmacology"><a class="header" href="#bipolar-lithium-pharmacology">Bipolar (Lithium) Pharmacology</a></h1>
<h1 id="anti-depressants"><a class="header" href="#anti-depressants">Anti-Depressants</a></h1>
<h1 id="anti-psychotics"><a class="header" href="#anti-psychotics">Anti-Psychotics</a></h1>

                    </main>

                    <nav class="nav-wrapper" aria-label="Page navigation">
                        <!-- Mobile navigation buttons -->
                        

                        

                        <div style="clear: both"></div>
                    </nav>
                </div>
            </div>

            <nav class="nav-wide-wrapper" aria-label="Page navigation">
                

                
            </nav>

        </div>

        

        

        

        
        <script type="text/javascript">
            window.playground_copyable = true;
        </script>
        

        

        
        <script src="elasticlunr.min.js" type="text/javascript" charset="utf-8"></script>
        <script src="mark.min.js" type="text/javascript" charset="utf-8"></script>
        <script src="searcher.js" type="text/javascript" charset="utf-8"></script>
        

        <script src="clipboard.min.js" type="text/javascript" charset="utf-8"></script>
        <script src="highlight.js" type="text/javascript" charset="utf-8"></script>
        <script src="book.js" type="text/javascript" charset="utf-8"></script>

        <!-- Custom JS scripts -->
        

        
        
        <script type="text/javascript">
        window.addEventListener('load', function() {
            window.setTimeout(window.print, 100);
        });
        </script>
        
        

    </body>
</html>
